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1SOMMAEY
Studies in this thesis investigated various aspects of nitrogen 
metabolism in ruminant livestock. Nitrogen balance and digestive 
efficiency studies were conducted in order to obtain indicators of the 
apparent efficiency of absorption and retention of dietary nitrogen, 
while studies using radioisotopes provided more detailed information on 
the metabolism of nitrogen.
During the course of the work described here techniques were 
developed for the continuous intravenous and intraruminal infusion of 
substances into cattle and sheep respectively. A simplified polythene 
chute system to facilitate the collection of low dry matter calf faeces 
was also developed.
Section I
In this section the current literature relating to the use of 
exogenous beta-adrenergic agonists in farm livestock is reviewed.
These substances, termed 'repartitioning agents' alter the partitioning 
of nutrients such that lean tissue accretion is increased at the 
expense of fat deposition. This may produce the additional benefits of 
improved food conversion efficiency and daily liveweight gains.
Possible modes of action and adverse effects on meat quality are 
discussed.
Experimental work (Experiment I) describes nitrogen balance and 
digestive efficiency studies conducted with young steers given 
repartitioning agents. Ten castrated male Friesian calves (c. 120 kg 
liveweight) were restrained in metabolism stalls for fifteen weeks 
during which time they received continuous intravenous infusions of the 
beta-agonists clenbuterol (1 mg/day), bitolterol (1, 5, and 25 mg/day) 
and physiological saline (0.9% w/v). The experimental design was that 
of two simultaneous 5 x 5  Latin squares and each calf received each 
treatment for a period of three weeks. Separate digestibility and 
nitrogen balance studies were conducted during the second and third 
weeks of each period. Neither beta-agonist had any significant effect 
on voluntary feed intake, digestive efficiency or faecal nitrogen 
excretion. Urinary nitrogen excretion was significantly (P<0.001) 
reduced by clenbuterol (1 mg/day) and bitolterol (25 mg/day) giving 
rise to significant (PC0.01) increases in nitrogen retention. The 
effect of treatment on final carcass composition could not be
2differentiated as the different treatments were incorporated in a Latin 
square design. However the external appearance of treated steers 
displayed more musculature in the hind quarters than that of similar 
animals maintained on the same diet as possible replacements suggesting 
an improvement in the lean percentage of the carcass.
Section H
This section is concerned with the pathophysiological consequences 
of gastrointestinal nematode infection in cattle. In Western Europe 
the most abundant species are Qstertagia ostertagi and Cooperia 
oncophora which are typically located in the abomasum and small 
intestine respectively. The life cycle and pathogenesis of these 
nematodes is described together with the pathophysiological changes 
which precipitate clinical disease.
Three separate studies investigated the pathophysiological and 
parasitological consequences of gastrointestinal helminth infection 
established using multiple inoculations of either fresh or 
cold-conditioned 0. ostertagi larvae or a mixed infection of 0. 
ostertagi and C. oncophora. In each study a morantel sustained 
release bolus (MSRB) was administered to one group of infected calves 
in order to limit larval establishment (Jones, 1983).
The experimental design for each of the studies followed that of 
Armour et al (1987a). TWenty-five castrated male Friesian calves (c. 
120 kg liveweight) which had been reared under helminth-free conditions 
were allocated to three treatment groups.
Group A calves (clean) were maintained free of parasites. Five 
were used as control animals for digestion and nitrogen economy studies 
and a further two for radioisotopic investigations.
Group B calves (MSRB) were each given a morantel sustained release 
bolus (Paratect, Pfizer) and were subsequently dosed daily per os for 
six weeks with either 2000 fresh 0. ostertagi, 2000 cold-conditioned
O. ostertagi or 2000 0. ostertagi and 10,000 C. oncophora 
infective larvae. Five calves were allocated to digestion studies, two 
to pathophysiological investigations using radioisotopes and two 
necropsied 21 and 42 days after the initial infection.
Group C calves (infected) were similarly treated, without prior 
MSRB administration, with five calves allocated for digestion studies, 
two for radioisotopic work and two for necropsy during the course of 
the trial (days 21 and 42).
3Following an acclimatisation period of one week in metabolism 
stalls digestive efficiency and nitrogen balance data was obtained from 
four calves in each of the treatment groups clean, MSRB and infected 
during days 14-21, 35-42, 56-63 and 77-84. Radioisotopic 
investigations using tritiated water (TOH) to measure body water 
metabolism, and -^I-albumin and ^CrC^ to measure albumin 
metabolism and leakage of plasma into the gastrointestinal tract were 
conducted during days 35-47 and 70-82. All calves were weighed 
regularly and blood and faecal samples were obtained at weekly 
intervals for biochemical, haematological and parasitological analyses. 
Remaining calves in metabolism and isotope studies were necropsed on 
day 84 for parasitological examination of the digestive tract.
Daily inoculation of calves with 2000 0. ostertagi larvae 
(Experiment Ila) produced mild diarrhoea in infected untreated animals. 
These calves did not become inappetent and there were no significant 
differences in daily liveweight gain, digestive efficiency or nitrogen 
economy between treatment groups. However radioisotopic studies 
revealed increased faecal clearances of both - ^ I - a l b u m i n  an(g 
•^^ CrCl^  and an elevated catabolic rate of albumin for infected 
compared to clean control calves particularly during the first 
recording period. Small adverse changes in pathophysiological values 
were apparent when comparing MSRB treated and clean control calves.
A preliminary study (Experiment lib) demonstrated that short-term 
storage of 0. ostertagi infective larvae at 4°C resulted in an 
interruption in normal parasitic development akin to Pre-Type II 
ostertagiasis. Calves inoculated with 2000 cold-conditioned O. 
ostertagi larvae (Experiment lie) displayed no symptoms typical of 0. 
ostertagi infection and there were no significant differences in 
nitrogen economy or pathophysiological parameters between treatment 
groups. Interestingly the overall apparent digestibility of each of 
the major proximate feed fractions was significantly reduced for clean 
control compared to infected and MSRB treated calves. This may be 
attributed to interference with rumen volatile fatty acid and abomasal 
HC1 production by fenbendazole which was used at fortnightly intervals 
in this study in order to ensure that the clean calves remained 
parasite free.
A concurrent infection of O. ostertagi and C. oncophora 
(Experiment lid) produced clinical symptoms in infected untreated 
calves which ranged from a reduced rate of eating and mild diarrhoea in
4some individuals to almost complete inappetence, lethargy, profuse 
watery diarrhoea and a dramatic liveweight loss in others. Symptoms 
subsided towards the end of the trial but the appearance of the 
infected calves was greatly inferior to that of the clean and MSRB 
treated groups at necropsy on day 84. Examination of digestive 
efficiency data revealed a consistent and significant depression in the 
apparent digestibilities of the crude protein, ether extract and gross 
energy fractions for infected compared to clean and MSRB treated 
calves, A significant (P<0.01) reduction in nitrogen retention for 
infected calves during days 35-42 and 56-63 was attributable to 
increases in both faecal and urinary nitrogen Toss. Pathophysiological 
parameters measured using radioisotopes revealed marked disturbances in 
the metabolism of infected, and to a lesser extent MSRB treated calves 
compared to clean controls which persisted until the end of the 
experiment. For infected calves elevated faecal clearances of both 
^albumin and ^CrC^, an  ^consequent increases in the 
catabolic rate of albumin were associated with hypoalbuminaemia and 
hypoproteinaemia.
Parasitological examination of the digestive tracts at necropsy 
revealed a higher establishment of 0. ostertagi when given as a mixed 
rather than a monospecific infection in both infected and MSRB treated 
calves. Larger and more sustained elevations in plasma pepsinogen 
levels provided evidence of more persistent abomasal damage for the 
concurrent infection. Comparison of data obtained in this series of 
studies and that from a similar study using a monospecific C. 
oncophora infection (Armour et al, 1987a) reveals that the adverse 
effects of 0. ostertagi and C. oncophora in combination far exceed 
those of either monospecific infection. This is possibly attributable 
to the enhanced establishment achieved by both species, together with 
the greater total area of mucosal damage and consequent reduction in 
the ability of the gastrointestinal tract to compensate for localised 
damage.
Prior administration of a MSRB limited larval establishment, the 
anthelmintic effect apparently being directed against adult worms.
This resulted in a marked reduction in faecal egg output compared to 
infected controls.
5Section III
The epidemiology of 0, ostertagi and C. oncophora, together 
with that of the sheep nematode Qstertagia circumcincta are 
described. Measures for the prophylaxis and treatment of helminth 
disease in both cattle and sheep are discussed with particular emphasis 
on the avoidance of high levels of pasture larval contamination.
The experimental work employed a modification of the system 
developed for the continuous intravenous infusion of beta-agonists into 
cattle to investigate the effects of titrated doses of intraruminally 
adminstered levamisole hydrochloride on 0. circumcincta infection in 
lambs (Experiment III). Hiirty-six parasite naive crossbred lambs (c. 
35 kg liveweight) were allocated to six equal treatment groups. Lambs 
in groups 1-5 were daily dosed per os with 4000 0. circumcincta 
infective larvae for 21 days while those in group 6 were maintained as 
a parasite-free control. In addition lambs in groups 2-5 received 
infusions of levamisole hydrochloride in solution in physiological 
saline at rates of 1.0, 1.5, 2.0 and 3.0 mgAg/day for 24 days 
commencing on the first day of larval inoculation. Lambs were housed 
in metabolism stalls and separate digestibility and nitrogen balance 
studies were conducted during days 0-7, 7-14, 14-21 and 21-28. Half of 
the lambs in each treatment group were necropsied on day 24, and the 
remaining lambs on day 28 for parasitological examination of the 
digestive tract.
No clinical signs of 0. circumcincta infection were seen in any 
of the lambs and there were no statistically significant differences in 
nitrogen economy between treatment groups. However over the whole 28 
day period the apparent digestibilities of the dry matter, crude 
protein, crude fibre and ash proximate fractions were significantly 
(P<0.05) reduced for lambs receiving 3.0 mg levamisole 
hydrochlorideAg/day, compared to the clean control. The apparent 
digestibilities of the dry matter and crude fibre were also 
significantly (P<0.05) reduced for infected compared to clean control 
lambs. Higher daily doses of levamisole resulted in increased 
reductions in worm burdens at necropsy compared to the infected control 
but it seems likely that levamisole, like the substituted 
benzimidazoles, interferes with ruminant digestion when used 
continuously at levels approaching that required for efficient 
prevention of parasite establishment.
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8A. Experimental Animals and Management
1. Bovine studies
Castrated male Friesians which had been reared indoors were used 
for the bovine studies described in this thesis. Each separate study 
involved a separate group of animals, but all groups had an initial 
mean liveweight of approximately 120 kg and an initial mean age of 
between three and four months. For each study animals were allocated 
to treatment groups on the basis of liveweight such that the mean 
liveweight and the liveweight range was similar for all treatments. 
Initially calves were loose housed together in a strawbedded pen and 
individually fed using head locking feeders. During the 
parasitological studies described in Section II, clean control calves 
were maintained in a separate building from calves on infected 
treatments to avoid possible cross contamination via soiled bedding 
material. However during experiments lib and lie both clean and 
infected calves were housed together and the parasite-free status of 
the clean calves was maintained by regular anthelmintic treatment.
During metabolism studies calves were accomodated in standard 
metabolism stalls while those maintained as possible replacements 
remained in the loose housed accomodation.
Ihe experimental diet consisted of a grass/cereal mix/mineral 
complete cube preparation ('Superstar Cubes', Hamlyn Milling, Balgarvie 
Mill, Scone, Perthshire). In order to provide controlled intake of 
long fibre this was supplemented by barley siftings. Griseofulvin 
(Fulcin, Coopers Animal Health) was also admixed in the diet for seven 
days prior to the commencement of each experiment to control ringworm. 
Ringworm lesions present during the experiments were treated using 
topical applications (Mycophyt, Gist-Brocades and Imaverol, Janssen). 
All calves were vaccinated against infectious bovine rhinitis (Imuresp, 
Smith-Kline) on arrival.
2. Ovine studies.
The study described in Section III was conducted using parasite 
naive crossbred lambs of approximately 35 kg liveweight, which had been 
reared indoors. The lambs were randomly allocated to treatment groups 
on the basis of liveweight and sex such that the distribution on each 
treatment was similar. Initially all animals were housed in individual 
peat bedded floor pens for 14 days prior to the commencement of the 
experiment during which time lambs in four of the treatment groups were
9surgically fitted with indwelling ruminal catheters. Catheterized 
lambs and male lambs from the remaining two treatments were 
subsequently moved to metabolism stalls for nitrogen balance studies, 
digestive efficiency studies being conducted on all lambs. No possible 
replacements were maintained.
The experimental diet consisted of grassnuts and water was 
available ad libitum.
B. Digestibility and Nitrogen Balance Studies
1. Collection of urine and faeces
During digestibility and nitrogen balance studies animals were 
normally restrained in metabolism stalls. Sheep were fitted with a 
conventional body harness. Faeces from males was collected in a rubber 
bag and that from females was collected in a nylon mesh bag which 
allowed the through-passage of urine. Urine passed through the mesh 
floor of the metabolism stall and for males was funnelled through a 
glass wool filter into a collection iug. Urine from female sheep was 
not collected.
Calves were fitted with a specially designed body harness. Faeces 
was collected in a polythene lined canves bag or by a polythene chute 
system which increased collection efficiency during periods when 
parasitised animals were diarrhoeic. Urine passed through the slatted 
metal floors of the metabolism stalls onto sloping polythene-lined 
metal trays and into collection receptacles. Rubber cow matting was 
fitted at the front of the metabolism stalls to help maximise calf 
comfort.
2. The design of a novel calf body harness
The experiment decribed in Section I required calves to be fitted 
with an indwelling jugular vein catheter during metabolism studies.
The calf harness shown in Figure 1 was designed for this experiment and 
was used subsequently. It had a minimum of strapping in the neck 
region and was made of leather with the exception of the wide canvas 
girth strap which provided the main support for the faecal collection 
bag. An important feature was the foam back pad positioned either side 
of the calf's spine, reducing pressure in this area. A canvas faecal 
collection bag was attached to the harness by means of a tie to the 
dorsal cross-over and two quick release clips attached to buckles on 
the lateral straps. The dorsal tie slightly increased the time
10
11
point of attachment- 
of chute to harness
— open ended 
canvas faecal bag
calf harnesa
//,
pre-weighed  
polythene chute
metabolism stall-
pre-weighed bucket
Figure 2. A polythene chute system for the collection of 
low dry matter calf faeces.
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required to empty the collection bags compared to a three-clip 
attachment, but was necessitated because a dorsal clip supported the 
bag in a lower than ideal position.
3. An improved technique for the collection of low dry matter calf 
faeces.
Brockway (1979) first described a method for the collection of 
faeces from steers which utilized a long polythene chute in place of 
the conventional bag carried by the animal. The increasing weight of 
faeces collected in conventional bags contributes greatly to the 
causation of sores under the supporting harness and may also lead to a 
shifting of the harness resulting in spillage. These problems are 
exacerbated during the collection of low dry matter faeces. Thus in 
order to maintain collection efficiency, conventional faecal bags were 
replaced by a modification of this method during periods when calves 
became diarrhoeic.
The faecal collection chute is shown in Figure 2. The proximal 
part of the chute was comprised of a conventional canvas calf faecal 
collection bag and polythene liner, the bottoms of which were cut open. 
A second liner, cut square and open at both ends was taped onto the 
first liner forming the chute, the distal end of which rested on the 
bottom of a bucket suspended from the back of the metabolism stall. 
Suspension of the bucket in this manner allowed it to tilt if necessary 
when the calf lay down, ensuring that the bottom of the chute remained 
in situ. Attachment of the chute to the calf harness was as 
described for the conventional canvas bag with the addition of two 
elastic straps between the calf's back legs running from the bottom of 
the chute to a strap around the stifle region. These additional straps 
ensured good contact between the chute and the calf's skin under the 
anus and greatly improved faecal collection efficiency.
4. Daily routine during digestibility and nitrogen balance studies.
Digestibility and nitrogen balance measurements were conducted 
over seven day collection periods. Experimental animals were given 
their daily ration in two feeds, one at 07.30h and the other at 16.00h. 
Sheep feed was preweighed into paper bags in batches and stored in 
metal bins until required. Calf feed was weighed out directly at each 
feeding time. Any feed refusals were weighed and recorded. Water was 
available ad libitum.
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Faecal collection bags were emptied at each of the feeding times 
and additionally at 21.00h for calves. Sheep faeces were emptied 
directly into a preweighed container. The output for each calf for 
each 24 hour period was collected in a small pre-weighed bucket and 
weighed daily at 09.00h before bulking in a large container. Where 
calves were fitted with faecal chutes the suspended bucket and chute 
were preweighed. The faecal output for each 24 hour period was 
collected directly and the chute was replaced daily at 09.00h at which 
time the bucket and faecal contents were removed for weighing and 
bulking. Liners in conventional calf faecal collection bags were 
replaced on every second day.
At each of the feeding times the filtered sheep urine collected in 
jugs below the metabolism stalls was emptied into bulk containers 
acidified with 100 ml 5N HC1. Jugs were replaced and stalls washed 
with minimal amounts of water, the washings being bulked together with 
the urine. Collection receptacles for calf urine were emptied at 07.30 
h, 16.00 h and 21.00 h, the urine being filtered through glass wool 
into bulk containers acidified with 200 ml 5N HC1. Again stalls were 
washed with minimal amounts of water and the washings were bulked 
separately from the urine in containers acidified with 100 ml 5N HC1.
5. Preparation of feed, faecal, urine and washings samples for 
chemical analysis.
Random samples from each bag of feed used during each collection - 
period were taken and stored together in a small sealed container until 
the end of that period when the composite sample was chemically 
analysed.
The bulked faeces obtained from each animal during each seven day 
collection period was thoroughly mixed and suitable aliquots were 
retained for analyses. Approximately 2 kg was retained for dry matter 
(DM), crude fibre (CF), ether extract (EE), ash and gross energy (GE) 
determination, and 200 g was made into a slurry with water and 4 ml 
toluene for nitrogen estimation (C.A.B., 1961).
Bulked urine samples for each animal were thoroughly mixed and two 
separate 200 ml samples were retained for nitrogen determination. 
Washings were similarly treated but only one 200 ml sample was 
retained.
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C. Chemical Analyses of Feed, Faeces, Urine and Washings Samples
All the analytical methods used were officially established 
procedures i.e. MAFF et al 1973; Fertilizer and Feedingstuffs 
Regulations 1968, 1976 and 1982.
1. Dry matter (DM)
The dry matter in food and faecal samples was determined by 
heating known quantities (2 kg) in a hot air oven at 80°C for 
approximately 48 hours until a constant weight was attained. Dry
material was ground using an 8 inch laboratory hammer mill with a 2 mm
screen (Christy and Norris, England) and a sample of approximately 200 
g was taken for subsequent laboratory analyses.
2. Nitrogen and crude protein
Total nitrogen (N) in dried feed, faecal slurries and urine 
samples was measured by an automated semi-micro Kjeldahl technique 
(Kjell-Foss Automatic 16210). For feed and faeces crude protein was 
calculated as the product of total nitrogen and 6.25.
3. Ether extract (EE), crude fibre fCF) and ash
Ihe ether extract, crude fibre and ash contents of food and faeces 
were determined using standard methods (The Fertilizer and 
Feedingstuffs Regulations, 1975).
4. Gross Energy (GE)
The gross energy content of food and faeces was measured using a 
Gallenkamp automatic adiabatic bomb calorimeter equipped with a digital 
data systems calorific value microprocessor. Calibration was performed 
using benzoic acid (Thermochemical Standard, BDH). Both samples and 
benzoic acid were pelleted using a die operated by a hydraulic press.
5. Organic Matter (OM)
The organic matter content of food and faeces (gAg) was 
calculated as the difference between the dry matter and the ash content 
(gAg).
6. Nitrogen free extract (NFE)
The nitrogen free extract (gAg) of food and faeces was calculated 
as the difference between the organic matter (gAg) and the sum of the
15
crude protein, crude fibre and ether extract contents (gAg) •
D. Calculation of Digestibility Coefficients and Nitrogen Balance
'The digestibility of a food is most accurately defined as that 
proportion which is not excreted in the faeces and which is, therefore, 
assumed to be absorbed by the animal1 (McDonald, Edwards and 
Greenhalgh, 1981). It is commonly expressed in terms of dry matter as 
a coefficient e.g.
DM digestibility coefficient = amount of DM apparently absorbed
amount of DM in feed
The coefficients for each proximate fraction of the DM, eg CP, CF, 
EE, etc. can be calculated in the same way.
Although the proportion of food not excreted in the faeces is 
commonly assumed to be equal to that which is absorbed from the 
digestive tract there are objections to this assumption, particularly 
in the case of ruminants. For example, in ruminants methane arising 
from the fermentation of carbohydrate is lost by eructation and thus is 
not absorbed. This results in an over-estimation of the digestible 
carbohydrate and digestible energy of the feed. Also because of the 
presence of metabolic faecal nitrogen in the faeces, i.e. nitrogen 
arising from non dietary sources such as sloughed epithelial cells, 
enzymes etc., there is an under-estimation of the proportion of 
nitrogen absorbed by the animal. Ether extractable substances and 
minerals of metabolic origin are also found in the faeces, again 
leading to an under-estimation of their absorption. Consequently, the 
values obtained in digestibility studies are refered to as 'apparent' 
digestibility coefficients.
In this thesis, N balance is expressed as g N retained or lost on 
a daily basis and was calculated using the following equations 
N balance (g N) = g N feed - (g N faeces + g N urine)
Where useful, N balance data may also be expressed as a percentage of 
the dietary N intake.
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E. Infusion Studies
1. A system for the continuous intravenous infusion of beta-adrenergic 
agonists into cattle
A method for the accurate continuous infusion of substances over 
an extended time period was developed in order to assess the 
effectiveness of long term vascular administration of beta-agonists to 
growing cattle. During the period of active infusion digestibility and 
nitrogen balance studies were conducted and these are fully described 
in Section I. The infusion system was developed to simultaneously 
control the fluid flow to ten calves accomodated in metabolism stalls. 
Each calf was fitted with an indwelling jugular vein catheter and in 
order to prevent interference with this, the conventional headlocking 
restraint mechanism of the metabolism stalls was removed. Each calf 
was fitted with a headcollar to either side of which was attached a 
short chain and ring. The rings encircled the vertical bars at the 
front of the stalls along which they could slide allowing the calves 
freedom to lie down, but not to turn round or chew the infusion tubing. 
Only one bucket support was maintained on each stall, this being 
attached to the side opposite to that in which the catheter was 
inserted, thus preventing the calves possibly damaging the catheter by 
rubbing against the bucket. Water was available ad libitum except 
when feed was being offered. The restraint method is illustrated by 
Plate 1.
The arrangement of the infusion tubing was determined on a trial 
and error basis during a two week pre-experimental period. Catheter 
design however evolved during the period of active infusion. Various 
catheter types used are shown in Figure 3. The original design was 
made from Portex vinyl tubing (PVC) (BSS 52) and had an inserted length 
of 25 cm. A short, split outer sleeve bearing a single strand of 
nylon permitted suturing of the catheter to the calf's neck immediately 
above the insertion site. A locking connection to the infusion tubing 
was effected by means of a ground 14 G hypodermic needle inserted into 
the external tcp part of the catheter. This design was found to be 
unsatisfactory as the single suture did not provide firm anchorage and 
the inserted portion of the catheter displayed some tendency to loop 
out of the calf's neck resulting in expulsion. This was particularly 
noticeable when the split outer sleeve had also begun to detach itself 
from the main body of the catheter. A more pertinent problem was the 
susceptibility of the Portex vinyl material to environmental
17
a)
Plate 1. Restraint of calves during infusion studies by means 
of a headcollar and sliding chains.
b)
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temperature changes. As environmental temperatures decreased the 
external top part of the catheter became brittle and fissuring 
occurred.
The PVC catheter was superseded by a Teflon catheter (Intraflon 2,
G.14, i.d. 2.1mm. Vygon, Laboratoires Pharmaceutigues, BP7-95440, 
Ecouen, France). This came complete with its own internal trochar 
rendering the insertion procedure relatively simple compared to that 
previously required (see Appendix 1). The Teflon catheter had no 
external top part and so was not influenced by environmental 
temperature changes. Connection to the infusion tubing was via a 
'butterfly arrangement1 which also permitted suturing to the skin, 
providing firm anchorage. However the Teflon catheter had an inserted 
length of only 8 cm and the distal end readily exited from the jugular 
vein during periods of calf activity resulting in subcutaneous infusion 
and oedema. For this reason the effective life of the catheter was 
extremely short.
The ultimate, and extremely successful catheter was of similar 
design to the PVC catheter but was made from Tygon microbore tubing 
(formulation S54HL, Norton Industrial Plastics, P.O. Box 350, Akron, 
Ohio, USA). This material is soft so as not to cause undue damage to 
the jugular vein wall and also temperature insensitive so as not to 
become brittle and crack with falling temperatures. An entire outer 
sleeve bearing two lengths of nylon suture material allowed the 
catheter to be firmly stitched in position. Protection for all 
catheters was afforded by a sterile dressing and a canvas neck collar.
The catheter for each calf was connected to one of two peristaltic 
pumps (Watson-Marlow 5025/501M pumphead), positioned approximately 1.3m 
above the calves, by means of a single length of Marzinal tubing (1.6mm 
bore, Watson-Marlow Ltd. Falmouth, Cornwall, England). Support for 
this tubing was effected by means of a horizontal wire positioned 
approximately 1 m above the middle of the calves backs, and an elastic 
strap between the wire and the calf harness. The infusion tubing was 
tied to the elastic strap in a looped fashion permitting the calves to 
lie down and stretch the strap without undue tensioning of the tubing. 
The general arrangement of the infusion tubing is shown in Plate 2, and 
Figure 4 illustrates in detail how a loop of the infusion tubing was 
fixed onto the neck strap of the calf harness and another stitched to 
the calf's neck such that exaggerated calf movement closed the loops 
rather than tensioning the catheter connection. Marzinal tubing is
20
Plate 2. Hie arrangement of infusion packs, regulatory pumps, 
tubing and calves during the continuous intravenous 
infusion of beta-agonists.
Plate 3. The Watson-Marlow 501M pumphead and associated 
peristaltic tubing.
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very elastic and formed good airtight connections at both the catheter 
and pumphead.
Each peristaltic pump simultaneously controlled the fluid flow to 
five calves and also that in a calibration line which permitted direct 
measurement, by volume, of flow rate. Flow rates for individual 
animals were also calculated from the difference in weight of the 
infusion packs taken at twice daily weighings. Variations in flow rate 
between individual animals were attributable to changes in delivery 
pressure at the catheter. Reductions in flow rate occurred if the 
catheter became kinked, if it became trapped against the vein wall or a 
valve, or if it was partially blocked by a small blood clot. Such 
changes could be reversed by examination of the catheter to remove 
kinks and flushing with heparinized saline. It was found that 
decreasing temperatures resulted in a general reduction in flow rate 
possibly through a contraction of the pumphead tubing in both length 
and diameter, and also a slight increase in the viscosity of the 
infusion solutions. However the most salient factor responsible for 
random changes in flow rate was wear on the pumphead tubing. This 
tubing consisted of 89 mm lengths of 0.1 mm internal diameter silicone 
rubber which were tensioned across the cylindrical pumphead rotor, as 
illustrated by Plate 3 and Figure 5. Ihis tubing tended to stretch 
through time resulting in undesirable random increases in flow rates.
In order to maintain accurate control of fluid flow to all calves, the 
pumphead tubing was changed every six days. Complete sterilised 
pumphead tubing units, as shown in Figure 6 were exchanged rather than 
just the tubing itself as it was far easier to form connections to wide 
bore marzinal tubing and to the administration set from the infusion 
pack, than to mount relatively narrow bore pumphead tubing onto the 
pumphead connectors. Thus continued asepsis of the system was 
promoted. Exchange of a complete tubing unit had the added advantage 
that all junctions at the pumphead could be sealed by silicone sealant 
prior to sterilisation and incorporation in the infusion system, thus 
reducing the potential for air influx.
It was noticed that on removal used pumphead tubing was very 
distorted and had a mean length of 93 mm, with a range from 90-96 mm.
At any given time the infusion rate in lines connected to pump A was 
greater than that for lines connected to pump B. The arrangement of 
animals was such that the pumpheads were turning in opposite directions 
to achieve the same effect and it is possible that direction of
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pumphead rotation affected the wear on the pumphead tubing. 
Watson-Marlow have noticed this with other pumphead types.
A detailed description of the procedure involved in changing the 
pumphead tubing is given in Appendix 1.
The beta-agonists to be infused were held in solution in 1 litre 
sterile 0.9% saline infusion packs positioned above the pump and 
connected to the pumphead tubing units by means of infusion fluid 
administration sets (Travenol, England). Each litre of solution was 
infused over a four day period, the administration set facilitating 
rapid replacement of empty infusion packs. Infusion packs were 
prepared immediately prior to requirement by injection of suitable 
aliquots of stock solutions of beta-agonists into the saline bags after 
withdrawal of the same volume of saline. Fluid flow rates were 
maintained at a level such that each infusion pack lasted slightly 
longer than four days. Packs were changed at the same time on every 
fourth day and any residual fluid in the existing pack was rapidly 
infused before replacement with the new one. The reserve fluid ensured 
that in the event of slight random increases in flow rate, the infusion 
packs would not empty before the appointed replacement time. The 
procedure for preparation and exchange of infusion packs is described 
in Appendix 1.
2. A modified system for the continuous intraruminal infusion of 
anthelmintics into growing lambs.
The infusion system developed for the continuous intravenous 
administration of beta-agonists to cattle was adapted to provide 
continuous intraruminal infusion of anthelmintic to sheep. The 
intraruminal infusion system was essentially similar to that for 
intravenous infusion except that Tygon catheter was replaced by a Foley 
catheter (22 Fr, Warne Surgical Products, Andover, Hants). The 
connector from the marzinal tubing was inserted into the top of this 
catheter and was secured by a small tie. A rubber disc, approximately 
5 cm in diameter fitted tightly around the catheter and was positioned 
against the sheep's skin at the insertion site preventing the catheter 
from invading the rumen and also minimizing leakage of rumen fluid.
The Foley catheter is illustrated in Figure 7 and Plate 4.
During infusion sheep were restrained in standard metabolism 
stalls. Each sheep was fitted with a dog collar and was chained to the 
front of the stall. In most cases this prevented animals chewing the
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Plate 4. The position of the inserted Foley catheter.
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infusion tubing. VJhere this was a problem however, the elastic strap 
and accessible infusion tubing was surrounded by a thick piece of 
protective polythene tubing, as shown in Plate 5.
3. Daily routine during infusion studies.
Infusion studies involved a fairly intensive daily routine in 
addition to that required for digestibility and nitrogen balance 
studies. Greater care and vigilance was required for intravenous 
compared to intra-ruminal infusion as continued asepsis in the infusion 
system was essential and the presence of a significant air lock could 
prove fatal to one of the experimental animals. Problems such as 
blocked catheters were also more difficult to resolve for the 
intravenous infusion system.
During intravenous infusion catheters were inspected at least four 
times per day at 07.30h, 12.00h, 16.00h and 21.00h. It was important 
to check that the insertion site was dry, dampness being indicative of 
a cracked and leaking catheter or possible infection. The connection 
between the catheter and infusion tubing was tested and tightened if 
found to be loose. The sutures to the skin were checked to ensure that 
they provided continued firm anchorage of the catheter. These sutures 
tended to work loose through time with exfoliation and required 
periodic replacement. Bandaging over the insertion site also required 
regular replacement.
During intraruminal infusion catheters were inspected three times 
per day at 07.30h, 16.00h and 21.00h. Both the connection between the 
catheter and the infusion system and the anchorage of the catheter in 
the rumen were tested. Hie water filled balloons of the Foley 
catheters tended to deflate through time and occasional injection of 
additional water was required. The rubber of some balloons perished 
through time, necessitating catheter replacement. At 07.30h and 16.00h 
the intraruminal insertion site was bathed with antiseptic solution 
(Hibitane), thoroughly dried and sprayed with antibiotic (Polybactrin).
At times of catheter inspection, infusion tubing was also 
inspected to ensure that it had not been chewed. During intravenous 
infusion studies particular attention was also paid to air locks in the 
infusion tubing and any of significant size were removed as described 
in Appendix 1.
Following catheter inspection, observation was made of the 
infusion packs and the peristaltic pumps. It was important to check
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Figure 8. An example of the daily infusion rate record sheets
kept separately for each animal during infusion studies.
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intravenous infusion of beta-agonists into cattle.
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that a drip formed regularly in the reservoir of each administration 
set connected to each infusion pack. Absence of dripping indicated a 
blockage somewhere in the particular infusion line, usually at the 
catheter. The procedure for flushing catheters is described in 
Appendix 1. The connectors at the pumphead were checked to ensure that 
they were at the bottom of their supporting slots. Occasionally the 
action of the pumphead rotor caused them to move to the top of the 
slots, slightly reducing the contact between the pumphead tubing and 
rotor resulting in an increase in flow rate. At approximately 08.30h 
and 16.30h each infusion pack was weighed and the 24 hour flow rate was 
calculated from the decrease in pack weight compared to that recorded 
at a similar time on the previous day. The volume of fluid that had 
passed through the calibration line was also noted. Separate records 
for the infusion rate to each animal were kept and problems with the 
catheters or infusion tubing were recorded thereon. A daily record of 
general observations was also made and examples of these records are 
given (Figures 8 and 9).
On every fourth day fresh infusion packs were prepared and 
exchanged for existing packs. Catheters were flushed at this time if 
residual fluid in existing packs could not be infused at the expected 
rapid rate. On every sixth day the pumphead tubing was replaced.
During intravenous infusion studies units of pumphead tubing which had 
been prepared and sterilised were supplied in sterile packs. During 
intraruminal infusion studies, pumphead tubing units were assembled as 
required.
Detailed time costing of procedures carried out during infusion 
studies is given in the appropriate sections of this thesis.
F. Radioisotopic Studies
1. Daily routine
Radioisotopic studies were conducted simultaneously with 
metabolism studies for the experiments described in Section II. The 
duration of each study period was 16 days during which time calves were 
accomodated in metabolism stalls. Each calf was dosed daily per os 
with 10 ml of 0.75 % (w/v) potassium iodide (KI) to prevent uptake of 
radioactive iodine by the thyroid gland. The dosing commenced four 
days prior to injection of radioiodine and continued throughout the 
study period. Blood samples and sub-samples of the total daily faecal 
and urinary outputs of each animal were collected regularly for the
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measurement of radioactivity. Daily intakes of feed and water were 
recorded.
2. Preparation of isotopes for injection
(i). Tritiated water (TOH) and 51cr-chromic chloride (^ -klrC^ )
Stock solutions of TOH and -^^ CrClg (Amersham International,
Amersham, Buckinghamshire, UK) were diluted with 0.9% (w/v) 
physiological saline to give solutions with activities of 11.0 and 7.4 
MBg/ml respectively.
(ii). -^I-labelled albumin
Bovine serum albumin (Fraction V, 97% pure, Sigma Chemical Company) was 
trace-labelled with radioiodine by the iodine monochloride method of 
McFarlane (1958). The protein in a slightly alkaline medium was 
treated with iodine monochloride to which the radioactive iodine had 
been added as a carrier-free iodide. A substitution reaction occurred 
in which 125 j replaced hydrogen in the 3 and 5 positions of the 
benzene rings of the tyrosine groups.
A 2% solution of bovine serum albumin was prepared by dissolving 
600 mg of the freeze-dried protein in 30 ml of physiological saline.
A stock iodine monochloride solution was prepared by dissolving 5.00 g 
of potassium iodide and 3.22 g of potassium iodate in 37.50 ml of 
distilled water. 37.50 ml of concentrated HC1 and 5 ml of carbon 
tetrachloride were added and the solution was shaken for several 
minutes. 0.1 M potassium iodide was added dropwise until a faint pink 
colouration was observed. The solution was then diluted 1:350 with 
physiological saline giving a concentration of 0.42 mg of iodine/ml as 
iodine monochloride.
Two glycine buffers A and B (pH 8.5 and 9.0) were prepared by 
adding molar sodium hydroxide (NaOH) to a molar solution of glycine in
0.25 M sodium chloride until the reguired pH was attained. Buffer A 
was used to convert iodine monochloride to the hypoiodite and buffer B 
provided the alkaline medium necessary for the reaction to occur. 
Procedure:- 15 ml of buffer B was added to 30 ml of 2% bovine serum 
albumin solution in a 100 ml conical flask. In a separate flask 6 ml 
of iodine monochloride was added to 15 ml of buffer A. Approximately 
37 MBq of carrier-free radioiodine was added to the buffered iodine 
monochloride solution and then this was transferred to the buffered 
albumin solution. Iodination of the albumin occurred instantaneously
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and the solution was poured into a dialysis sack and dialysed for 48 
hours against two changes of physiological saline.
3. Preparation of standards
A known weight (approx. volume 1 ml) of each of the 
radioisotopically labelled preparations was emptied into a 100 ml 
volumetric flask. Hie contents of the flask were made up to the mark 
with 0.02 N NaOH. 1 ml of this solution was dispensed into counting 
vials and made up to 10 ml with 0.02 N NaOH. The standards served as 
corrections against decay, changes in the sensitivity of the counting 
equipment and for calculation of the injected dose.
4. Injection of isotopes
Known weights of each isotope solution (approx. volume 10 ml) were 
injected into each calf via a jugular catheter. A double injection of 
74 MBq 51crCl3 anc3 15 MBq of 125i-fc>ovine albumin followed a 
single injection of TOH four days earlier. Prior to the injection of 
TOH food and water were withheld from the calves for 18 hours to 
standardise water in the gut and enhance equilibrium. The jugular 
catheter was flushed with physiological saline after each injection and 
prior to its withdrawal from the jugular vein.
5. Collection and preparation of blood, faecal and urine samples for 
counting
Blood samples (5 ml) were collected from the opposite jugular vein 
into heparinized vacutainer tubes 15, 30, 60, 120 and 360 minutes after 
each injection. Twice daily samples were taken thereafter in the 
intervening period between the TOH and the SlcrCl^/l^Sj-albumin 
injections and for a five day period following the combined injection. 
For the remainder of the study period blood samples were taken once 
daily.
A packed cell volume estimation was carried out on all blood 
samples after which 1 ml aliquots of plasma were pipetted into counting 
vials and made up to 10 ml with 0.2 N NaOH.
Total daily faecal and urinary outputs were recorded following the 
combined injection only. The daily faecal collection was thoroughly 
mixed and eight weighed subsamples of approximately 10 g (approx. 
volume 10 ml) were packed into counting vials. Four weighed urine 
subsamples (approx. volume 1 ml) were transferred to counting vials and
35
made up to 10 ml with 0.2 N NaOH.
Radioactivity measurements for 125j an<3 51cr in the plasma, 
urine and faeces were determined in an automatic well-type 
scintillation spectrometer (Canberra Packard Minaxi'tf Autogamma 5000 
series gamma counter). TOH in the plasma was determined using a liquid 
scintillation spectrometer (Canberra Packard Tricarb Liquid 
Scintillation spectrometer). The calculation of cross-over factors was 
based on the relative count rates of the standard solutions at each 
photo peak. All samples were corrected for background radiation.
6. Calculation and expression of results
(i) Total injected activity (TIA)
This was calculated by determining the net counts/min/ml of several 
aliquots of each standard solution. The total standard radioactivity 
(TSR) was calculated as the product of the mean radioactivity in 1 ml 
of standard solution (cpm) and the volume of the standard (100 ml).
From TSR it follows that the total activity injected into each 
animal was;
Total injected activity = wt of labelled preparation injected x TSR
wt of labelled preparation in standard (g).
(ii) Total body water and body water turnover
Gastrointestinal parasitism often produces an alteration in the body 
composition of the host animal. Commonly there is an increase in the 
proportion of water in the carcass and thus the full economic 
implications of parasitism cannot be gauged from changes in body weight 
alone. Other features of many parasitisms include the occurrence of 
diarrhoea and inappetence and hence a reduction in water intake by the 
host animal.
Total body water, its distribution and turnover can be calculated 
using the dilution principle. Equilibration or extrapolation methods 
may be employed. In ruminants the contents of the rumen, reticulum and 
abomasum may constitute up to 25% of the total body water and because 
of this equilibration of an injected marker takes between three and 
four hours. Deprivation of food and water for 18 hours prior to 
injection of the marker slightly reduces the amount of water present in 
the gut and so enhances equilibration.
Body water measurements were made using TOH as the injected
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marker. From the activity in the plasma of blood samples taken at 15, 
30, 60, 120 and 360 minutes post injection the point of equilibration 
of the marker was determined and the total body water was calculated 
from the equilibration equation thus;
Total body water = Total radioactivity injected (cpm)
Radioactivity of sample removed at equilibration (cpm/ml)
Total body water was also calculated by the extrapolation method. 
The plasma activity of each blood sample taken in the four days 
following the TOH injection was plotted against time using semi-log 
graph paper. Extrapolation of the negative slope back to zero time 
gave an estimation of the plasma radioactivity (cpm/ml) if 
equilibration could occur instantaneously following injection. Using 
this value in the previous equation permitted calculation of total body 
water by the extrapolation method. The biological half-life of the TOH 
(tl/2) was calculated from the slope of this line permitting 
calculation of body water turnover thus;
Turnover (litres/day) = 0.693 x total body water (litres)
t 1/2 (days)
(iii) Plasma Volume
This was calculated by the dilution principle using 125i_aibumin as 
the radioisotopic marker. Equilibration of injected 125];_aibumin 
with plasma took approximately 10 minutes and plasma volume was 
calculated thus;
Plasma volume (Vp) = Total injected activity (cpm)
cpm/ml of plasma at equilibration
(iv) Faecal Clearance of SlCr 3nd 125i-aibumin
One of the characteristic features of most gastrointestinal parasitic 
infections is that they lead to changes in the concentration and 
distribution of the plasma proteins of their host. Usually these take 
the form of a depression in albumin and elevations in globulin levels. 
Current thinking suggests that the depression of albumin levels is 
primarily due to the leakage of this small blood constituent through a 
damaged mucosa into the digestive tract from which it is subsequently
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excreted. Injection of -^I-albumin and subsequent daily measurement 
of this marker in plasma and faeces permits calculation of the faecal 
clearance of albumin. However this parameter is underestimated due to 
reabsorption of iodine from the digestive tract prior to excretion. 
Injection of ^CrC^ also permits calculation of plasma losses into 
the gastrointestinal tract and this marker has the advantage that it is 
not reabsorbed to any significant extent.
Using semi-log graph paper a graph was plotted of plasma activity of 
125I-albumin or 51Cr as a percentage of that at equilibration 
against time. From this the total plasma activity at the beginning of 
each 24 hour period was determined. The total faecal, activity for each 
24 hour period was calculated as the product of mean faecal activity of 
the daily subsamples (counts/gram of faeces) and total faecal output. 
Faecal clearance for each 24 hour period was. then calculated;
Faecal clearance ml/day = total faecal activity (cpm) over 24 hours 
(51<:r or -^I-albumin) total plasma activity at start of 24
hour collection period
(v) Albumin disappearance (t 1/2)
Ihe biological half-life of the -^I-albumin was calculated from the 
negative slope of the graph of plasma activity of 125I-albumin 
against time.
(vi) Fractional catabolic rate of albumin (F (CA))
Increases in the faecal clearance of 125I-albumin may be reflected in 
elevations of the fractional catabolic rate of albumin. The fraction 
of the intravascular pool of albumin broken down each day was 
calculated by the method of Campbell et al (1956) based on the 
excreted activity in urine and faeces. The excreted isotope in the 
urine and faeces was assumed to be proportional to the amount of 
labelled albumin in the intravascular pool where degradation occurred. 
The fraction of the plasma pool broken down each day was determined 
from the total daily excreted activity (urine and faeces) and the 
activity present in the plasma at the beginning of the 24 hour 
collection period.
F (CA) = Total excreted activity (U and F) over 24 hours
Total plasma activity at beginning of 24h collection period
38
The fractional catabolic rate thus calculated provides an index of 
metabolism and not an absolute value as steady state conditions rarely 
exist in parasitised animals,
G. Parasitological Techniques
1. Culture and harvesting of infective larvae
Qstertagia ostertagi and Cooperia oncophora larvae were 
cultured from the faeces of experimentally infected calves which had 
previously been reared and maintained parasite-free. Qstertagia 
circumcincta larvae were similarly cultured from the faeces of 
experimentally infected sheep. Donor animals were fitted with a body 
harness and faecal collection bag. The complete daily faecal output 
was mixed with vermiculite to produce a mouldable consistency. Ihe 
faeces were then incubated in screw top containers for 12-14 days at 
26°C. At the end of this period the containers were filled with 
lukewarm tap water and kept for three hours to allow migration of 
larvae into the water, after which contents of the containers were 
poured through a coarse sieve (60 meshes per inch) to remove gross 
faecal matter. The fluid containing the larvae was then filtered 
through two layers of eight inch milk filters (Maxa Filters, A. 
McCaskie, Stirling) by suction using a Buchner apparatus and suction 
pump. The filter paper was then removed and placed larval side 
uppermost on a coarse metal sieve (150 micron pores) which was placed 
on top of a glass funnel. The funnel was closed at the stem with a 
piece of rubber tubing and a clip and was filled with lukewarm tap 
water. Motile larvae were left to migrate through the paper and sieve 
into the water below where they accumulated at the neck of the funnel 
and were collected 12 hours later.
2. Preparation and administration of larval doses
The concentration of the larval suspension was determined by 
examining 40 x 0.025 ml aliquots. The suspension was mixed 
continuously during this procedure in order to evenly disperse the 
larvae in the fluid. Once the concentration of larvae had been 
determined appropriate doses were pipetted into universal bottles, also 
during continuous mixing, and the volume was made up to approximately 
15 ml using tap water. With the exception of experiment lie larval 
doses were made up in small batches and, where required, short term
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storage was at room temperature (16°C). In experiment lie larger 
batches of larval doses were prepared and were stored at 4°C until 
required.
Larval doses were administered per os after thorough mixing.
Each bottle was then half-filled with water, shaken and the rinsings 
also given to each animal.
3. Faecal egg counts
Faecal samples were either collected directly per rectum or from 
the faecal collection bags. Ihe samples were examined by a modified 
McMaster technique (Gordon and Whitlock, 1939). In this technique 3 g 
of faeces were homogenized with 42 ml of water and the resultant 
suspension was passed through a 250 micron sieve (Endecotts Test Sieves 
Ltd., Morden, London). After thorough mixing of the filtrate, two 15 
ml aliquots were withdrawn into flat bottomed centrifuge tubes 
(capacity 15 ml) and centrifuged at 2000 rpm for two minutes. Hie 
supernatents from both tubes were discarded and the remaining faecal 
mass broken up by rotary agitation. One tube was then filled with 
saturated salt solution to its former level, inverted six times and a 
volume of the resulting suspension quickly transferred by pipette to 
fill both chambers of a McMaster slide. The number of eggs under the 
etched area of the slide were counted and the result multiplied by 50 
to give an estimation of the number of eggs per gram (epg) of faeces 
according to the following calculation
3 g faeces in 42 ml gives 1 g in 15 ml
Volume under one square equals 0.15 ml
.*. No. of eggs seen in two squares x 50 = No. of eggs/gram
4. Necropsy procedure and estimation of parasite burdens
Sheep were killed by electrical stunning and cattle were 
euthanased with a captive bolt and pithing. Immediate exsanguination 
followed by severing each jugular vein. At this time a blood sample 
was collected. Where Qstertagia sp was the only parasite present the
omasum and abomasum were removed intact together with approximately 0.5
m of small intestine. For cattle with a mixed infection of Qstertagia 
ostertagi and Cooperia oncophora the pyloric sphincter was ligatured 
on opening the abdominal cavity and the omasum and abomasum were 
removed together with the entire small intestine. A faecal sample was
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obtained from the large intestine.
Abomasa were prepared by firstly removing the omental fat, omasum 
and remaining duodenum. The abomasum was opened by an incision along 
its greater curvature and the contents were collected into a graduated 
bucket. A sample of abomasal fluid (approximately 200 ml) was retained 
for pH determination using a Radiometer pH meter type PHM 26c (Electric 
Measuring Instruments Ltd. Copenhagen, Denmark). A pH stick 
(Gallenkamp) was also used. Hie abomasal folds were carefully washed 
under a slow stream of water into the bucket and the volume made up to 
a standard two litres for sheep and four litres for cattle. After 
thorough mixing, two 200 ml aliquots of abomasal washings were 
withdrawn into jars, 10 ml of 40 % formalin was added and the samples 
were stored for subsequent microscopic examination.
Hie washed abomasum was laid out on a dissecting board and a 
nodulation score was ascribed. Cattle abomasa were then cut in half 
longitudinally and the mucosa from one half was scraped off with a 
sharp post mortem knife. Entire sheep abomasa were scraped. Hie 
mucosal scrapings were digested in three times their own volume of a 
pepsin-hydrochloric acid mixture (Herlich, 1956) at 42°c for six 
hours. Hie digested mixture was then made up to four litres for cattle 
or two litres for sheep and two 200 ml aliquots were withdrawn, 
formalized and stored as described previously.
In cattle experimentally infected with Cooperia oncophora the 
retained small intestine was cut into three sections, each of 
approximately 6 m which roughly corresponded to the duodenum, jejenum 
and ileum. Each section was opened along its length using a pair of 
sharp scissors. Hie intestinal contents from the separate sections 
were collected into graduated buckets and the inner surfaces washed 
under a slow stream of water until a volume of four litres of washings 
was attained in each case. Two 200 ml aliquots were withdrawn, 
formalized and stored as for abomasal washings.
To one of each pair of washings and digest samples from each 
animal 2-3 ml of iodine solution (720 g potassium iodide and 450 g 
iodine crystals per litre of distilled water) was added and mixed 
thoroughly. Ten 4 ml aliquots were withdrawn by pipette into scored 
petri dishes and 2-3 ml of sodium thiosulphite was added to clear the 
background leaving the parasites stained with iodine. Hie aliquots 
were examined under a dissection microscope and parasites present were 
classified as adult male or female, developing fourth or fifth stage
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larvae or early fourth stage larvae on the basis of bursal or vulvular 
development, the presence of a sheath projection and size respectively. 
The sum of the parasites present in the ten aliquots from each original 
subsample was multiplied by the appropriate dilution factor (50 for 
sheep, 100 for cattle) to give the total number of parasites present in 
the original two or four litres.
5. Pathology
Tissue samples were excised from the duodenum, jejunum and ileum 
before opening the gut while those obtained from the abomasum were 
taken immediately following opening along the greater curvature.
Samples for light microscopy were fixed in 10 per cent formalin or 
Carnoy's fluid. Discs of tissue were also fixed in paraformaldehyde- 
gluteraldehyde for a minumum of 24 hours for scanning electron 
microscopy (SEM).
Formalin fixed tissues were post fixed in corrosive formol and 
processed in a standard 24-hour cycle. Sections (5 urn) were stained 
with haemotoxylin and eosin for general histopathology and to 
demonstrate globule leucocytes, and Alcain blue (pH 1 and pH 2.5) to 
demonstrate goblet cells. Carnoy fixed tissue was similarly processed 
and sections stained with Astra blue and Sofranin to demonstrate mast 
cells.
For SEM, specimens were coated with gold in an Emscope sputter 
coater, before viewing in a Phillips 501 B Scaning electron microscope.
6. Morantel sustained release bolus (MSPB)
During the parasitological investigations described in Section II 
of this thesis the morantel sustained release bolus (MSRB, Paratect, 
Pfizer Inc., Sandwich, Kent, England) was used to limit parasitic 
infection. The bolus was first described by Jones (1983) and comprised 
of a stainless steel tube (9.1 cm in length and 2.7 cm in diameter) 
fitted at each end with a sintered polythene disc impregnated with 
cellulose triacetate hydrogel. The tube was encased with a heat shrunk 
polyolefin band and each end had a circumferential crimped aluminium 
cap. It was filled with a blend of 22.7 g morantel tartrate 
(equivalent to 13.5 g morantel base), 14.7 g polyethylene glycol 400 
and 4.1 g sodium metaphosphate and was reported by Jones (1983) to have 
been designed to release approximately 90 mg of base per day for at 
least 60 days. Experimental results recorded in the same publication
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in fact show a declining release rate through time and a residue of 
4.69 morantel still present in the bolus after 90 days.
H. Blood biochemical techniques
Blood samples for biochemical analysis were obtained directly from 
the jugular vein into heparinized vacutainer tubes (Beckton Dickinson 
Ltd.).
I. Plasma pepsinogen estimation
Plasma pepsinogen was estimated by the method described by Edwards 
et al (1960). Plasma was incubated with bovine serum albumin (BSA) 
substrate at pH 2 for 24 hours and the phenolic amino acids liberated 
(tyrosine) were estimated using Folin-Ciocalteu's reagent. Corrections 
were made for the normal (non-incubated) content of tyrosine-like 
substances and also the release of these substances from the feSA 
substrate by acid-hydrolysis during the incubation period.
Whole blood was centrifuged at 2000 rpm for 20 minutes. Two 0.5 
ml aliquots of plasma were withdrawn and added to 2.5 ml of acidified 
2% BSA (pH 1.5) in two universal bottles labelled 'Test' and 'Control'. 
The 'Test' was incubated for 24 hours at 37°C while the 'GQntrol' was 
immediately precipitated by the addition of 5.0 ml of trichloracetic 
acid (TCA).
BSA blanks were set up (in duplicate) so that corrections could be 
made for the normal (non-incubated) content of tyrosine-like substances 
and also for the release of these substances from BSA alone. For each 
blank 2.5 ml of acidified BSA and 0.5 ml distilled water were dispensed 
into universals. Two universals (incubated-blanks) were incubated for 
24 hours at 37°C and the other two (unincubated-blanks) were 
immediately precipitated with 5.0 ml 4% TCA.
After mixing precipitated 'controls' and 'unincubated-blanks' were 
allowed to stand for 10 minutes to ensure efficient floculation of the 
precipitate. Hiey were then filtered through a Whatman No.44 filter 
paper. Following incubation 5.0 ml of 4% TCA was added to 'Tests' and 
'incubated-blanks' and the resulting suspensions were similarly 
filtered. 2.0 ml of each filtrate was pipetted into a suitably 
labelled 50 ml conical flask containing 20 ml of 0.25 N NaOH. A 
reagent blank was set up containing 2.0 ml distilled water and 20 ml
0.25 N NaOH. Flasks were also set up (in duplicate) containing 2.0 ml 
of each working tyrosine standard (o.2 ju mols and 0.4 mols). Three
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ml of diluted Folin-Ciocalteu's reagent was added to all flasks and 
after standing for 30 minutes the blue colour was read in a 
spectrometer at 725 mu.
Results were calculated by firstly subtracting the reagent blank 
from all readings. All readings were converted to u mols tyrosine 
using a factor calculated from the spectrophotometer readings of the 
tyrosine standards. The total release of tyrosine on incubation was 
calculated by subtracting the value of non-incubated BSA and plasma 
from that from incubated BSA and plasma (A). Similarly the release of 
tyrosine from BSA substrate due to incubation alone (i.e. no 
pepsinogen) was calculated by subtracting the value for non-incubated 
BSA alone from that for incubated BSA alone (B). The subtraction A - B 
gave the u mols of tyrosine released on incubation of the equivalent of
0.125 ml serum for 24 hours with substrate. (2.5 ml serum originally 
made up to 15 ml from which 6 ml containing 2.5 x 6/15 = 1.0 ml serum 
was withdrawn for incubation. Following precipitation, total filtrate 
volume approximated 16 ml from which 2 ml was withdrawn for addition of 
Folin-Ciocalteau's reagent. This contained 2/16 x 1.0 = 0.125 ml 
serum). The amount of tyrosine released per 1000 ml plasma per minute 
(International Units) was the product of 5.56 and the ja mols released.
1.e. ju mols released x 1000 x 1
0.125 24 x 60
volume adjustment factor time adjustment factor
2. Total serum protein, albumin and urea
These were estimated by continuous flow analysis (standard 
Technicon Auto Analyser II methods).
3. Haematocrit
Haematocrit estimations were performed using an electronic 
particle counter (Model ZF, Coulter Electronics, Harpendon, Herts.).
The machine was calibrated daily using standard blood sample of known 
value (Coulter Electronics).
I. Statistical analysis
Statistical analysis of the experimental results contained in 
Sections I and II of this thesis was performed on a microcomputer using
an interactive analysis of variance programme and 1 MINITAB' (Ryan, Penn
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State University) respectively. A formal test (F-test) was applied in 
order to ascertain which factors significantly contributed to the total 
variation observed. Where treatment effects were shown to be 
significant mean values were compared using a multiple comparisons 
procedure. For the experiment described in Section III an analysis of 
variance was carried out for each data set. For parasitological 
parameters this was performed using 'MINITAB1 on a microcomputer. 
Analysis of digestibility and nitrogen balance data was performed using 
the programme 'RUMMAGE' (PLU, Edinburgh) on an ICL 2988 computer. The 
model incorporated three main effects and allowed for first and second 
order interactions.
For some parasitological assessments where population 
distributions were not normal non^parametric procedures (e.g. 
Mann-Whitney) were carried out, also using the 'MINITAB' programme.
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LITERATORE REVIEW 
Introduction
In recent years there has been an increasing awareness of health 
problems which might be associated with high levels of dietary fat.
This growing public concern has been fuelled by two reports linking 
excessive intake of dietary lipid with coronary heart disease (National 
Advisory Committee on Nutrition Education 1983; Department of Health 
and Social Security 1984). In the UK approximately thirty three 
percent of the fat consumed is derived from meat (Jones, 1985).
Carcass fat in farm livestock can be limited nutritionally by 
restrictive feeding but this practice is associated with undesirable 
reductions in .growth rate. Slaughtering at an earlier stage of 
physiological maturity results in leaner carcasses as fat is a late 
maturing tissue. However as meat processing costs have risen the 
tendency has been to produce heavier carcasses which are incompatible 
with the requirement for lean meat. Control of growth has been 
achieved chemically using exogenous steroids and/or feed additives but 
the use of such substances is now limited due to the body of public 
concern over residue accumulation.
More recently pharmacological agents have been identified which 
increase the accretion of lean tissue and limit the deposition of fatty 
tissue in growing animals. These substances, termed 'repartitioning 
agents', are beta-adrenergic agonists and are similar in structure to 
epinephrine (adrenalin). Perhaps the best known are clenbuterol 
(benzyl alcohol, 4-amino-R-(t-butyl-amino) nethyl-3,5-dichloro) and 
cimaterol (anthranilonitrile, 5-(l-hydroxy-2-(isopropylamino)ethyl)-) 
shown in Figure 10.
Itays iological mode of action
The exact mechanism by which synthetic beta-adrenergic agonists 
exert their repartitioning effect has yet to be fully elucidated.
These compounds may exert a direct effect on metabolism and/or an 
indirect effect by alteration of circulating hormone levels.. Receptor 
systems activated by sympathomimetic amines have been classified as 
alpha, betap or beta2 types dependent on the response elicited by 
various agonists and antagonists (Lands et al, 1967). It was 
considered that activation of beta-^  receptors was associated with 
lipolysis and cardiac stimulation, activation of beta2 receptors
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NH2
Clenbuterol 
OH
i
CH-CH2NHC(CH3)3
Cimaterol
OH
CH-CH2NHCH(CH3)2
Epinephrine
CH-CH2NHCH3
Figure 10. The chemical structures of some 
beta-adrenergic agonists.
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brought about bronchodilation and vasodepression, and that alpha- 
receptor activity played an important role in vasopressor action, 
intestinal relaxation, contraction of the vas deferens (rat) and 
stimulation of the pregnant uterus. More recent evidence however 
suggests that lipolysis and also brown adipose tissue thermogenesis are 
mediated by both beta-^  and beta2 receptor systems (Belfrage, 1978).
The synthetic compounds which stimulate body protein deposition and 
reduce the proportion of body fat have been loosely classified as 
beta2 adrenergic agonists.
The proportions of alpha and beta2 receptor types varies between 
tissues and thus the strength of the response to agonist stimulation 
also varies. Beta-receptors are present on cell membranes and form one 
component of the hormone sensitive adenylate cyclase system. The other 
components of this system are a catalytic moiety which converts 
adenosine 5'-triphosphate (ATP) into adenosine 3':5*-cyclic 
monophosphate (cAMP) and a guanine nucleotide regulatory protein (N 
protein). Activation of beta-receptors by beta-agonists stimulates the 
membrane bound enzyme adenylate cyclase and this action leads to the 
intracellular accumulation of cAMP (Stiles et al, 1984). In 
adipocytes intracellular protein kinase and triacylglycerol lipase are 
also stimulated (Fain and Garcia-Sainz, 1983). In the presence of cAMP 
inactive protein kinase disociates into regulatory and catalytic 
subunits, the latter of which catalyses the ATP dependent 
phosphorylation of its enzyme substrate. Phosphorylation generally 
activates enzymes involved in store breakdown and inactivates those 
involved in store deposition (Vernon and Peaker, 1983). It may be 
hypothesised that this mechanism promotes lipolysis resulting in 
liberation of free fatty acids which are then used as an energy source 
sparing amino acids otherwise destined for gluconeogenesis for protein 
production.
The direct action of beta-adrenergic agonists on muscle may result 
in fibre hypertrophy via a decrease in protein degradation and/or an 
increase in accretion (Ricks et al, 1984a). The evidence in support 
of this hypothesis is largely equivocal. Detailed investigations of 
both lipid and protein metabolism have been undertaken with often 
conflicting results, and the possibility of an indirect effect of 
beta-agonists via alterations in circulating hormones cannot be 
discounted.
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Lipid metabolism
Lipolysis is the major pathway for the release of free fatty acids 
and glycerol from adipose tissue. Triglyceride lipase is the rate 
determining enzyme and it is controlled by an enzyme cascade which 
involves adenylate cyclase and a protein kinase (Galton and Wallis,
1982). Beerman et al (1985a) demonstrated a 60% increase in plasma 
free fatty acid concentration over controls in lambs fed the 
beta-agonist cimaterol for periods of six or twelve weeks. There was a 
simultaneous decrease in plasma insulin and an increase in thyroxine 
levels. Intravenous infusions of beta-agonists similarly produced 
increases in circulating free fatty acid levels in cattle (Blum et 
al, 1982) and the response was enhanced by temporary starvation. 
Increased plasma free fatty acids suggest that beta-agonists stimulate 
lipolysis. Indeed Eadara et al (1987) concluded that 'cimaterol 
selectively stimulates lipolysis in white adipose tissue and 
lipoprotein lipase activity in skeletal muscle with no major changes in 
de novo fatty acid synthesis'.
In contradiction to these findings is a study by Grisdale-Helland 
et al (1986a) in which no change in plasma fatty acid concentration 
was observed during infusion of cimaterol into lambs. Plasma insulin 
concentrations were significantly increased. Duquette and Muir (1985) 
incubated rat adipose tissue with several beta-agonists including 
clenbuterol and measured rates of lipolysis and lipogenesis using 
radiolabelled (14c) acetate and glucose. They concluded that 
clenbuterol was apparently 5-10 times more potent as an anti-lipogenic 
than a lipolytic agent. In a similar study involving porcine adipose 
tissue Mersmann (1987) demonstrated that clenbuterol failed to 
stimulate lipolysis and concluded from the overall results that the in 
vivo effect of clenbuterol on adipose tissue was indirect and that 
there was no interaction with adipose beta-receptors.
Ihe anti-lipogenic activity of clenbuterol is implicated in in 
vivo studies by Hamby et al (1986). Rambouillet X Finn crossbred 
wether lambs received 0 and 2 ppm clenbuterol in their diet for 
approximately 40 days prior to slaughter. Carcass characteristics were 
compared with those of a similar group of lambs slaughtered at the 
beginning of the feeding period. It was found that subcutaneous fat 
thickness had increased by 88% in the control group compared to the 
initial kill group, but remained unchanged in the clenbuterol treated 
group. Most investigations into the effects of beta-agonists on
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carcass characteristics have not employed an initial slaughter group 
and so it has been impossible to differentiate between reductions in 
fatness due to stimulation of lipolysis or depression of lipogenesis.
It is interesting that in studies where increased plasma free fatty 
acids have been observed, the beta-agonist involved has been cimaterol 
whereas anti-lipogenic activity has generally been attributed to 
clenbuterol. It is possible that these two beta-agonists act in 
slightly different ways to achieve the same effects on carcass 
fatness.
It has been reported that beta-agonists may stimulate lipogenesis 
and at the same time increase lipolysis. This would result in an 
increased lipid turnover rate and a consequent reduction in the total 
energy available for fat deposition. Stimulation of the adrenergic 
system is known to increase metabolic rate and thereby increase energy 
expenditure. Williams et al (1987a) estimated that over a 100 day 
treatment period with clenbuterol the energy expenditure of calves was 
increased by a mean of 12% (calculated from the total energy intake and 
the energy retained in the carcass). Increased energy expenditure 
coupled with increased energy retained as protein is an alternative 
mechanism for reducing the proportion of total energy available for fat 
deposition.
Protein metabolism
On the basis of comparative slaughter experiments with calves 
(Williams et al, 1987a) and similar studies with rats (Reeds et al,
1988) it would appear that the protein anabolic properties of 
beta-agonists are mainly confined to skeletal muscle. The effect 
apparently predominates in type II muscle fibres which are 
characterized as fast contracting mixed glycolytic/oxidative fibres, as 
opposed to type I fibres which are characterized as slow contracting 
and oxidative. This was demonstrated by Hamby et al (1986) who noted 
the tendency for muscle from clenbuterol fed sheep to utilize glucose 
at faster rates than controls, to have a reduced lipid content and to 
fail to esterify radiolabelled palmitate at measurable rates. Together 
with the marked hypertrophy of the muscle these characteristics are 
indicative of a greater proportion of type II muscle fibres. Following 
incubation of rat muscle with clenbuterol, Reeds et al (1986) 
observed an increase in skeletal muscle protein and RNA without any 
increase in DNA and concluded that the increase in muscle protein mass
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arising from beta-agonist treatment was due to muscle hypertrophy 
rather than hyperplasia. However in certain selected muscles from 
sheep an approximately equal increase in the cross-sectional area of 
both type I and type II muscle fibres has been observed (approximately 
28%) with an increased percentage of type II fibres present (Beerman 
et al, 1985b, Beermann et al, 1987). This effect was not apparent 
in all muscles examined and suggests that the increase in size of some 
muscles at least results from hypertrophy of both fibre types coupled 
with selective hyperplasia of type II fibres. The proportion of type I 
and type II fibres in muscles, together with the degree of maturity
attained is likely to influence the magnitude of response to
beta-adrenergic stimulation.
The mechanism for adrenergic stimulation of muscle hypertrophy has
yet to be identified. In rats given twice daily subcutaneous
injections of clenbuterol (1 mgAg bodyweight) for seven days, the 
fractional rate of protein synthesis was apparently increased by 34% 
(Emery et al, 1984) and it was considered unlikely that this was 
entirely due to an increased intake of metabolizable energy compared to 
the controls. However the weight of evidence suggests that the major 
long-term effect of beta-agonists on muscle protein metabolism is a 
reduction in the rate of protein degradation. MacRae et al (1986) 
measured plasma leucine turnover and oxidation in sheep at intervals up 
to 20 days after the start of treatment with clenbuterol. Leucine flux 
was initially unaltered, was elevated temporarily by day 11 indicating 
a transient rise in synthesis, whereas leucine oxidation (which can be 
considered to measure overall amino acid catabolism) was significantly 
lower on days 4, 11 and 18 as urinary N excretion decreased and N 
retention increased. The reduction in leucine oxidation may be 
representative of a reduction in protein degradation. In vitro 
incubation of muscle cell cultures from the legs of twelve-day old 
broiler chicken embryos with cimaterol demonstrated no effect on the 
rate of incorporation of 3H-leucine into the soluble protein fraction 
and slight but significant increases in the incorporation rate into 
myosin heavy chains. Thus the apparent effect on protein synthesis was 
small. However 10-7 m cimaterol caused significant increases in the 
quantity of the myofibrillar fraction, the myosin heavy chain and the 
total cellular protein in the muscle cultures. Extra protein was 
deposited in the absence of any marked change in the rate of synthesis 
and the most probable cause is a reduction in the rate of degradation
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(Young et al, 1987).
Similar conclusions may be drawn from studies using sheep (Bohorov 
et alf 1987) and calves (Williams et al, 1987a). After 37 days of 
clenbuterol treatment (10 mgAg diet) fractional rates of protein 
synthesis in wether lambs were unchanged but protein acretion was 
increased indicating that degradation rates had fallen. Similarly 
after 75 days of clenbuterol treatment the fractional degradation rate 
of protein in calves was only 65% of the control values.
Grisdale-Helland et al (1986b) concluded from whole body protein 
turnover studies in fasted sheep that catecholamine like substances, 
including cimaterol, exerted their anabolic effect by differential 
suppression of both endogenous synthesis and degradation of protein.
A distinction must be made between the effects of beta-agonists 
occurring in skeletal muscle and those occurring in non carcass 
components. Williams et al (1987a) reported that in clenbuterol 
treated calves nitrogen retention in the carcass was increased but that 
retained in the gut, hide and organs was reduced. Jones et al (1985) 
also noted a reduction in the weights of heart and kidneys of pigs 
treated with cimaterol. Hie mechanism for this redistribution of 
nitrogen within the body has yet to be elucidated.
Indirect effects
Various authors (eg Mersmann 1987, Mirbahar & Eyre, .1985) have 
suggested that the physiological responses induced by exogenous 
beta-agonists do not arise from direct stimulation of beta-receptors.
It may be summised that the action of these substances is mediated via 
alterations in circulating hormone levels particularly insulin, growth 
hormone and thyroxine. Insulin has a known lipogenic effect and is the 
primary hormone responsible for glucose entry into cells prior to 
metabolism. Mean plasma insulin levels increase with increasing age 
and adiposity and marked diurnal fluctuations are observed associated 
with feeding periods. Ruminant white adipose tissue has a greater 
sensitivity to insulin than that from non-ruminants. In the fed state 
insulin plays an important role in maintaining proteolysis at a low 
level, its mode of action being to reduce the formation of lysosomes by 
which muscle protein degradation is effected (Lindsay, 1983). Both 
growth hormone and thyroxine influence protein synthesis and thyroxine 
is also thought to have a regulatory role in the sensitivity of adipose 
tissue to beta-agonists (Fain & Garcia-Sainz, 1983).
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The evidence for alterations in circulating hormone levels during 
exogenous beta-adrenergic stimulation is equivocal. Beermann et al, 
(1985a) reported a 50% reduction of insulin and a 25% increase of 
thyroxine over controls in lambs receiving 10 ppm cimaterol in their 
diet. However Grisdale-Helland et al, (1986a) reported increases in 
the plasma insulin concentration of lambs receiving a cimaterol 
infusion (69 ng/kg/min).
Chronic treatment of rats with clenbuterol did not affect plasma 
insulin, growth hormone or triiodothyronine levels (Emery et al,
1984). It has been noted (Stiles et al, 1984) that the symptoms of 
hyperthyroidism and excessive beta-adrenergic stimulation are similar. 
Thyroid hormones may increase beta-receptor number or affinity or 
affect the coupling mechanism within the cell membrane.
More rigorous tests suggest that the involvement of growth hormone 
in mediating beta-adrenergic stimulation is unlikely. From independent 
studies examining the cellular aspects and composition of skeletal 
muscle growth in lambs fed 10 ppm cimaterol for seven or twelve weeks 
and in swine receiving up to 200 uq/kg/6 porcine somatotrophin (growth 
hormone) from 45 to 100 kg Beermann et al (1987) concluded that, 
while both agents increased muscle protein deposition, 
somatotrophin-induced muscle hypertrophy appeared to act through 
satellite cell proliferation whereas cimaterol induced hypertrophy did 
not. Thus if an exogenous beta-agonist and growth hormone apparently 
exert their effect in different ways it is unlikely that the action of 
the beta-agonist is mediated via endogenous growth hormone. However, 
Williams et al (1987b) did note a synergistic effect between 
exogenous bovine growth hormone and clenbuterol in young calves.
Thiel et al (1987) conducted an experiment using normal and 
hypophysectomized rats given cimaterol at between 0 and 100 ppm in the 
diet for 14 or 21 days, to determine if the repartitioning effects of 
cimaterol were dependent on a functional pituitary axis. Muscle 
weights were increased by approximately 21% in both types of rats 
indicating that the pituitary axis was not important for the 
repartitioning effect of this agonist.
The involvement of insulin in mediation of exogenous 
beta-adrenergic stimulation is more difficult to define. An 
explanation for the discrepancy between the results of Beermann et al 
(1985a) and Grisdale-Helland et al (1986a) may lie in the fact that 
in the former study the sheep were fasted overnight whereas in the
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latter blood sampling was carried our for a six hour period immediately 
following withdrawal of food when background insulin levels would be 
low and high respectively. If insulin an3 its antagonist glucogen are 
involved in the beta adrenergic response they may exert their effect 
via alterations in membrane fluidity. An increase in membrane fluidity 
would increase the sensitivity of the membrane bound beta-receptors as 
these normally exist as separate subunits within the membrane which 
have to become physically associated before they can be subject to 
stimulation (Houslay, 1985).
Incidentally beta-receptors can be desensitized by a novel method 
of 'down regulation1 in which receptors are seguested away from the 
cell surface in small membrane bound compartments which remain 
physically associated with the cell membrane (Strader et al, 1984).
Down regulation may also occur as a result of receptor uncoupling 
(Stiles et alf 1984).
A reduction in voluntary food intake has occasionally been noted 
following the use of relatively high levels of beta-agonists in pigs 
(Moser et al, 1984), cattle (Ricks et al, 1984a) and sheep (Baile 
et al, 1972). Hiis response is more clearly defined in monogastric 
than in ruminant animals. Voluntary food intake is thought to be 
adrenergically controlled and it is possible that a reduction in 
voluntary food intake mediated by exogenous beta-agonists results in 
reduced levels of circulating insulin (related to feeding behaviour) 
and hence reduced lipogenic stimulation by this circulating hormone. 
This sequence of events is however unlikely as significant reductions 
in fat accretion have been noted in trials where voluntary food intake 
has been unaltered.
Another possible mechanism by which beta-agonists may exert their 
repartitioning effect is by a redirection of blood and hence nutrient 
flow, altering the pattern of nutrient availability between different 
tissues. Stimulation of beta-receptors on blood vessels leads to 
relaxation of the smooth muscle and. vasodilation (Vernon & Peaker,
1983). Vatner et al, (1986) demonstrated that there were different 
patterns of beta-receptor subtypes on different bovine tissues, heart 
being predominantly beta-], lung predominantly beta2 and the large 
coronary artery being intermediate with a ratio of beta-j : beta2 of 
1.5-2.0 : 1.0. It is thus possible that if different blood vessels 
carry varying proportions of beta-j^ and beta2 receptors subtypes 
selective vasodilation may occur during exogenous beta stimulation
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resulting in a redirection of nutrient flow.
While the exact mechanisms are still uncertain, the repartitioning 
of nutrients appears to occur as a result of the direct action of 
beta-agonists on the receptors of both adipose and muscular tissue with 
alterations in circulating hormones perhaps having a minor effect. 
Selective vasodilation resulting a redirection of nutrient supply may 
also be involved.
Effects on the carcass composition and performance of farm livestock
When included in the normal diet of cattle, sheep, pigs and 
poultry beta-agonists increase protein deposition in the carcass (+ 15% 
approximately) and reduce total body fat (- 18% approximately). These 
effects occur in entire males, castrates and females. Summary tables 
relating to the published work on the effect of beta-agonists on 
livestock performance and body composition are given by Williams 
(1987).
Where different levels of beta-agonists have been given there are 
indications of dose related changes in carcass composition in pigs up 
to an inclusion level in the diet of 1.0 ppm. In sheep responses have 
been achieved with clenbuterol up to 2.0 ppm and cimaterol up to 10.0 
ppm in the feed (Williams, 1987). Parenteral administration of 
cimaterol has been shown to have a similar effect to oral 
administration in altering the body composition of cattle, sheep and 
pigs (Hanrahan et al, 1986). By either route of administration, the 
effects of beta-agonists on body fat and protein have been relatively 
consistent within each commercial livestock class examined.
Studies in which clenbuterol was orally administered to rats 
(Berne et al, 1985) demonstrated the existence of a strain X 
treatment interaction. Whilst the agonist achieved consistent 
reductions in fatness for all four strains of rat examined, the effect 
on muscle protein acretion was influenced by the rat strain. No such 
interaction was observed on feeding cimaterol to a variety of sheep 
breeds with different propensities to fatten (Hanrahan et al, 1986). 
However in pigs, investigations using heart muscle and adipose tissue 
have revealed that the Pietrain breed has between 31 and 38% more beta- 
receptors than the Large White breed (Bocklen et al, 1986). These 
receptors have equal affinities for beta-agonists and thus the Pietrain 
breed may be much more responsive to exogenous beta stimulation.
The majority of trials examining the effects of exogenous
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beta-agonists on the body composition of commercial livestock have 
involved animals at a relatively late stage in their development.
Baker et al (1984) suggested that the treatment response is enhanced 
with increased maturity and liveweight. This was confirmed in an 
experiment by Mersmann et al (1987) which failed to demonstrate any 
effect of dietary cimaterol at 0, 0.25 or 0.50 mg/kg diet when fed to 
growing pigs slaughtered at 60 kg liveweight. Dietary cimaterol has 
proved extremely effective in altering the carcass composition of 
finishing pigs. However, Williams et al (1986) was able to 
demonstrate an increase in nitrogen acretion and a reduction in fat in 
veal calves given 0.1 or 1.0 mgAg diet clenbuterol from 21 days of age 
until a slaughter weight of 150-170 kg was achieved. In this trial it 
was also noted that the increased nitrogen acretion occurred in the 
carcass rather than in the hide, gut or viscera yielding a beneficial 
increase in carcass weight at the expense of non carcass components.
Besides the repartitioning of nitrogen between carcass and non 
carcass components, animals treated with beta-agonists also undergo 
conformational changes. When lambs were treated with cimaterol 
individual muscles responded differently so that the hind leg 
consistently represented a higher proportion of the carcass (Beermann 
et al, 1986). This effect may have arisen because the hind limb 
muscles are relatively late maturing and thus may have been influenced 
to a greater extent by the beta-agonist. The superior development of 
the hind quarters of treated animals represents a qualitative 
improvement in the carcass in addition to any quantative changes which 
have occurred, increasing carcass value.
In studies with broilers (Dalrymple et al, 1984) the 
repartitioning effect of dietary clenbuterol was more pronounced in 
female than in male birds. Uiis effect may be related to the tendency 
for females of any species to have a greater body fat content than 
males of the same species at approximately equal age and liveweight.
If the repartitioning effect of beta-agonists primarily results from 
nutrient sparing due to increased rates of lipolysis, then one would 
expect greater repartitioning effects in initially fatter animals.
This hypothesis may also provide the explanation for more pronounced 
repartitioning effects in more mature or heavier animals where initial 
levels of fatness would also be greater.
In contrast to the relatively consistent action of beta-agonists 
on body composition, no concensus has been reached concerning their
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effect on performance characteristics. The food conversion efficiency 
(food intake : liveweight gain) would-be expected to improve in an 
animal utilizing a greater proportion of its nutrient intake for 
protein deposition as this energetically more efficient than the 
production of body lipid. However exogenous beta-adrenergic 
stimulation has been shown to increase metabolic rate resulting in 
elevated maintenance requirements which may offset any benefits of 
reduced lipid deposition (Beerman et alr 1986). In addition the 
maintenance cost of 1 kg protein is greater than that for 1 kg fat once 
deposited (Moser et aly 1986).
Effects on liveweight gain reflect the relative effects on the 
rates of protein (and water) and fat deposition. In animals showing 
rapid liveweight gains or nearing maturity, where the rate of fat 
deposition is high, there is a large potential for the action of a 
beta-agonist with respect to fat deposition and liveweight gain may be 
reduced. Alternatively where the magnitude of the protein anabolic 
effect is greater than the reduction in fat, weight gain will be 
increased (Williams, 1987).
Investigations have been made into the effect of beta-agonists 
under different dietary conditions. Young pigs given adequate as 
opposed to inadequate dietary protein with or without clenbuterol had 
inproved performance and carcass characteristics but these effects were 
attributable solely to the protein and not to the beta-agonist 
(Mersmann et al, 1987). In a separate study with lambs Beermann £t 
al (1986) reported that when fishmeal replaced soya in the diet all 
msasures of skeletal muscle development were increased. When cimaterol 
was given the response with fishmeal was always less than with the 
soya, although the observed muscularity was always greater (i.e. the 
effects of fishmeal and cimaterol were not additive). A differential 
effect occurred in that the effects of cimaterol and fishmeal on the 
muscles of the fore-limbs were always smaller than those on the hind 
limbs. This was attributed to the contrasting growth potential of the 
different muscle groups since at the start of the experiment the 
muscles of the hind limbs had attained a smaller proportion of mature 
size than those of the fore-limbs and so had a greater potential for 
growth.
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Meat quality effects
Meat quality is affected by both the handling of animals prior to 
slaughter and the procedures adopted immediately after slaughter during 
the processing stage, in addition to any compositional changes in fat 
and muscle induced during the life of the animal. Wood and Brown 
(1987) reported no changes in the firmness of shoulder fat or muscle 
quality of pigs following dietary administration of a beta-agonist 
during the finishing period. The pH in the longissimus dorsi at 45 
minutes post slaughter and the reflectance of light from this muscle (a 
measure of paleness) did not differ between treated and control groups. 
Similar results were obtained in pigs by Moser et al (1986) following 
cimaterol treatment but a significantly increased marbling score was 
noted. It has been proposed that cimaterol may increase lipolysis and 
consequently increase the use of free fatty acids as an energy source 
in muscle. It is possible that some of these free fatty acids may be 
esterified by muscle adipocytes increasing the marbling score.
Contrary to these findings are the reports of several authors 
indicating that treatment with beta-agonists increased the proportion 
of type II fibres in skeletal muscle (Hamby et al, 1986; Beermann et 
al, 1985b; Beermann et al, 1987). Type II muscle fibres are 
associated with a reduced muscle lipid content and increasing the 
proportion of type II fibres also increases the glycolytic activity of 
the muscle. Post-mortem glycolysis is important in achieving the 
correct depression in muscle pH and any factor reducing glycogen levels 
in muscle prior to slaughter consequently limits post-mortem 
glycolysis. Muscle pH remains high which facilitates bacterial 
degradation of the meat and in cattle causes dark cutting; i.e. an 
undesirable darker meat. Reduced muscle glycogen stores are implicated 
following the administration of cimaterol to lambs, resulting in a 
higher ultimate pH (+ 0.31 units) 24 hours after slaughter (Beermann 
et al, 1985c). Measures designed to limit pre-slaughter stress may 
be necessary in order to conserve limited glycogen stores following 
beta-agonist treatment and permit normal post-mortem glycolysis .
Apart from adverse effects on post-mortem glycolysis, treatment of 
animals with beta-agonists may also increase the tendency for 'cold 
shortening' to occur. This phenomenon is associated with the rapid 
chilling of hot carcasses while the muscle is in the early pre-rigor 
condition and may be a feature of carcasses with reduced fat cover. A 
muscle temperature drop to between 10 and 15oc produces a greater
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degree of inter-digitation of actin and myosin and a greater measure of 
cross-bonding during the onset of rigor mortis (cold shortening) 
resulting in increased toughness of the meat. This is measured by 
changes in shear force values. Beermann et al 0 985c) found no 
evidence of increased meat toughness in lambs following cimaterol 
treatment. However shear force values were increased for meat from 
lambs treated with clenbuterol (Hamby et alr 1986) and pigs treated 
with cimaterol (Jones et alf 1985). Cold shortening is primarily a 
feature of leaner carcasses rather than a specific effect of 
beta-agonists.
Effect of withdrawal period
A withdrawal period is usually required for the registration of 
growth manipulating substances in order to ensure that there is no 
residual metabolic activity when animals are slaughtered for human 
consumption. There is a dearth of information about tissue residues 
resulting from the use of beta-agonists. MacRae et al (1986) found 
that, although clenbuterol treatment increased mean heat production by 
0.5 MJ/day for a 40 kg sheep, in the seven day period immediately after 
its withdrawal, mean heat production was not significatnly different 
from pretreatment values. This may be taken as an indication that the 
metabolic effects of beta-agonists are short-lived and that any 
residual activity of these compounds arises from their sequestration in 
organs such as the liver.
During a seven day pre-slaughter withdrawal period cimaterol 
treated pigs displayed a compensatory increase in feed intake and an 
accelerated rate of fat deposition compared to untreated controls. 
However at slaughter levels of carcass fat were still less than in 
untreated animals, while muscularity remained the same as in treated 
animals not subject to a withdrawal period (Jones et al, 1985b). A 
five day withdrawal period in poultry did not negate effects on protein 
and fat in the carcass compared to treatment up to slaughter (Da.lrymple 
et al, 1984).
Side effects of beta-agonists as repartitioning agents
Apart from its repartitioning activity, clenbuterol hydrochloride 
displays bronchodilator and tocolytic properties and is marketed in two 
preparations with the trade names 'Planipart' and 'Ventipulmin1. The 
former is used in cattle and sheep to relax the uterus and delay the
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onset of parturition, while the latter is used as a bronchodilator 
during pulmonary disease in horses. Contra-indications and warnings 
state that intravenous dosing can produce transient mild muscular 
tremor and sweating (Owen, 1981).
Tachycardia has been observed following the initiation of 
clenbuterol treatment in cattle and sheep. The heart rate of two lambs 
was raised from 150 to 250 beats per minute within four hours after the 
commencement of an intragastric infusion containing clenbuterol (1.5 
mg/day) and deep rectal temperature was elevated by approximately 1°C 
(Herbert et al, 1985). Within three days one lamb had adapted to the 
drug and on a second challenge the effect on heart rate was greatly 
reduced. No such adaptation was made by the other lamb necessitating 
drug withdrawl.
Brockway et al (1987) reported an increase in heart rate and a 
decrease in blood pressure during the first three days of oral 
administration of clenbuterol to sheep. Tachycardia may be a reflex 
reaction in response to vasodepression (beta2 effect) or it may arise 
directly from beta  ^stimulation. The subsidence of tachycardia 
indicates that the cardiovascular system can become desensitized to 
beta-agonists. No such desensitisation is apparent in the muscular 
system.
In addition to an intial cardio-vascular insult, there is a 
suggestion that the inclusion of cimaterol in the diet of fnishing pigs 
precipitates a greater incidence of hoof lesions (Jones et al, 1985). 
However this apparently does not affect locomotive scores (Jones et 
al 1985, Moser et al, 1986). It is probable that in repartitioning 
nutrients towards the carcass, cimaterol promotes the formation of a 
softer type of horn which is more susceptible to damage.
Oonmercial future for beta-agonists
The beta-agonists currently available (clenbuterol and cimaterol) 
exert consistent effects on the body composition of commercial 
livestock increasing protein acretion (a beta2 effect) and reducing 
fat deposition (a beta^ effect). These effects are probably mediated 
by pharmacologically distinct mechanisms. Beta-^  stimulation of the 
cardiovascular system resulting in undesirable side effects 
(tachycardia and elevated metabolic rate) would limit the use of these 
current compounds commercially, especially in situations where group 
feeding results in inaccurate control of administration rate. Even
61
short term tachycardia represents a severe insult to an animals 
metabolism and this may necessitate the production of analogues of 
clenbuterol which selectively stimulate the required traits (Asato et 
al, 1984).
Effects of beta-agonists on fat deposition are likely to be 
dimished by the requirement for a pre-slaughter withdrawal period but 
this may be beneficial in terms of reducing the incidence of cold 
shortening. Current slaughter practices may have to be altered to take 
account of reduced muscle glycogen levels in beta-agonist treated 
animals. Finally further work is required to quantify residues, if 
any, in meat accruing from the use of repartitioning agents.
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EXPERIMENT 1
NITROGEN BALANCE AND DIGESTIVE EFFICIENCY STODIES CONDOCTED WITH YODNG
STEERS GIVEN EEPAKTITIONING AGENTS
Introduction
The present experiment describes the nitrogen balance and 
digestive efficiency results obtained when beta-adrenergic agonists 
were infused intravenously into young growing steers for a period of 15 
continuous weeks. Graded doses of bitolterol (4-Methylbenzoic acid 
4-(2-((lfl-dimethylethyl)amino)-l-hydroxyethyl)-l,2-phenylene ester; 
P-toluic acid- 4-(2-(t-butylamino)-l-hydroxyethyl) -o^ phenylene ester 
-((tert-butylamino)methyl)-3,4-dihydroxybenzyl alcohol 
3,4-di-p-toluate) a beta-agonist of unknown potency were compared with 
infusions of the established agonist clenbuterol or physiological 
saline. Administration by continuous intravenous infusion rather than 
by an oral route negated possible deleterious effects of the digestive 
system on the beta-agonists weakening their physiological effect and 
thus promoted accurate assessment of dose response relationships.
Materials and methods
Experimental design
The design was that of two identical 5 x 5  Latin Squares using ten 
calves (1-5, and 7-11). There were five treatments which were changed 
after each three week period.
Period Weeks 1 2 3 4 5 7 8 9 10 11
I 0-3 A B C D E A B C D E
II 3-6 E A B C D E A B C D
III 6-9 D E A B C D E A B C
IV 9-12 C D E A B C D E A B
V 12-15 B C D E A B C D E A
The intended treatment rates were:
A = Physiological Saline (0.9% w/v NaCl)
B = Bitolterol 1 mg/day D = Bitolterol 25 mg/day
C = Bitolterol 5 mg/day E = Clenbuterol 1 mg/day
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Animals
Castrated male Friesian calves aged four months and weighing 
approximately 120 kg at the beginning of the trial were used. Ten 
animals were permanently housed in metabolism stalls following an 
initial acclimatisation period of at least seven days. In addition, 
five similar calves were group-housed in a straw-bedded pen and 
maintained as possible replacements.
Feed
Within each trial period all calves, including the replacement 
group, received the same daily allowance of a grass/cereal mix/mineral 
complete cube preparation ('Superstar1 cubes, Hamlyn Milling, Balgarvie 
Mill, Scone, Perthshire? mean analysis (10 samples), crude protein (CP) 
147, crude fibre (CF) 143, ether extract (EE) 42 and ash 97 g per kg 
dry matter (DM). For calves in metabolism stalls this was supplemented 
with barley husks (siftings) to increase long fibre intake and prevent 
bloat. The two feed components were offered as a uniform mixture. 
Replacement calves received additional long fibre from barley straw 
used as bedding material. Daily feed allowance was increased at the 
beginning and end of the third treatment period in order to maintain an 
average daily gain of 0.5 kg. Feed refusals were generally small.
Water was available ad libitum.
Infusion treatments
Treatments were administered to calves accommodated in metabolism 
stalls by the continuous intravenous infusion system described in 
'General Materials and Methods' (Section E.l). Preparation of infusion 
packs containing beta-agonists and maintenance procedures for the 
infusion system were as described in Appendix 1. Treatments were 
changed after each 21 day period and this was achieved by simply 
replacing existing infusion packs with full packs containing the new 
infusion treatments at a standard time (11.00 h).
Digestibility and nitrogen balance studies
Hie ten calves were permanently housed in metabolism stalls 
throughout the 15 week experiment. Separate total collections of urine 
and faeces were made during days 7-14 and 14-21 of each of the five 21 
day treatment periods (I to V). Food intake was also recorded at these 
times. Subsampling and subsequent chemical analysis of food, faecal
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and urine samples were as previously described.
Time cost study
A detailed account was kept of the time required to carry out 
routine procedures associated with both the metabolism studies and 
maintenance of the infusion system. An estimation was also made of the 
total time spent in dealing with unanticipated occurrences such as the 
loss of a catheter.
Statistical Analyses
The experimental results were assessed in an analysis of variance 
in which three factors namely period, calf and treatment were included 
in an array of 10 calves and 5 time periods. A Formal test (F-test) 
was applied and where treatment effects were significant a multiple 
comparisons test between mean values was performed. For nitrogen 
balance data only separate partial analyses of periods I-II and III-V 
were carried out in order to ascertain whether the increased feed 
input, and consequent increased nitrogen input, from period III onwards 
markedly affected the potency of either beta-agonist.
Results
General and clinical observations
The clenbuterol treatment was included as an 'internal marker' in 
that its effect upon various measured attributes was expected, whereas 
the effect of the bitolterol titration upon these same attributes was 
unknown. The design of the experiment was based on treatment periods 
of three weeks duration. Measurements of digestive capacity and 
nitrogen balance were not conducted until the second and third weeks of 
any period in order to facilitate the removal of any potential slight 
carryover effects and ensure that the animals were properly attuned to 
the current treatment.
The mean growth rate of the calves over the total experimental 
period of 15 weeks was 0.54 kg/d. Interestingly, these calves visually 
gave the impression of a marked increase in muscular development, 
especially of the hindquarters, when compared to calves maintained on a 
similar diet as possible replacements. During the total course of the 
trial it was necessary to replace four of the experimental animals for 
reasons not related to treatment. Replacement calves were introduced 
at the beginning of a treatment period to allow acclimatisation. The
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calves showed no adverse reactions to treatment except that 
occasionally a mild muscular tremor together with tachycardia were 
observed in calves receiving the clenbuterol treatment or bitolterol 
(25 mg/d) when residual fluid was rapidly infused before replacement 
with a new infusion pack. The catheter for each calf was replaced on 
average 3.3 times during the course of the 15 week trial. Hie 
principal reasons for replacement were fissuring of the PVC catheters 
used in the preliminary stages of the trial and calf interference.
Infusion Rates
Stock and working solutions were stored at ambient tenperature 
(12oc) with the exception of the stock bitolterol 25 mg/d which was 
stored at 4QC. The results of analyses of the treatment samples 
taken from the saline packs at the end of each treatment period are 
shown in Table 1. Clenbuterol was administered at the intended target 
rate of 1.0 mg/d. However, the bitolterol treatments were all lower 
than target throughout all five periods and over the whole experimental 
period the dose rates for the 1, 5 and 25 mg/d treatments were 50, 74 
and 82% of those intended respectively, namely 0.5, 3.7 and 20.5 mg/d. 
The stock solutions were known to be stable when stored at ambient 
temperatures (as above). The observed reductions of bitolterol 
concentrations is attributed to the adsorption onto the plastic surface 
of the infusion packs.
Table 1. Concentration and infusion rates, intended and determined for 
clenbuterol and bitolterol during each of the five treatment 
periods
Concentration mg/1 saline Dosage rate mg/d
Intended Actual in Period Intended Actual
Overall
I II III IV V Overall
Bitolterol 4 2.1 2.4 2.9 2.1 1.3 2.1 1 0.5
Bitolterol 20 15.6 14.2 15.7 14.4 14.1 14.8 5 3.7
Bitolterol 100 82.9 78.7 86.2 85.1 79.6 82.5 25 20.6
Clenbuterol 4 4.4 4.1 4.3 4.0 4.1 4.2 1 1.0
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Digestive efficiency
No carryover was apparent when a comparison of the separate 
results from the two recording weeks in any period was made. Also a 
separate examination of the data analysed as two 5 x 5  replicate blocks 
(ignoring the calf effects, which were small) showed there to be no 
period X treatment effects.
The mean digestibility coefficients for the various proximate 
fractions of the complete diet given to the calves for days 7-21 
inclusive of each period are presented in Table 2 (individual values 
are detailed in Appendix 2). There were no significant effects of the 
infusion treatments on the digestive efficiencies of the calves.
A calculation using the mean energy digestibility coefficient of 
0.63 shows that the mean intake of 3.88 kg DM feed containing 68 MJ 
Gross Energy (GE) yields 43 MJ Digestible Energy (DE) which may be 
calculated (MAFF, 1984) to supply about 35 MJ Metabolisable Energy 
(ME). The feed thus had an energy concentration (M/D) of 9 MJ ME/kg 
DM, and for a calf of mean iiveweight 150 kg this ration provides 
sufficient energy to support a calculated daily liveweight gain (DIWG) 
of 0.5 kg. The actual mean DIWG observed was 0.54 kg.
Nitrogen balance
Feed allowance was increased during the 15 weeks of the experiment 
to allow for sustained growth of the calves. Consequently, nitrogen 
intakes were about 50% greater in periods III-V than in periods I and 
II (approximately 93 and 67 g nitrogen/day, respectively).
Mean nitrogen balance data for days 7-21 inclusive for periods I- 
II and periods III-V together with all periods combined revealed a 
highly significant (P<0.001) increase in nitrogen retention for 
clenbuterol (1 mg/d) compared to saline, with a smaller but also 
significant (P<0.05) increase for bitolterol (25 mg/d). These effects 
were principally derived through significant (PC0.01) reductions in 
urinary nitrogen excretion, faecal nitrogen excretion being apparently 
unaffected by treatment.
Separate analyses of periods I-II and periods III-V (where N 
intakes were about 67 and 93 g/d respectively) revealed no significant 
treatment effect on nitrogen retention for either level of nitrogen 
intake. However in periods III-V both clenbuterol (1 mg/d) and 
bitolterol (25 mg/d) treatments resulted in significant (P<0.01, 0.05 
respectively) reductions in urinary nitrogen excretion compared to
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Table 3. Mean nitrogen balance (g/d) with SE mean for days 7 to 21 
inclusive of calves receiving infusions of physiological 
saline, 1 mg/d clenbuterol and 1, 5 and 25 mg/d bitolterol.
Period I and II Intake Faeces Urine Retention
Saline (A) 67.24 28.55 19.57 18.56
Bitolterol 1 (B) 67.24 29.04 18.36 21.04
Bitolterol 5 (C) 66.20 29.65 17.38 18.59
Bitolterol 25 (D) 66.03 29.13 16.81 20.71
Clenbuterol 1 (E) 67.24 29.00 16.61 21.19
SE Mean 0.71 0.74 0.86 0.65
Significance 
between treatments
NS NS NS NS
Period III to V
Saline (A) 93.60 37.75 27.19 28.66
Bitolterol 1 (B) 92.99 35.67 25.77 31.54
Bitolterol 5 (C) 93.08 36.46 23.68 32.95
Bitolterol 25 (D) 92.39 36.31 23.20 32.86
Clenbuterol 1 (E) 93.09 36.96 20.34 35.78
SE Mean 1.19 1.01 1.26 1.56
Significance 
between treatments
NS NS AD*
AE,BE**
NS
All periods
Saline (A) 83.07 34.07 24.38 24.62
Bitolterol 1 (B) 82.71 33.02 22.34 27.34
Bitolterol 5 (C) 82.34 33.72 21.40 27.21
Bitolterol 25 (D) 81.85 33.44 20.44 28.00
Clenbuterol 1 (E) 82.77 33.77 18.97 29.95
SE Mean 0.70 0.62 0.92 1.04
Significance 
between treatments
NS NS ACfBE*
AD**
AE***
AD*
AE***
Significance * PC0.05, ** P<0.01, *** P<0.001
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saline. Nitrogen balance data expressed in terms of percentage of 
nitrogen intake and individual calf data are contained in Appendix 2.
Time cost study
The average time required to perform the basic daily routine 
during this study was approximately four and a half hours per day and a 
breakdown of the operations involved is given in Figure 11. Of the 
total routine daily time only 19% was spent in monitoring the infusion 
system while the remaining 81% of the time was engaged in conducting 
metabolism studies. In addition to the daily routine, many operations 
such as changing pumphead tubing and subsampling of urine and faeces 
were carried out on a regular but not daily basis and the average time 
cost of these .is given in Table 4a. In Table 4b an estimation is made 
of the considerable time spent in dealing with problems associated with 
the infusion system.
Of the total time involved in carrying out daily and regular 
routine procedures during the 15 week experiment, 23.9% was spent on 
maintenance of the infusion system and the remainder was spent 
conducting the metabolism studies. The most time consuming operation 
was emptying the faecal collection bags which accounted for 14.0% of 
the total time. This was followed by checking the peristaltic pumps 
and recording flow rates which took 9.7% of the total time. Although 
checking catheters only took 6.5% of total time actual time spent 
maintaining the catheters was considerably longer due to the various 
problems encountered. The time required to deal with such problems was 
dependent on such factors as environmental temperature (affecting the 
flexibility of the tubing) and calf cooperation. An unquant if iable but 
not inconsiderable time was also spent in investigating random 
decreases in flow rate and straightening kinked catheters. Complete 
catheter replacement accounted for the majority of non-routine time 
spent on catheter maintenance as it was the most time consuming 
operation and was usually eventually necessitated by other catheter 
problems.
70
Transfer of faeces from small to bulk containers 
Replacement of urine filters
Checking cathetersWashing the metabolism 
house floor
Checking pumphead and 
^infusion tubing
Weighing infusion packs
—  20 -
30Washing metabolis 
stalls
30
Emptying urine 
receptacles 20
Weighing fe e d30
75 30
Feed distributionEmptying faecal  
collection bags
Refilling water buckets
Routine total time cost : 4 hours 23 minutes/day
Values indicate time taken (minutes)
Shading separates metabolism from infusion duties
Figure 11. The time cost of procedures carried out on a 
daily basis during the continuous intravenous 
infusion of beta-agonists into cattle.
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Table 4. The time cost of additional procedures carried out during 
metabolism studies with continuous intravenous infusion of 
beta-agonists into ten steers
a) Regular but not daily procedures 
Procedure Interval
(days)
Time Reqd 
(minutes)
Changing pumphead tubing 6 12
Replacement of empty infusion packs 4 45
Preparation of infusion packs 4 30
Weighing/subsampling bulk faecal and urine 7 & 14 360
collections
Washing receptacles for faeces and urine 7 & 14 80
Preparation of faecal slurries 7 & 14 30
Grinding dried faecal and feed samples 7 & 14 70
Washing sample drying trays 7 & 14 20
Labelling sample containers 7 & 14 20
Checking and adjusting calf harness 3 15
Grooming calves 3 45
b) Irregular procedures 
Procedure
Application of topical ringworm treatment
Occurrence Time Reqd 
(No. times) (minutes) 
Dependent on 
infection
*Renewal of bandaging
Catheter disconnected from infusion tubing 3
Chewed tubing - joint with S-type connector 5
- complete replacement 2
Cracked and leaking catheter 15
Needle disconnected from plastic part of catheter 2 
Catheter looping out of calf's neck with/without 
stitch detached from skin 12
Catheter pulling through outer sleeve 2
Teflon catheter lying subcutaneously 8
Complete catheter replacement 33
10
15
20
30
30
20
10
12
15
45
*A11 catheter/tubing problems involved the renewal of bandaging.
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Discussion
In previous investigations into the physiological effects of 
beta-agonists in farm livestock, these substances have either been 
administered orally or by discrete injections. Both of these routes 
provide a pulsed dosage of the substance concerned and this may 
represent a greater insult to the animals metabolism than continuous 
low level administration. The uptake of beta-agonists from the 
digestive tract may be influenced by dietary composition and thus the 
'metabolic dose rate1 is not clearly defined. For this reason results 
obtained from this trial may not be strictly comparable with those 
obtained from feeding trials.
Intravenous administration of either clenbuterol or bitolterol did 
not adversely-affect voluntary food intake. Oral administration of 
clenbuterol to steers at 500 mg/day has been shown to reduce voluntary 
food intake and also rumen fermentation (Ricks et al, 1984a).
Voluntary food intake is thought to be adrenergically controlled and 
reductions may result from high levels of adrenergic agents crossing 
the blood/brain barrier and engaging in excessive stimulation. However 
adrenalin is known to depress rumen motility and it is possible that 
other agonists may also directly affect the rumen in this way, slowing 
the on passage of digesta and consequently limiting intake. If rumen 
fermentation is restricted one would perhaps expect a concomitant 
reduction in digestive efficiency. In view of the absence of effects 
on voluntary food intake, the lack of effect of either intravenous 
clenbuterol or bitolterol on the digestibility of the experimental diet 
or faecal nitrogen excretion is to be expected.
Both clenbuterol and bitolterol apparently acted at the metabolic 
level, their principal effect being to reduce urinary nitrogen 
excretion and thereby increase nitrogen retention as demonstrated at 
the higher intakes of nitrogen during periods II-V. Higher intakes of 
nitrogen occurred in the latter periods of the trial because the 
animals were gaining weight and thus required more food. Reduced 
urinary nitrogen excretion and consequent increased nitrogen retention 
was evident, thought not significant, in both the earlier experimental 
periods (I-II) when nitrogen intake was lower.
From nitrogen balance results it may be concluded that clenbuterol 
is a much more potent agonist than bitolterol since an infusion of only 
1 mg/day induced a greater response than 25 mg/day bitolterol. While 
the structure of clenbuterol is very similar to that of adrenalin
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(Figure 10, ) bitolterol has a very different chemical structure 
(Figure 12, below).
H O C H C H 2 N H C (C H 3 )3
F igure72. The chemical  s tructure  of b i to l te ro l
The repartitioning agents currently used in farm livestock 
(clenbuterol and cimaterol) have been loosely classified as beta~2 
agonists and the exact mechanism by which they exert their effect has 
yet to elucidated. There is some disagreement as to whether these 
substances act primarily as lipolytic or antilipogenic agents with 
regard to fat metabolism, but the consensus regarding protein 
metabolism appears to be that they reduce degradation. The structure 
of bitolterol is entirely different from that of clenbuterol and thus 
it is possible that the observed increases in nitrogen retention may be 
mediated by an entirely different mechanism. If both agonists act via 
the same physiological mechanism then it is probable that the strength 
of the response will be different because the chemical structures are 
different, resulting in differing intensities of receptor stimulation. 
Unfortunately no blood analyses were carried out to measure circulating 
free fatty acid or hormone concentrations in the calves.
The effect of treatment on final carcass composition could not be 
differentiated as the experimental design was that of a Latin square in
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which each animal received each treatment. However the external 
appearance of the steers was considerably more muscular than that of 
similar animals maintained on the same diet as possible replacements 
suggesting that the use of a repartitioning agent in general had 
improved the lean percentage of the carcass and resulting animal.
With the exception of occasional instances when residual fluid was 
rapidly infused into animals prior to replacement of infusion packs, no 
adverse reactions such as tachycardia were observed in any of the 
calves. Since these reactions represent a severe metabolic insult to 
the animal, in practice the most efficient way to administer 
beta-agonists to animals would be by means of a suitably designed 
implant or slow release device. However the nitrogen balance data from 
this trial suggests a slightly diminished response to adrenergic 
stimulation through time and thus long term low level continuous 
administration may not be practicable.
In view of the relatively high doses of bitolterol required to 
significantly increase nitrogen retention when administered by 
intravenous infusion compared to clenbuterol, very high doses indeed 
would be required if administration was via an oral or subcutaneous 
route where losses of the drug would inevitably occur. Considering 
also that excessive doses of this substance produce the same adverse 
reactions in cattle to excessive doses of clenbuterol, bitolterol 
apparently has no advantage over existing and more potent beta- 
adrenergic agonists.
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UTERMHRE REVIEW 
Introduction
The bovine gastrointestinal tract may be inhabited by a variety of 
nematodes, the most important genera being Ostertagia, Cooperia, 
Trichostrongylus and Nematodirus. In North Western European countries 
the most abundant species are Cooperia oncophora and Ostertagia 
ostertagi which typically are located in the small intestine and the 
abomasum respectively (Kloosterman et al, 1984). 0. ostertagi is
generally regarded as the nore pathogenic species (Anderson et al,
1965? Entrocasso et al, 1986a; Frankena, 1987) and has been 
associated with most recorded clinical outbreaks of bovine parasitic 
gastroenteritis (PGE) (Armour and Ogbourne, 1982). However the 
deleterious contribution of C. oncophora to PGE has been difficult to 
assess as this parasite is expelled rapidly in comparison to 0. 
ostertagi and residual populations are consequently small by the time 
that clinical symptoms are apparent.---
Experimental studies have demonstrated that C. oncophora is a 
potential pathogen if massive numbers of infective larvae are ingested 
by susceptible animals (Herlich, 1965; Armour et al, 1.987a) and under 
these conditions its pathogenicity may equal or exceed that of 0. 
ostertagi. Under field conditions Baker (1988) asserts that in cattle 
Ostertagia does not occur as a causative agent of PGE without the 
accompaniment of Cooperia and occasionally Nematodirus.
Life cycle
Both 0. ostertagi and C. oncophora have a direct 1i fe cycle 
involving distinct free-living and parasitic stages as summarised in 
Figure 13. In the free-living stage, eggs passed in the faeces develop 
into first stage larvae (Lj) which hatch, develop and moult to become 
second stage larvae (L2). These in turn develop and moult to the 
third infective stage (L^ ). All of this occurs within the faecal 
pat. Under moist conditions the larvae then migrate onto the 
herbage retaining the outer sheath of the L2 which renders them the 
most resistant of the free-living stages. Following ingestion, the 
parasitic cycle involves the development to adults through and 
L5 stages.
Hie parasitic development of 0. ostertagi has been described by 
several authors (e.g. Clark-Osbourne et al, 1960; Ritchie et al,
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Figure 13. The life cycle of Ostertagia ostertagi and 
Cooperia oncophora.
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1966: Rose, 1969). Maturation from the to adult stage occurs 
within the gastric glands of the abomasum and takes between 16 and 21 
days. There is much associated tissue damage particularly on emergence 
of the adult worms into the abomasal “lumen.
Development of the parasitic stages of C. oncophora is less we11 
documented. Ingested exsheath in the abomasum and moult to the 
fourth larval stage in the small intestine, the final habitat.
Isenstein (1963) observed that three days after the oral inoculation of 
L3 to ca1ves all of the larvae were located in the proximal small 
intestine and that the prepatent period varied from 17 to 22 days.
Until recently it was generally accepted that the development of 
C. oncophora took place in the intestinal lumen and that no mucosal 
penetration occurs. This was often the reason cited for its apparently 
low pathogenicity (Frankena, 1987). However Armour et al (1987a) 
recovered approximately 50% of the larval stages of C. oncophora from 
the mucosal digests of calves necropsied at 21 and 42 days during a 
continuous 42 day experimental infection. These authors also noted 
that in the calf necropsied at 21 days, the worm burden was principally 
located in the duodenum whereas in the calf necropsied at 42 days the 
distribution in the intestine and stadial structure had altered such 
that the majority of worms were present in the ileum. In further 
calves subsequently necropsied at 82 days (42 days after the cessation 
of larval inoculation) the majority of infection was again recovered 
from the duodenum. From these findings the authors speculated that the 
worm burden may have migrated through the intestine during the course 
of the infection. However in view of the fact that only one animal was 
necropsied at 21 and 42 days an equally likely explanation is that 
differences in digesta, especially with the respect to acidity on exit 
from abomasum, may have influenced the predilection site in the two 
animals. Indeed in a separate study (Coop et al, 1979) where nine 
calves were experimentally infected with C. oncophora the majority of 
the worm burden was located in the first quarter of the small intestine 
in all but one animal in which it was located in the second quarter, 
demonstrating the existence of differences in predilection site in 
different animals.
The clinical disease
Most recorded field cases of clinical parasitic gastroenteritis 
have been associated with 0. ostertagi infection. Symptoms are
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usually apparent in first year grazing cattle towards the end of the 
grazing season and include ill thrift and failure to gain weight, a 
'staring coat1, inappetence, lethargy and intermittent profuse 
diarrhoea which is bright green in colour. In severe infections the 
eyes may appear sunken and submandibular oedema may be present.
Following reports by Martin et al (1957) of 'atypical parasitic 
gastritis' in which these symptoms occurred in cattle which had been 
winter housed and apparently healthy for up to five months a detailed 
field study of suspected outbreaks of ostertagiasis was carried out in 
south-west Scotland and northern England (Anderson et al, 1965).
These authors classified the disease into three phases, two of which 
(Type I and II) were clinically obvious. Type I ostertagiasis 
corresponds to the classical description of parasitic gastritis seen in 
first season grazing calves between July and October. The majority of 
the ingested larvae develop to maturity within the expected three week 
period. In Pre-Type II ostertagiasis large numbers of Ostertagia are 
present in cattle but the majority are inhibited in the early fourth 
larval stage. Affected animals show no clnical symptoms and usually 
have no history of diarrhoea although they have been grazing heavily 
infected pastures in the autumn. Clinical Type II ostertagiasis arises 
as a result of the synchronous maturation of these inhibited larvae and 
may be manifest up to six months after removal of cattle from pasture. 
The sequential development of Type I and Type II ostertagiasis in young 
cattle has been described by Entrocasso et al (1986a).
In contrast to 0. ostertagi which gives a relatively late and 
low peak in faecal egg output of infected calves associated with a 
constant turnover of worms, C. oncophora gives a rapid high peak 
followed by a dramatic decline as a result of host immunity. The 
majority of worms are expelled and only a small fraction is retained 
(Albers, 1981). Using experimental infections and the criterion of 
faecal egg output Coop et al (1979) concluded that acquired immunity 
becomes effective within two months after primary inoculation. Thus, 
although C. oncophora may be a predisposing factor in the occurence 
of PGE later in the grazing season, by the time clinical symptoms are 
apparent the numbers of this nematode are relatively small. Under 
experimental conditions single and multiple inoculations of calves with 
C. oncophora have resulted in anorexia, depressed weight gain and 
diarrhoea (Herlich 1965; Armour et al 1987a; Borgsteede and Hendriks, 
1979) but these have been of a transient nature in all but extremely
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heavy infections and Cooperia alone has never been associated with 
clinical disease under field conditions.
The propensity for arrested development of C. oncophora in 
tracer calves has been shown to be greater than for 0. ostertagi 
(Brunsdon, 1971; Bisset and Marshall, 1987) but there is no late season 
accumulation of early fourth larval stages in resident animals due to 
host immunity, and no disease syndrome comparable to Type II 
ostertagiasis in known. However in field cases of Pre-Type II 
ostertagiasis Anderson et al (1965) did note the presence of low 
numbers of inhibited Cooperia and it is possible that these may develop 
synchronously with 0. ostertagi and contribute to clinical Type II 
disease.
Pathogenesis
Structural changes produced by 0. ostertagi
The principal lesions of ostertagiasis are white, raised, 
umbilicated nodules on the surface of the abomasum which may be 
accompanied by hyperaemia and oedema. These primary lesions, located 
predominantly in the fundic region, are caused by the enlargement of 
the larvae within the gastric glands and any cellular changes are 
initially confined to the parasitised glands.
As larvae develop, the parasitised gland distends and stretches 
the surrounding glands stimulating multiplication of new cells in order 
to maintain the continuity of the epithelium. At this time the 
parietal cells become incorporated into this stretched epithelium and 
lose their microvillary structure which is necessary for HC1 secretion. 
Parietal cells in the parasitised glands are permanently lost, being 
replaced by mucous neck cells (Murray, 1968? Murray et al, 1970). 
Approximately seven days after infection, collagen accompanied by 
fibroblasts is deposited in the tissue around the parasitised glands 
and structural fibres abound in the necks of these glands 
(Stringfellow, 1974). The capillary network around the infected glands 
is also disrupted (Stringfellow, 1977).
By the time of emergence of adult 0. ostertagi from the gastric 
glands marked cellular changes have occurred and these are associated 
with clinical symptoms and alterations in the biochemical values of 
blood and abomasal fluid. Macroscopically there is hyperplasia and 
loss of cellular differentiation particularly of the parietal cells 
both in the parasitised and surrounding glands. In heavy infections
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where coalescence of these lesions occurs the mucosa assumes a Morocco 
leather appearance. Ultrastructurally some parietal cells are still 
distinguishable but are non functional resulting in elevations in the 
pH of abomasal fluid and permitting the survival of bacteria. The 
undifferentiated and hyperplastic mucosa is also abnormally permeable 
to macromolecules due to the breakdown of the junctional complexes 
between many cells. If the newly emerged adult worms are removed, 
glands surrounding the parasitised glands are able to resums normal 
function and re-establish ultrastructural characteristics within 48 
hours. However, glands which harboured developing larvae do not 
readily resume their normal glandular function (Armour et al, 1967a).
Structural changes produced by C. oncophora
A detailed study involving the serial slaughter of calves at 
regular intervals during infection with C. oncophora has not been 
undertaken and so consequently little is known about the associated 
structural damage. It has been generally accepted that the parasitic 
development of this nematode occurs entirely within the lumen of the 
small intestine resulting in only limited morphological changes to the 
tissues immediately in the vicinity of the worms. In calves necropsied 
two weeks after a 20 week continuous infection with C. oncophora,
Coop et al (1979) noted that consistent pathological changes were 
only present in areas of the small intestine occupied by the worms and 
that these were comprised of limited compression or distortion of the 
lateral margins of the intestinal villi in immediate contact with the 
worm bodies. However, Armour et al (1987a) reported the development 
of a good immunity after approximately six weeks using a similar 
infection rate of third stage larvae and thus the limited damage 
observed after 22 weeks may simply have been that remaining after major 
repair of the tissues had been effected. Armour et al (1987a) 
infected calves daily for 42 days with 10,000 C. oncophora infective 
larvae, sacrificing one animal on day 21, another on day 42 and the 
remainder 42 days after the last larval inoculation. At 21 days the 
worm burden, both adults and larvae, was in the duodenum and 
pathological changes were limited to a flattening of epithelial cells 
where worms were lying deep between the villi. At 42 days the worm 
burden was primarily in the jejunum and was associated with an obvious 
thickening of the mucosa and broadening of the villi. Worms had 
migrated deep in between the villi and those present in the lumen were
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often surrounded by sloughed epithelial cells and mucus. There was 
obvious destruction and sloughing of the surface epithelium throughout 
the small intestine and mucosal blood capillaries were congested. In 
contrast to other reported work, at both 21 and 42 days approximately 
fifty per cent of larvae had penetrated the intestinal mucosa, 
particularly in the ileum. By 84 days after the initial larval 
inoculation only minimal damage to the intestinal mucosa was present 
although scanning electron microscopy showed the villi to remain 
flattened and thickened.
Effect on voluntary food intake
A reduction in voluntary food intake is widely recognised as a 
major factor in the pathogenisis of gastrointestinal parasitic 
infections. The degree of inappetence varies with the degree and 
duration of infection and may also be influenced by the quality of the 
diet, particularly with respect to protein content (Abbott, 1982).
There is some evidence to suggest that parasitism of the small 
intestine has a greater effect on appetite than abomasal parasitism 
(Steel et al, 1982). The causitive factors have yet to be identified 
and have recently been reviewed by Symons (1985). Pain may be 
important but its effect is difficult to quantify. Structural damage 
to the gastrointestinal tract may also influence the digestion and 
absorption of nutrients and this in turn may influence voluntary food 
intake. Leng (1981) proposed that changes in the availability of amino 
acids for absorption would change the protein : energy ratio of 
absorbed nutrients and reduce food intake as well as the efficiency of 
utilization of absorbed amino acids. O. ostertagi infection is 
responsible for well documented increases in abomasal pH which may 
inhibit the denaturation of proteins by pepsin and also promote the 
survival of increased numbers of bacteria resulting in increased 
deamination. Both of these factors would influence the amino acids 
available for absorption from the small intestine. C. oncophora may 
directly limit the uptake of amino acids by reducing absorptive 
capacity. However as the central portion of the small intestine is 
primarily responsible for amino acid absorption and this nematode 
predominantly occupies the proximal portion, extensive malabsorption is 
unlikely. Indeed Symons (1976) concluded that malabsorption, at least 
of the major constituents of the diet, is not an important factor 
exacerbating anorexia.
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Reduced absorption of dietary phosphorus has been reported in 
lambs infected with T. colubriformis (Coop, 1981) and it has been 
proposed that this is associated with a reduction in salivary secretion 
resulting in reduced availability to rumen microbes associated with 
fibre digestion. Hie consequent reduction in rate of passage of fibre
V.
through the rumen may limit intake.
Intake is unlikely to be limited by increases in gut volume 
resulting from diarrhoea as Grovum and Phillips (1978) could produce no 
change in voluntary food intake when the wet faecal output of sheep was 
doubled as a result of abomasal administration of a bulk laxative.
The neuropeptide cholecystokinin has been implicated as a satiety 
factor but evidence for its involvement in the long term inappetence 
produced by parasitic infection in largely equivocal.
Feed Utilization Effects
The loss of production arising as a result of gastrointestinal 
parasitism is primarily associated with reduced voluntary food intake 
but pair-feeding experiments (e.g. Sykes and Coop, 1976 and 1977) have 
demonstrated that specific parasite effects also operate to influence 
the digestion and utilization of dietary nutrients. These effects may 
be mediated by alterations in the biochemical values of the blood and 
gastric contents which predispose to changes in the animal's 
metabolism.
Gastric pH and serum gastrin
0. ostertagi infection is associated with an increase in 
abomasal pH from the normal 2.2 to 7.0 in heavy infections. Using 
cannulas to monitor abomasal fluid changes, Jennings et al (1966) 
reported that the period of maximum change immediately followed the 
emergence of adult parasites from the gastric glands and was a 
consequence of the associated parietal cell destruction. Any 
differentiated parietal cells remaining may show morphological 
characteristics indicative of reduced activity (Murray et al, 1970).
The functional consequences of elevated abomasal fluid pH are a failure 
to activate pepsinogen (secreted by the zymogen cells) to pepsin 
resulting in a failure to initiate the denaturation of protein, and a 
loss of bacteriostatic effect. The increased numbers of bacteria in 
the abomasum resulting from the latter have often been cited as the 
cause of diarrhoea which is generally apparent at this time, its onset
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and duration closely following the elevated pH (Armour and Ogbourne, 
1982).
Normal abomasal pH has been shown to be detrimental to the 
survival of adult 0. ostertagi and the immersion of freshly collected 
worms in a solution of pH 2.2 resulted in 100% mortality within 60 
minutes (Eiler et alf 1981). Uiese authors suggested that the 
hypochlorhydria observed during ostertagiosis may be partially mediated 
by a chemical released from the parasite. Local parasite effects on 
HC1 production have also been implicated in studies using sheep 
infected with Ostertagia circumcincta and surgically prepared with 
separated fundic pouches (Anderson et al, 1976). EXiring continuous 
infection of previously worm free animals acid secretion of the 
parasite free pouches was maintained or increased, whereas that of the 
abomasum was reduced. However in calves infected by surgical 
transplantation of adult 0. ostertagi (McKellar et al, 1987) no 
significant alterations in abomasal pH were observed.
Both of these studies reported an increase in plasma gastrin, a 
hormone concerned with the regulation of digesta flow and abomasal pH, 
suggesting a physiological mechanism whereby the host is attempting to 
counteract actual or potential abomasal pH changes. Indeed Anderson 
et al (1981) reported hypergastrinaemia just eight days after 
infection of sheep with O. circumcincta implying that in the absence 
of any change in abomasal pH, the parasites may stimulate the endocrine 
cells directly to produce gastrin, or indirectly by stimulating the 
release of a gastrin secretagogue from the gastric mucosa.
Using the gastrin analogue, pentagastrin, Bell et al (1977) 
concluded that gastric emptying was slowed by gastrin and that the 
effect was mediated via the smooth muscle of both the body and the 
antrum rather than a general change in the tone of the gut or 
inhibition of the antral pump alone. This finding is difficult to 
reconcile with diarrhoea observed during clinical Ostertagia infection 
which is suggestive of increased gut motility. However it is possible 
that differential effects on motility may occur along different 
portions of the digestive tract.
The effects of C. oncophora on gastric pH and serum gastrin have 
not been investigated. Gastrin is produced by G-cells which are mainly 
found in the antrum of the stomach and the duodenum (Olowu-Orokun,
1975). It is possible that the presence of C. oncophora in the 
duodenum may disrupt the G-cells and gastrin production, particularly
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if the mucosa is penetrated by developing larvae. A mixed infection of 
0. ostertagi and C. oncophora may exacerbate abomasal 
hypochlorhydria as the presence of Cooperia in the duodenum may limit 
any gastrin mediated stimulation of abomasal parietal cells, otherwise 
inhibited by the presence of 0. ostertagi.
Pepsinogen and serum proteins
A characteristic feature of 0. ostertagi infections is an 
increase in serum pepsinogen concentrations coincident with emergence 
of the worms from the gastric mucosa. Abomasal pH is also elevated at 
this time resulting in partial or complete inactivation of pepsinogen 
to pepsin. Murray (1969) observed electron opaque material lying 
between the epithelial cells of an undifferentiated and hyperplastic 
abomasal mucosa and proposed that the separated cell junctions 
facilitated the passage of macromolecules, particularly small serum 
proteins leaking into the digestive tract and inactivated pepsinogen 
leaking into the circulation. Although this theory of macromolecules 
flowing in and out of the epithelial sheet has been generally accepted, 
Stringfellow and Madden (1979) have challenged its validity. In 
studies involving experimental infection of calves with 250,000 larvae 
of 0. ostertagi there was a significant increase in plasma pepsinogen 
concentrations in the absence of any detectable leakage across the 
gastric mucosa. Pepsinogen granules were completely denuded from chief 
cells suggesting a mechanism whereby pepsinogen was secreted directly 
into the circulation rather than being taken up from the gastric 
contents through a damaged vasculature.
Alterations in serum protein concentrations are also 
characteristic of bovine ostertagiasis where typically there is a 
depression in serum albumin, a concurrent increase in gamma globulin 
and little change in total protein (Mahrt et al, 1964; Ross and Todd, 
1965). However, in heavy infections the reduction in albumin is 
eventually accompanied by a drop in globulin resulting in overall 
hypoproteinaemia. Packed cell volume estimations support the view that 
haemoconcentration is associated with a fall in albumin levels in early 
infection but there may be an expansion of plasma volume in the later 
stages of infection, this being more typical in thin and wasted 
animals.
Both albumin and immunoglobulin turnover rates are affected by 
clinical parasitism. Neilsen (1966) demonstrated that these were
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greatly accelerated in animals when clinical signs were apparent, but 
were normal (or even sub-normal) during a quiescent period or 
convalescence. Subsequent studies have confirmed these findings 
(Halliday et al, 1968? Holmes and MacLean, 1971). It seems 
reasonable that increased immunoglobulin turnover is due to the immune 
response mounted by the host. Increased albumin turnover is probably a 
consequence of albumin hypercatabolism and it has been suggested that 
this is primarily due to abnormal leakage of plasma proteins into the 
gastro-intestinal tract (Mulligan et al, 1968). In support of this 
suggestion, studies using 51cr (Holmes and MacLean, 1971) and 
polyvinyl pyrolidione (PVP) (Jarnum, 1962) have demonstrated increased 
losses of plasma by this route. However increased endogenous albumin 
catabolism may also contribute, this being principally associated with 
the inflammatory changes occurring in the abomasum. There is little 
doubt that 0. ostertagi infection results in increased losses of 
exfoliated epithelial cells and increased mucus production due to 
proliferation of goblet cells. Preliminary radioimmunoassay of rat 
intestine has established that infection with Nippostrongylus 
brasiliensis results in increased mucin release. This was associated 
with greater release of DNA which may be indicative of increased 
epithelial cell shedding and death (Forstner et al, 1982). The role 
of gastrointestinal mucus in the elimination of parasitic nematodes and 
protozoa has recently been reviewed by Miller (1987).
Herlich (1965) reported transient hypoproteinaemia in calves given 
a single inoculum of 350,000 C. oncophora infective larvae. In 
contrast no significant changes in haematocrit, serum urea, total 
protein and albumin concentrations were reported when calves were daily
infected with 10,000 L3 for 42 days (Armour et al, 1987a). However 
these authors did note a slightly increased faecal clearance of plasma 
in infected animals indicating that sane degree of enteric loss was 
occurring.
Protein and energy metabolism
Nitrogen balance studies have demonstrated that reduced nitrogen 
retention is a characteristic feature of gastrointestinal parasitism. 
This generally arises as a result of increased urinary nitrogen loss 
(Parkins et al, 1973; Armour et al, 1987a) implying a reduction in 
the efficiency of utilization of absorbed amino acids. Faecal nitrogen 
may also be increased however as a result of impaired digestion or
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increased endogenous losses into the gastrointestinal tract. In view 
of the apparently large capacity of the bovine intestines to compensate 
for any parasite-induced alterations in the breakdown or absorption of 
proteins increased endogenous losses are most likely to be responsible 
for any decrease in the apparent digestibility of dietary nitrogen, 
especially at high nitrogen intakes where the capacity for reabsorption 
of endogenous nitrogen may be exceeded (Coop, 1981). Indeed Bown et 
al (1988) reported that the inferior nitrogen balances of sheep 
infected with Trichostrongylus colubriformis were caused by excessive 
endogenous loss rather than by malabsorption and that this induced 
protein deficiency was a major factor limiting efficient food 
utilization. Of the additional endogenous protein excreted in the 
faeces, only a small proportion is thought to originate as a result of 
plasma leakage (Steel and Symons, 1982).
Using radiolabelled leucine and tyrosine, the pattern of amino 
acid utilization in sheep and guinea pigs infected with T. 
colubriformis, and mice infected with Nematospiroides dubius has 
been studied (Symons and Jones, 1971; Symons 1985). In general these 
studies demonstrate that parasitised animals show reduced rates of 
skeletal muscle protein anabolism which is partially attributable to 
reduced voluntary food intake. However there is a corresponding 
increase in protein synthesis by both the liver and the gastric mucosa 
which is unrelated to intake. In guinea pigs infected with T. 
colubriformis increased mucosal protein synthesis occurred along the 
entire length of the small intestine and was probably associated with 
increased epithelial cell turnover, this being a consequence of mucosal 
damage at the site of parasitism and compensatory absorption in the 
distal regions. In sheep infected with T. colubriformis the tyrosine 
flux, a measure of protein synthesis, was unaltered with respect to 
bodyweight but increased in relation to intake demonstrating an 
increased protein turnover. Synthesis of structural liver proteins 
increased as did amino acid incorporation into membrane bound 
ribosomes, those responsible for the synthesis of blood proteins 
(Symons, 1985). It may thus be hypothesized that gastrointestinal 
parasitisms are responsible for increased endogenous nitrogen losses 
both in terms of accelerated turnover of the mucosal epithelium and 
leakage of plasma proteins. Amino acids are consequently diverted from 
more productive sites to the liver and gastric mucosa to compensate and 
net synthesis of skeletal muscle is reduced. In severe infections net
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catabolism of skeletal muscle may occur, particularly if voluntary food 
intake is severely restricted.
Reduced intake limits the energy available to an animal at a time 
when it is faced with increased demands arising from increased protein 
turnover, but it is induced protein deficiency rather than energy 
deficiency which limits animal production as demonstrated by Bown et 
al (1988). Post-ruminal infusions of protein into lambs infected with 
T. colubriformis replaced endogenous nitrogen losses and restored 
nitrogen and energy balance whereas isocaloric infusions of energy 
produced only partial restoration. However these authors did consider 
that at extremely low food intakes energy availability may be the 
primary factor limiting growth.
Body water turnover
In view of the inappetence and diarrhoea which typify clinical 
gastric parasitic gastroenteritis, alterations in body water metabolism 
are to be expected. In calves infected with 0. ostertagi 
significantly greater amounts of water (approximately 20%) may be 
excreted in both urine and faeces (Parkins et al, 1982). However 
diarrhoea may not necessarily be accompanied by an overall increase in 
fluid loss. Bremner (1982) reported that in calves with heavy 
infection of Cooperia pectinata urine water losses were considerably 
below normal and, despite excessive faecal water loss, overall output 
from infected animals was less than that from worm free controls.
Studies of water metabolism in parasitised ruminants have been 
conducted using tritiated water (TQH) (Halliday et al, 1965? Baker 
et al, 1965; Holmes and Bremner, 1971). In general these studies 
indicate that body water as a percentage of body weight is increased 
and that water turnover rate is reduced implying a conservation of body 
water under conditions of reduced intake. Paic feeding experiments 
using sheep infected with 0. circumcincta (Holmes and Bremner, 1971) 
have demonstrated that anorexia is the primary cause of reduced water 
turnover and Baker et al (1965) suggested that depletion of serum 
albumin in bovine ostertagiasis may result in altered osmotic pressure 
of the serum and physiological conditions promoting generalised oedema. 
Where increased water retention occurs, the tissue loss attributable to 
parasite infections cannot be readily determined from changes in 
bodyweight alone.
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Interactions between O. ostertagi and C. oncophora
Under natural field conditions both concurrent and sequential 
infections of 0. ostertagi and C. oncophora occur. During the 
early grazing season low numbers of both species are ingested with 
pasture to establish small host parasite populations. Due to the 
superior fecundity of C. oncophora it is reasonable to suppose that 
host populations of this nematode initially increase more quickly than 
those of 0. ostertagi. However as a result of the rapid development 
of host immunity to C. oncophora, 0. ostertagi predominates during 
the later part of the grazing season. Direct interaction between the 
two nematode species cannot occur because they occupy different 
portions of the digestive tract. Indirect interaction may be mediated 
by the hosts physiological or immunological mechanisms.
Physiologically mediated interactions are not inconceivable 
because 0. ostertagi infection usually results in elevations of the 
pH of abomasal digesta and this may adversely affect the small 
intestine microclimate. Such an effect has been demonstrated in sheep 
with infections of Haemonchus contortus and Nematodirus battus in 
the abomasum and small intestine respectively (Mapes and Coop, 1970). 
However experimental studies have demonstrated that reciprocal negative 
interactions between C. oncophora and 0. ostertagi only occur in 
sequential and not in concurrent infections, implicating the 
involvement of the hosts immune system (Kloosterman et al, 1984).
Indeed Keus et al (1981) reported cross-reacting IgG antibodies for 
0. ostertagi and C. oncophora using the saline extracts of adult 
worms. More recent work (Frankena, 1987) has shown that primary C. 
oncophora infection stimulates a degree of acquired immunity which is 
expressed against challenge infections of C. oncophora and to a 
lesser extent 0. ostertagi in the form of stunted growth and 
development of the worms. Worm burdens and faecal egg output were not 
affected and local abomasal responses were independent of those in the 
small intestine.
Summary
Under experimental conditions infection of calves with 0. 
ostertagi and C. oncophora either singly or in combination may 
result in clinical parasitic gastroenteritis. Under natural grazing 
conditions the relative contribution of each species to clinical 
disease outbreaks is difficult to assess due to differential rates of
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development of the host immune response and worm expulsion. 0. 
ostertagi is generally regarded to be the more pathogenic of the two 
species because of the greater persistency in the host and the well 
documented penetration of, and damage to, the abomasal mucosa by 
developing larvae. However substantial damage to the small intestine 
mucosa has been reported for C. oncophora and experimental studies 
suggest that the detrimental effects on calf metabolism and production 
of these two nematode species together far exceed those of either 
species alone.
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GENERAL INTRODUCTION TO EXPERIMENTAL STUDIES
A previous study conducted at the University of Glasgow (Armour 
et aly 1987a) investigated the deleterious effects of experimental 
C. oncophora infection in growing calves. Daily infections over a 
six week period resulted in inappetence, weight loss, impaired nitrogen 
retention and a loss of plasma proteins into the gastrointestinal 
tract. During this period infections occurred in the duodenum, jejunum 
and ileum and many larval stages were present in intestinal mucosa. At 
necropsy on weeks three, six and ten after the initial inoculation 
stunting and thickening of the villi were noted with excessive mucus 
production and even at week twelve there was continued loss of plasma 
proteins into the gastrointestinal tract despite the expulsion of most 
of the worms.
The results of this study demonstrated that C. oncophora 
infections given at a level frequently encountered under natural 
conditions in the West of Scotland can cause considerable 
pathophysiological changes in calves which persist beyond the 
development of a good immunity after approximately six weeks. Despite 
evidence such as this, C. oncophora has largely been disregarded in 
favour of O. ostertagi as the primary cause of bovine parasitic 
gastroenteritis. However it may be that infection with parasites such 
as C. oncophora is a prerequisite for the development of more severe 
clinical disease in 0. ostertagi infected cattle in the field 
situation.
Experimental studies in this section follow that of Armour et al 
(1987a) but use monospecific infections of 0. ostertagi and a 
subsequent mixed infection of 0. ostertagi and C. oncophora.
Kloosterman et al (1987) concluded that there was no interaction 
between 0. ostertagi and C. oncophora in a concurrent infection and 
consequently it may be expected that parasitological data for either 
nematode in the combined infection would resemble that in the 
respective monospecific infections. However for pathophysiological 
parameters it is probable that the detrimental effects of a concurrent 
infection will far exceed those of either monospecific infection 
because of the greater total area of mucosal damage and consequent 
reduction in the compensatory digestive capacity of the gut. Such an 
infection may therefore result in more severe and prolonged clinical 
disease.
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Data from the following series of studies, together with that from 
Armour et al (1987a) permit a comparison of the relative 
pathogenicities of 0. ostertagi and C. oncophora when given as 
monospecific infections under similar experimental conditions. More 
importantly, a comparison can be made between the effects of either 
monospecific infection and those of the combined infection, this being 
the sum of the two monospecific infections. C. oncophora was 
administered to calves at a level frequently encountered under natural 
grazing conditions (Entrocasso, 1984). Administration of 0. 
ostertagi was at a level calculated to produce mild clinical disease 
and thus allow maximum expression of any additional detrimental effects 
attributable to C. oncophora in the combined infection.
In all studies a morantel sustained release bolus (MSPB; Paratect, 
Pfizer) was given to one group of infected calves to limit larval 
establishment and the efficacy and mode of action of this anthelmintic 
device are discussed.
EXPERIMENT H a
PATHOPHYSIOLOGICAL AND PARASITOLOGICAL STODIES ON TYPE I 
OSTER5PV5IA OSIEREAGI INFECTIONS IN CALVES
Introduction
The following study investigates the pathophysiological 
consequences of daily experimental infections of 0. ostertagi in 
calves and the effectiveness of the MSRB in preventing adverse 
pathophysiological changes.
Materials and Methods
Animals and experimental design
Twenty-five castrated male Friesian calves aged four months, 
weighing approximately 120 kg, and which had been reared under 
helminth-free conditions were allocated to three treatment groups.
Group A calves (clean) were maintained free of parasites. Five 
were used as control animals for digestion and nitrogen economy studies 
and a further two for radioisotopic investigations.
Group B calves (MSRB) were each given a morantel sustained release 
bolus (MSRB, Paratect; Pfizer). The calves were subsequently dosed 
per os with 2,000 0. ostertagi infective larvae daily for six 
weeks. Five calves were allocated to the digestion studies, two to the 
radioisotopic investigation and two necropsied 23 and 42 days after 
initial infection. The bolus was administered in order to limit the 
establishment of the larvae (Jones 1983).
Group C calves (infected) were treated similarly, but without 
prior MSRB administration, with five calves allocated for digestion 
studies, two for radioisotopic work and two for necropsy during the 
course of the trial (days 23 and 42).
Clean control calves were housed separately from those in infected 
groups to prevent possible autoinfection from bedding material. All 
calves were clinically examined and weighed every three weeks and blood 
and faecal samples were collected weekly for biochemical, 
haematological and parasitological analyses.
The remaining calves in the metabolism and isotope studies were 
slaughtered on day 84 of the experiment.
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Feed allowance
The calves were individually given a complete ration twice a day 
(Superstar cubes; Hamlyn Milling). Mean analyses were 0.89 dry matter 
(DM), with 157 g crude protein (CP), 174 g crude fibre (CF), 43 g ether 
extract (EE), 102 g ash and 18.0 MJ gross energy (GE) kg DM”1. The 
daily feed allowance of 3.0 kg/day was calculated to supply sufficient 
metabolisable energy (ME) to allow for a daily liveweight gain of about 
0.35 kg (MAFF et al 1984).
larval infections
The O. ostertagi larvae were harvested from faecal cultures no 
more than 21 days prior to oral inoculation of the calves, and were 
maintained at room temperature (17° C) until required. The daily 
dose of 2000 larvae was equivalent to that ingested by calves grazing 
pastures contaminated at a level of 800 infective larvae per kg of 
dried herbage, assuming a daily intake of 2.5 kg dry matter.
Parasitological techniques
Faecal egg counts were carried out by the modified McMaster method 
of Gordon and Whitlock (1939). At post-mortem, trichostrongyle 
parasites were recovered using the technique described by Ritchie et 
al (1966).
Pathology
Tissue was taken from the fundus and pylorus, fixed and processed 
as previously described.
Blood analyses
Blood urea, total protein and albumin concentrations were measured 
using continuous flow analysis (Standard Technicon Auto-Analyser II).
Plasma pepsinogen activity was assayed by the method of Edwards 
et al (1960) where one international unit (I.U.) is equivalent to the 
release of one m/mol tyrosine/litre plasma/minute.
Digestibility and nitrogen balance studies
The fifteen calves involved in the metabolism study were allocated 
to three equal sized treatment groups such that the mean weight and 
weight range of each group was similar. Of the five calves in each 
group four were used for the metabolism studies while the remaining
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animal was maintained as a potential replacement.
Digestibility and nitrogen (N) balance data were obtained from 
four animals in each of the three treatment groups on days 14-21,
35-42, 56-63 and 77-84 post infection.
Calves were accommodated in standard metabolism stalls and 
individually fed twice daily at 0730 and 1630 h for seven days before 
the following seven day recording period. Individual feed intakes were 
recorded for the whole 14-day period and faecal and urinary outputs 
were measured over the seven day collection period. Feed, faecal and 
urine collection methods and their analyses were as previously 
described.
Radioisotopic measurements
Radioisotopic studies using 51crCl3f 125i-albumin and 
tritiated water (TOH) were conducted with two calves from each of the 
treatment groups clean, MSRB and infected on days 35-47 and 70-82 
following the first infection. Each calf received 74 MBq of 
51CrCl3 and 15 MBq of 125i_koVine albumin by intrajugular 
catheter at the beginning of each study period. This followed an 
infusion of 110 MBq of TOH four days earlier. Plasma samples were 
collected 15, 30, 60, 120 and 360 minutes after injection and then 
twice daily for five days and then once daily for the remainder of the 
experimental period. .The calves were restrained in metabolism stalls 
during the investigations and fitted with faecal bags. On each day the 
total faecal output of each calf was thoroughly mixed before eight 10 g 
subsamples were taken for 51cr and 125i radioactivity 
determination. Total daily urine outputs were also collected and 
weighed 1 ml subsamples diluted with 0.02 N NaOH before radioactivity 
measurement. Calves were dosed daily per os with 10 ml 0.75% KI 
solution for three days prior to the isotope injection and during the 
subsequent recording period in order to ensure rapid excretion of 
125i from catabolised 125i-aibumin.
Plasma protein losses in the gastrointestinal tract, plasma 
volume, and albumin turnover and catabolic rate were calculated as 
described by Holmes and Maclean (1971). Total body water and water 
turnover were determined from the plasma disappearance rate of TOH and 
application of the dilution technique using extrapolated plasma values.
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Statistical analysis
Statistical analyses were performed using 'Minitab1 (Ryan, Penn 
State University) on a microcomputer. Metabolism study and blood 
biochemical data were analysed using a standard analysis of variance 
and multiple comparisons procedure, while t-tests were performed on 
parasitological data for infected and MSRB treated calves.
Results
Clinical observations
Infected calves showed marked softening of the faeces and one calf 
became diarrhoeic between days 49-63 after the start of the infection. 
The MSRB calves showed only occasional softening of the faeces and the 
clean calves remained clinically normal throughout. There were several 
instances of bloat in all groups during the whole course of the trial 
and one calf (infected) died as a result. There was no depression of 
appetite due to the parasitic infection.
The mean liveweights of the 15 calves used in the metabolism 
studies are shown in Figure 14. After 84 days, when the experiment 
ended, there were no significant differences in the total mean 
liveweight gains between treatments; these were 27.6, 26.2 and 22.0 kg 
(0.33, 0.31 and 0.26 kg/d) for the clean, MSRB and infected groups 
respectively.
Biochemistry
Plasma pepsinogen values are shown for the metabolism study calves 
in Figure 15. Mean values for the infected calves were significantly 
(P<0.001) greater than both clean and MSRB groups from day 21 and the 
values for MSRB calves were greater than those of the clean calves 
between days 14 and 63 of the trial.
Blood urea and total protein concentrations were similar for all
treatment groups. However a significant (PC0.05) depression in mean 
albumin concentration was observed for infected calves on day 42 (35.7
mmol/1) compared with the clean and MSRB groups (39.2 and 38.4 mmol/1
respectively).
Apparent digestibility coefficients
Examination of the apparent digestibility of each of the standard 
proximate feed fractions for each of the four separate recording 
periods revealed only a significant depression in the digestive
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Figure 14. Mean liveweights of metabolism study calves 
infected with Ostertagia ostertagi, infected 
after administration of a MSRB or maintained as 
clean controls.
O
S
99
rrri) ua6omsdad eujseid
Fi
gu
re
 
15
. 
Me
an
 
pl
as
ma
 
pe
ps
in
og
en
 
va
lu
es
 
(i
.U
.)
 
fo
r 
me
ta
bo
li
sm
 
st
ud
y 
ca
lv
es
 
in
fe
ct
ed
 
wi
th
 
Os
te
rt
ag
ia
 
os
te
rt
ag
i, 
in
fe
ct
ed
 
af
te
r 
ad
mi
ni
st
ra
ti
on
 
of 
a 
MS
EB
 
or 
ma
in
ta
in
ed
 
as
 
cl
ea
n 
co
nt
ro
ls
.
100
efficiency of the EE and NFE fractions in infected calves 56-63 days 
after infection began. No other differences occurred and no trends in 
the digestibilities with time were noted. Overall values (means of all 
four recording periods) are presented in Table 5 and individual data is 
contained within Appendix 3.
Nitrogen balance
Mean results for the daily nitrogen input, output in urine and 
faeces together with the apparent retentions for the three treatment 
groups in each of the four recording periods are presented in Table 6. 
Individual values and data expressed in terms of percentage of nitrogen 
intake are given in Appendix 3. There were no significant treatment 
related differences in the nitrogen economy of the calves. Retentions 
for the clean calves remained relatively constant throughout the trial, 
but both the infected and MSRB treated animals suffered a reduction in 
nitrogen retention during days 35-42 as a result of increased urinary 
nitrogen excretion followed by an apparent recovery during days 56-63.
Radioisotopic measurements
Elevated faecal clearances of both -^I-albumin and ^CrC^ 
were shown by the infected calves compared to the clean controls and 
this increased albumin loss to the gastrointestinal tract was reflected 
in an increase of approximately 30% in the albumin catabolic rate and a 
reduced -^I-albumin half life (Table 7). MSRB treated calves showed 
only marginal increases in faecal clearance of - ^ I - a l b u m i n  an(3 
albumin catabolic rate compared to the clean controls. During days 
70-82, one infected calf, 03, had a persistently elevated faecal 
clearance of ^CrClg and also an elevated albumin catabolic rate 
compared to the clean controls. The continued loss of albumin into the 
gastrointestinal tract was associated with a continued elevation of 
plasma pepsinogen levels and a high faecal egg output. The other 
infected calf, 04, was apparently recovering from infection at this 
time and had a reduced faecal clearance of ^CrC^. In this animal 
the albumin catabolic rate was particularly low at this time and this 
is associated with a greatly extended JI-albumin half life. Plasma 
pepsinogen had also returned to pre-infection levels.
No adverse pathophysiological differences were observed when 
comparing the MSRB treated calves to the clean control animals during 
the second investigation period.
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Table 5. Mean overall apparent digestibility coefficients for 
calves infected with Ostertaaia ostertagi, infected 
after prior administration of a MSRB or maintained 
as clean controls
DM
Clean 
0.633 ±0.006
MSRB 
0.632 ±0.006
Infected 
0.643 ±0.008
CP 0.606 ±0.009 0.613 ±0.007 0.617 ±0.007
CF 0.298 ±0.018 0.277 ±0.017 0.308 ±0.021
EE 0.884 ±0.004 0.887 ±0.004 0.889 ±0.004
Ash 0.509 ±0.015 0.512 ±0.021 0.516 ±0.015
NFE 0.755 ±0.005 0.755 ±0.007 0.765 ±0.008
0M 0.647 ±0.006 0.644 ±0.006 0.657 ±0.009
GE 0.626 ±0.008 0.631 ±0.007 0.638 ±0.009
n=16, four calves in each of four recording periods
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Table 6. Mean nitrogen balance (g/day) ±SE for calves
infected with Ostertagia ostertagi, infected after 
prior administration of a MSRB or maintained as a
Days 14-21 
Intake 
Faeces 
Urine 
Retention
Days 35-42 
Intake 
Faeces 
Urine 
Retention
Days 56-63 
Intake 
Faeces 
Urine 
Retention
Days 77-84 
Intake 
Faeces 
Urine 
Retention
control
Clean 
n=4 
70.67 ±0.23 
27.10 ±1.05 
28.20 ±1.60 
15.38 ±1.98
n=4
63.72 ±0.00
25.90 ±0.96
21.98 ±2.31 
15.84 ±2.06
n=4
67.09 ±0.00
25.33 ±0.86
26.98 ±1.34 
14.79 ±1.40
n=3
67.66 ±0.00
27.91 ±1.96
24.60 ±0.94
15.15 ±1.99
MSRB 
n=4
68.03 ±1.93 
27.12 ±1.15
25.75 ±1.87
15.16 ±0.63
n=4
62.48 ±0.74
25.91 ±0.90
24.03 ±0.91
12.53 ±1.11
n=4
66.10 ±0.99
25.48 ±0.94
24.54 ±0.55 
16.08 ±1.39
n=4
67.66 ±0.00
24.49 ±0.82 
24.14 £1.49
19.04 ±1.57
Infected 
n=4
69.75 ±0.53
27.71 ±1.43
24.60 ±1.01 
17.45 ±1.74
n=4
63.34 ±0.23
25.71 ±1.07 
25.89 ±1.84 
11.74 ±2.55
n=4
66.73 ±0.36 
23.97 ±0.72 
25.82 ±1.25 
16.94 ±1.20
n=4 
67.59 ±0.07 
25.31 ±0.15 
26.36 ±1.23 
15.93 ±1.20
Missing data during days 77-84 is due to one 
calf suffering from bloat.
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Table 7. Pathophysiological changes in calves infected with Ostertagia ostertagi
infected after prior administration of a MSRB or maintained as clean controls
Clean MSRB Infected
Days 35-47 B1 B2 Y63 Y64 03 04
Plasma Vp (mlAg) 50.2 47.6 42.9 45.4 46.5 45.3
Volume
Faecal I-albumin 37.4 39.5 41.5 41.0 46.9 58.9
Clearance (ml/day)
Faecal Cr 272.8 321.1 341.4 307.8 432.3 437.1
Clearance (ml/day)
Catabolic rate % 4.5 5.2 5.2 5.5 6.8 6.1
of albumin
Albumin I-albumin 27.8 20.0 23.0 27.6 18.7 18.4
Disappearance Tl/2 (days)
Tbtal body % bodywsight 73.3 74.1 74.0 72.5 84.6 73.4
water
TOH Tl/2 170 168 144 168 207 227
Disappearance (days)
Days 70-82 B1 B2 Y63 Y64 03 04
Plasma Vp (ml/kg) 46.4 47.1 41.6 47.3 51.5 47.9
Volume
Faecal I-albumin 46.3 30.6 28.9 23.7 42.6 54.1
Clearance (ml/day)
Faecal Cr 345.6 324.0 222.8 279.4 295.4 292.6
Clearance (ml/day)
Catabolic rate % 5.4 7.2 5.7 4.8 6.7 4.8
of albumin
Albumin I-albumin 12.4 16.0 19.4 20.6 16.3 35.8
Disappearance Tl/2 (days)
Total body % bodyweight 65.1 72.4 70.6 62.7 69.0 69.7
water
TOH Tl/2 252 145 161 129 103 129
Disappearance (days)
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During days 35-47 total body water as a percentage of bodyweight 
was increased in one infected calf and the tritiated water half-life 
was increased in both infected calves. However during the second 
period body water measurements were normal for all six calves and no 
significant differences were recorded.
Plasma volume measurements for both investigation periods, days 
35-47 and days 70-82, revealed no significant differences between 
treatment groups.
Pathology
The gross appearance of the abomasa in the infected and MSRB 
calves slaughtered 23 days after infection began were similar with 
nodules due to 0. ostertagi being confined to the fundic region.
There was no associated congestion or oedema at this time.
At necropsy at 42 days, nodules were apparent on both the fundus 
and pylorus of the abomasum from the infected calf and had colaesced 
forming ulcerative lesions. There was obvious congestion and oedema, 
thickening of the larger folds and enlargement of the lymph nodes.
This substantial abomasal damage was associated with the observed 
symptoms of Type 1 ostertagiasis, notably a softening of faeces and 
mild diarrhoea. Nodules were still present in the fundic region of the 
abomasum of the MSRB treated calf necropsied at 42 days, but more 
widespread abomasal damage was not apparent and no clinical signs were 
seen.
Few nodules due to O. ostertagi were observed in abomasa from 
either infected or MSRB treated calves necropsied at 84 days. However, 
the abomasa from some infected calves still appeared congested with a 
morocco leather appearace typical of more chronic ostertagiasis and 
widespread secondary fungal tracts were present as a consequence of the 
raised abomasal pH (Ritchie et al, 1966). This contrasted with the 
normal appearance of abomasa from MSRB treated calves.
Parasitology
The weekly trichostrongyle faecal egg counts (Appendix 3) showed 
that the faeces of the clean controls were negative throughout the 
trial. In the MSRB group only occasional positive counts were recorded 
(maximum mean of 70 epg) whereas the infected calves had positive 
counts by day 28 rising to a mean maximum of over 700 epg on day 49 and 
declining steadily to values of 250 epg at day 84 when the experiment
Ta
bl
e 
8
. 
Me
an
 
bu
rd
en
s 
of 
Os
te
rt
ag
ia
 
os
te
rt
ag
i 
an
d 
ab
om
as
al
 
pH 
fo
r 
ca
lv
es
105
X
CO VO 3CO VO <CO r-<T>iH in co CMiH• • • • • •CMO CO Q o
-H ■H ■H
c rH O O O O O  Q
JU
CO
o o O O in ■H■H 4-3 o VO O C- CM4-) P r- in VO co
O rH CO «H CO
0
X
e
•H X O o O o o  o <T>
iH O o O in -H CMrH D CM CM in rH
0
3
r- r- CM o
•H iH rH CO
X
•H
c
•H
in
o O O o o  o O
o O O o -HU X vo o H 1
0 CO CM
X iH
X
0
X
w o O O o O  Q
>< o O O o -H rH0 J CM H' CM 00 iH
TJ CM TT
00
TS c rH rH iH rH r- C"
G
0
CM c
s> O O O O o o> O O O O o
•H o Q O O oCO cn w XD H 1 H*CM H 1 00 00 00CO
X
0u
0
X
jc
g> >i co m CM CM
D
0
rH
s CM CM H 1 H 1 00 00
0
X
C
X
0
0U
E-»
TJ C9 C —0 03 0 0 WX CQ X 0 cnO 25 O rH -H0 u ^Xc cM M
-H
(0
oo
CMo\r">
CO CM 
CO VO 
CM O
° 9
0
CO t"-oo r- oo vo 
•H +i
VO*
oooh1oo
TJ —
0 ta
X
C
M-tO
'O<u *> •h in nj o
X
rH(0o
■8XO0VW
C•rH
o
s
* cn
o
v
XI0
0oc0o•HU-J•Hc
106
Plate 6. Scanning electron micrograph (x 80) of pylorus from an 
infected calf necropsied on day 84. Note worms on the mucosal surface 
and the large amount of mucous plus necrotic debris.
Plate ?. Scanning electron micrograph (x 320) of pylorus fran an 
MSHB calf necropsied on day 84 after infection. The mucosal surface 
epithelium appeared intact but the cells looked swollen and their
107
Plate 8. Scanning electron micrograph (x 320) of pylorus from a 
clean calf necropsied on day 84. The mucosal surface epithelium is 
intact with a small amount of mucus present. Note the clear 
delineation between individual cells.
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was terminated.
Examination by scanning electron microscopic techniques confirmed 
that epithelial cellular hyperplasia was still present in the infected 
calves necropsied on day 84? worms could be seen on the mucosal surface 
which was covered with a thick layer of mucus and necrotic material 
(Plate 6). The mucosal surface epithelium of the MSRB calves 
necropsied on day 84 appeared intact but the cells looked swollen with 
some excess mucus present and the cell junctions were not fully 
delineated (Plate 7). In contrast the mucosal surfaces of the clean 
calves were intact with scant mucus being present (Plate 8).
The mean worm burdens of the calves slaughtered on days 23, 42 and 
84 are given in Table 8. (Individual values are presented in Appendix 
3). No 0. ostertagi were recovered from the clean calves. The 
establishment of L3 larvae in the infected calves slaughtered 23 and 
42 days after the initial infection was 77% and 40% respectively 
whereas in the MSRB calves the corresponding values were 37% and 19%.
By day 84 means of 8117 and 243 total worms remained in the infected 
and MSRB groups respectively. Very few developing .larvae were present 
at that time, and the abomasal pH was significantly (P<0.01) higher in 
the infected calves compared to the clean group.
Discussion
The life cycle of 0. ostertagi involves several larval stages. 
Ingested third stage larvae enter the gastric glands of the abomasum 
and develop through the fourth and fifth larval stages before emerging 
as adults approximately 21 days later. The principal lesions of 
ostertagiasis are white raised umbilicated nodules and these, together 
with associated abomasal damage have been described by Ritchie et al,
(1966).
Both the worm burden data and visual appraisal of abomasa in this 
study demonstrated the efficacy of the MSRB in reducing the 
establishment of 0. ostertagi and preventing associated adverse 
pathophysiological changes.
The anthelmintic morantel acts on nematodes as a potent agonist 
against acetyl choline muscle receptors causing contraction and 
depolarisation (Harrow and Gration, 1985). However there is only a 
relatively low activity against larval stages found in the gastric 
mucosa (Cornwell et al, 1973). Plasma pepsinogen values (Fig. 15) 
for the infected and MSRB treated calves show similar increases up to
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day 21 of infection at which time young adult parasites would be 
emerging from the glands. Thereafter values for the infected calves 
continued to rise, while those for the MSRB treated calves were 
maintained at a level slightly higher than that of the clean control 
calves indicating that the MSRB was limiting infection but that some 
degree of larval development was occurring. The development of these 
larval stages may have a beneficial effect in priming the host immune 
system so that through time this may act in combination with the MSRB 
limiting larval establishment and apparently increasing the 
anthelmintic efficacy. It is interesting that Borgsteede (1983) 
suggested that morantel has a sublethal effect on the larvae allowing 
them to grow sufficiently to induce an immune response in the host 
before they were expelled.
Despite evidence of relatively severe and persistent abomasal 
damage, no depression of appetite or daily liveweight gain of the 
infected calves was apparent. Possibly increased water retention was 
responsible for part of the liveweight gain of the infected calves and 
there was evidence to support this during days 35-47 of the 
pathophysiological study.
The pathophysiological measurements gave some indication of the 
adverse effects of 0. ostertagi on calf metabolism. Alterations in 
pathophysiological values were greatest during the expected period of 
emergence of adult worms from the abomasal mucosa (days 21-63). During 
this time plasma pepsinogen values for the infected calves became 
elevated in relation to the values for the clean controls. Parasite 
development within the gastric glands causes loss of differentiation 
and stretching of the abomasal mucosa resulting in cell junction 
breakdown and increased permeability to macromolecules and hence a rise 
in plasma pepsinogen concentration.
Leakage of blood constituents into the abomasa of infected calves 
also occurred at this time as was demonstrated by increased faecal 
clearances of both 125 albumin and ^^ -CrCl^ j increased albumin 
catabolic rates and reduced half life of the radioactive albumin 
compared to the clean calves. Loss of albumin in this manner leads to 
increased rates of synthesis, and in severe infections, where this 
cannot match increased losses, hypoalbuminaemia results (Mulligan et 
al, 1963).
Pathophysiological measurements made after the completion of worm 
emergence (days 70-82) revealed differing responses of the two infected
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calves. One calf continued to show evidence of leakage of 
macromolecules between the blood and the abomasum while the other was 
apparently recovering from infection and was normal for most of the 
pathophysiological parameters measured. The particularly low value for 
albumin catabolic rate recorded for this calf implies the occurrence of 
post-infection hypocatabolism of albumin.
The increased half life of tritiated water and the slight increase 
in total body water indicates a degree of water retention by the 
infected calves during the first pathophysiological investigation.
This contrasts with work by Halliday et al, (1968) in which there was 
no evidence of increased water retention in calves suffering from 
Type I ostertagiasis following administration of large single doses of 
0. ostertagi larvae. Holmes & Bremner (1971) found that in sheep 
given a large single infection of O. circumcincta a reduction in body 
water turnover was principally associated with anorexia induced by 
parasitic infection. Calves in this experiment did not become 
inappetent and the cause of the reduced body water turnover rate is 
unclear.
The alterations to the protein metabolism of the infected and to a 
lesser extent the MSRB treated calves, as shown by the 
pathophysiological study, occurred without alterations in apparent 
protein digestion. The high abomasal pH of the infected calves implies 
that abomasal protein digestion may have been reduced, and that a 
possible compensatory increase in digestive efficiency occurred in the 
lower gut. The increased leakage of albumin into the abomasa of the 
infected calves did not result in significant increases in faecal 
nitrogen content and thus this albumin was possibly broken down and 
recycled as aitmonia.
Finally, it is interesting that the level of infection used in 
this trial, which may be encountered under natural grazing conditions 
in the U.K., produced pathophysiological changes in infected calves 
without acute clinical disease. Prior administration of a MSRB 
prevented these changes by reducing the establishment of infection and 
possibly promoting the development of the immune response.
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EXPER3MHCT lib
A PRELIMINARY STUDY OF THE EFFECT OF CDLD CONDITIONING CN 
INFECTIVE IARVAE OF OSTEEOaGIA OSTERTAGI
Introduction
Arrested larval development, or hypobiosis, is a predisposing 
factor in the development of Type II ostertagiasis. This phenomenon 
may be defined as the temporary cessation of development of a nematode 
at a precise point in its early parasitic life and in the case of 
Ostertagia species this occurs at the early fourth larval stage 
(EL^ ). An increased incidence of hypobiosis has been associated with 
autumn grazing (Anderson et al, 1965; Armour et al, 1969a) and 
Martin et al (1957) originally suggested that this resulted as a 
consequence of immunity acquired by the host in response to larval 
challenge during the grazing season. However Armour et al (1969a) 
reported similar levels of EL^  in both autumn grazing permanent and 
tracer calves irrespective of number of days grazed and subsequently 
suggested (Armour et al, 1969b) that arrested development may be a 
feature of ageing larval populations or may be attributed to the effect 
of the autumn environment on either the larvae or the host. Other work 
(Armour and Bruce, 1974; Michel et al, 1974; Michel et al, 1975) 
demonstrated that autumn temperature changes are primarily responsible 
for the induction of hypobiosis and that host endocrine changes are not 
involved. Spontaneous redevelopment of arrested larvae usually occurs 
16-18 weeks after entry into the host, 21-23 after the commencement of 
the conditioning treatment (Michel et al, 1976).
The present trial investigates the effect of storage of 
0. ostertagi L3 at 4°C prior to oral inoculation of calves on the 
incidence of arrested larval development and assesses the MSRB as a 
means of controlling nematode populations in the calf.
Materials and Methods
Animals
Nine castrated male Friesian calves aged eighteen weeks, weighing 
approximately 140 kg and which had been reared under helminth-free 
conditions were used. Throughout the trial they were loose housed 
together in a straw bedded pen and received a daily feed allowance of 3 
kg hay and 1 kg of a standard 15% CP (fresh matter) concentrate pellet
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(190 Keystart Rearer Pencils, BOCM Silcock Ltd., Basingstoke,
Hampshire). The concentrate allowance was reduced slightly towards the 
end of the trial period to ensure that the ration was completely 
consumed.
Treatments
Equal numbers of calves were allocated to each of three treatment 
groups.
Group 1 calves were dosed per os with 2,000 0. ostertagi 
infective larvae daily for 42 days. The larvae were harvested from 
faecal culture and were no more than 24 hours old at oral inoculation.
Group 2 calves were similarly dosed but larvae were initially 
chilled and subsequently maintained at 4°C for 28-35 days prior to 
oral inoculation.
Group 3 calves were dosed per os with 4,000 freshly harvested 
0. ostertagi infective larvae every second day for 42 days. One calf 
in each treatment group additionally received a morantel sustained 
release bolus (MSRB, Pfizer Ltd.) at the commencement of the trial 
(control and bolus treated calves).
Faecal samples were obtained per rectum from all calves at 
weekly intervals and examined for the presence of 0. ostertagi eggs 
by a modified McMaster technique (Gordon and Whitlock, 1939). Blood 
samples were also taken for plasma pepsinogen determination.
Calves were necropsied 84 days after the initial larval 
inoculation and the abomasa examined for O. ostertagi as previously 
described.
Results
Clinical Observations
Administration of freshly harvested infective larvae to calves 
resulted in reduced voluntary food intake and intermittent profuse 
diarrhoea, these symptoms being typical of Type I ostertagiasis and 
necessitating the necropsy in extremis on day 63 of one calf 
receiving 4,000 L  ^every second day. Prior administration of an MSRB 
prevented these changes and calves inoculated with cold-conditioned 
larvae also remained clinically normal throughout the trial.
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Plasma pepsinogen
Plasma pepsinogen values (Table 9) were increased above initial 
levels from day 28 for calves in all treatment groups, this being 
particularly so for calves inoculated with 2,000 fresh larvae per day. 
Prior administration of an MSRB limited the extent of this elevation.
Parasitology
Positive faecal egg counts were recorded for all calves from day
35 until the end of the trial period (Table 10).
At necropsy 84 days after the initial larval inoculation white 
raised umbilicated nodules typical of 0. ostertagi infection were 
observed on the abomasa of all calves. Examination of the worm burdens 
revealed no developing stages present in calves inoculated with fresh 
larvae. In those inoculated with cold-conditioned larvae however, 
approximately 14% of the given had become inhibited at the early 
fourth larval stage (55% of the total worm burden). Prior 
administration of an MSRB reduced total worm burdens by approximately 
78% in calves receiving fresh larvae but due to its apparent inactivity 
against inhibited forms, worm burdens were only reduced by 38% in 
calves receiving cold-conditioned larvae. Worm burdens and associated 
data are presented in Table 11.
Discussion
From the results of this study it may be concluded that exposure
to low temperatures, even for a relatively short period of time, is a
stimulus for inhibited parasitic development of 0. ostertagi larvae. 
Variations in the dosing regime using fresh larvae were not effective 
in inducing hypobiosis thus confirming the results of Anderson et al,
(1967). However cold-conditioning per se only induced 54% of the 84 
day worm burden to become hypobiotic and it is possible that under 
natural conditions other factors such as decreasing daylength may also 
be involved. Alternatively the relatively low percentage of inhibited
larvae may reflect the use of a laboratory strain of O. ostertagi for
experimental infection. Armour et al (1967b) have previously 
reported that laboratory strains show a reduced propensity for arrested 
development compared to field strains, this possibly being attributable 
to repeated passage through donor animals. Variation between field 
strains for this characteristic has also been reported however 
(Borgsteede and Eysker, 1987; Smeal and Donald, 1982).
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The MSRB provided good control of infections arising from fresh 
larval inoculation but, while giving good control of cold-conditioned 
larvae undergoing normal development, it was apparently without effect 
against those entering the hypobiotic state. Thus, in contrast to 
Bliss and Jones (1983) who suggest that the MSRB present and active in 
the reticulum/rumen of cattle prevents the establishment of ingested 
larvae, these results may indicate that the MSRB is primarily effective 
against adult worms. Alternatively, within a single strain of 
0. ostertagi there may be two morphs with differing propensities for 
arrested development. Third stage larvae which readily respond to 
cold-conditioning may be metabolically different from those that do not 
and this may reduce the efficacy of morantel against them on ingestion. 
Experimental studies suggest that inhibiting and non-inhibiting morphs 
of 0. ostertagi do exist (Armour, 1970; Smeal and Donald, 1984).
A reduced efficacy of the anthelmintic fenbendazole against larvae 
in the hypobiotic state has occasionally been reported (Duncan et al, 
1977) but this is not attributable to reduced anthelmintic uptake by 
larvae in a supressed metabolic state (Prichard et al, 1978).
Rather, the reduced energy requirements of such larvae dictate that 
lethal concentrations of this anthelmintic, which acts by disrupting 
parasite energy metabolism, must be maintained for a greater length of 
time in order to kill hypobiotic larvae compared to metabolically 
active developing larvae and adult worms. The presence of the MSRB in 
the rumen/reticulum of cattle should ensure that high concentrations of 
morantel are maintained in the host animal for some considerable time.
A possible explanation for the apparent lack of effect against 
hypobiotic larvae is that morantel acts by the induction of a 
neuromuscular block inducing rapid paralysis (Harrow and Gration, 1985) 
and thus promotes the expulsion of adult worms with digesta flow. 
However it is unlikely that this mode of action would effect the 
destruction and removal of hypobiotic larvae from within the gastric 
mucosa.
Anderson (1985) considered that currently the main application of 
controlled release technologies, such as the MSRB, was in reducing 
pasture contamination prior to and during a period when survival and 
development of the free-living stages of a parasite was especially 
favourable. Used in this way, the MSRB would limit pasture larvae 
exposed to conditions of late autumn and thus be effective in the 
prophylaxis of Pre-Type II and Type II ostertagiasis.
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EXPERIMENT lie
EMHomxsioaxxacavL and parasitological studies on pre type ii
OSTERTRGIA OS1EKEAGI INFECTION IN CALVES
Introduction
Pre-Type II ostertagiasis was first described by Anderson et al 
(1965) and normally occurs during the winter in cattle which have been 
grazing pastures heavily contaminated with O. ostertagi larvae in 
late autumn. No clinical symptoms are apparent despite the presence of 
large numbers of hypobiotic larvae in the abomasae of infected animals 
and it is the synchronous development of these larvae in the spring 
which eventually precipitates clinical Type II disease.
Gastrointestinal damage and associated physiological changes arising 
from O. ostertagi infection are primarily attributable to the 
emergence of adult worms from the gas tic mucosa and consequently the 
Pre-Type II condition would be expected to have minimal impact on 
animal metabolism. However Anderson et al (1965) did consider that 
cattle with Pre-Type II ostertagiasis frequently appeared ill-thriven. 
The following study investigates the pathophysiological consequences of 
Pre-Type II ostertagiasis in cattle produced by daily infections of 
coId-conditioned O. ostertagi larvae.
Materials and Methods
Animals and experimental design
The experimental design was essentially that described in 
Experiment Ila. Twenty-five castrated male Friesian calves aged four 
months, weighing approximately 120 kg, and which had been reared under 
helminth-free conditions were allocated to three treatment groups.
Group A calves (clean) were maintained free of parasites. Five 
were used as control animals for digestion and nitrogen economy studies 
and a further two for radioisotopic investigations.
Group B calves (MSRB) were each given a morantel sustained release 
bolus (MSRB, Paratect; Pfizer). The calves were subsequently dosed 
per os with 2,000 cold-conditioned 0. ostertagi infective larvae 
daily for six weeks. Five calves were allocated to the digestion 
studies, two to the radioisotopic investigation and two necropsied 21 
and 42 days after initial infection.
Group C calves (infected) were treated similarly, but without
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prior MSRB administration, with five calves allocated for digestion 
studies, two for radioisotopic work and two for necropsy during the 
course of the trial (days 21 and 42).
All calves were housed together and the parasite-free status of 
the clean control animals was ensured by dosing fortnightly with 10 ml 
fenbendazole (Panacur, Hoechst). Blood and faecal samples were 
collected at approximately weekly intervals for biochemical and 
parasitological analyses and calves were clinically examined and 
weighed every three weeks.
Feed allowance
The calves were individually given a complete ration twice a day 
(Superstar cubes; Hamlyn Milling). Mean analyses were 0.89 dry matter 
(DM), with 143 g crude protein (CP), 147 g crude fibre (CF),, 43 g ether 
extract (EE), 91 g ash and 18.0 MJ gross energy (GE) kg DM-1. This 
was supplemented with barley husks (siftings) to produce a uniform 
mixture during periods when calves were accommodated in metabolism 
stalls in order to increase long fibre intake and prevent bloat. The 
initial daily feed allowance of 3.0 kg starcubes and 0.3 kg siftings 
was increased to 4.0 kg starcubes and 0.4 kg siftings on day 42 to 
allow for sustained growth of the calves.
Larval infections
The 0. ostertagi larvae were harvested from faecal cultures less 
than 21 days prior to oral inoculation of the calves, and were 
maintained at 4°C following a period of initial chilling in order to 
induce hypobiosis.
Parasitology and pathology
Parasitological and pathological techniques were as described in 
Experiment Ila.
Blood analyses
Blood was analysed for plasma pepsinogen by the method of Edwards 
et al (1960) where one international unit (I.U.)is equivalent to the 
release of one m mol tyrosine/litre plasma/minute.
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Digestibility and nitrogen balance studies
The fifteen calves involved in the metabolism study were allocated 
to three equal sized treatment groups on the basis of liveweight. 
Digestibility and nitrogen balance data were obtained from four animals 
in each group on days 14-21, 35-42, 56-63 and 77-84 as described in 
Experiment Ila, the lightest animal in each group being maintained as a 
potential replacement.
Radioisotopic measurements
Radioisotopic studies were conducted with two calves from each of 
the treatment groups clean, MSRB and infected on days 35-47 and 70-82 
following the first infection. Each calf was given an intramuscular 
injection of 110 MBq of tritiated water (TOH) after overnight 
withdrawal of food and water to standardize water present in the gut. 
Total body water and body water turnover were determined by the 
dilution technique using extrapolated plasma values as previously 
described.
The TOH injection was follcwed by a combined intravenous injection 
of 125I-bovine albumin and 51CrCl3 three days later. During the 
first recording period 59 MBq of ^crC^ were given, this being 
increased to 73 MBq during the second recording period. 15 MBq of
1 pc
I-albumm was given m  both recording periods. Plasma, faecal and 
urine samples were obtained, analysed and used for calculation of 
plasma volume, plasma protein losses into the gastrointestinal tract, 
albumin turnover and albumin catabolic rate as previously described.
Statistical analysis
Analysis of varionce and t-tests were performed using 'Minitab1 
(Ryan, Penn State University) on a microcomputer, as for Experiment 
Ila.
Results
Clinical observations
AV calves remained clinically normal throught the trial and it 
was not necessary to include the calves maintained as possible 
replacements in the metabolism studies. Periodic softening of faeces 
did occur among the calves but this cleared up spontaneously and did 
not appear to be treatment related.
The mean liveweights for the 15 calves used in the metabolism
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Figure 16. Mean liveweights of metabolism study calves
infected with cold-conditioned Ostertagia ostertagi, 
infected after administration of a MSRB or maintained 
as clean controls.
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studies are shown in Figure 16. There were no significant differences 
in the total mean liveweight gains between treatments, these being 
45.4, 51.0 and 50.6 kg (0.54, 0.61 and 0.60 kg/day) for the clean, MSRB 
and infected groups respectively.
Blood and faecal analyses
Mean values for plasma pepsinogen and faecal egg output for the 
fifteen metabolism study calves are presented in Tables 12 and 13 
respectively. No positive faecal egg counts were recorded for clean 
control calves and plasma pepsinogen was maintained at normal levels 
(<1.0 I.U.). Positive faecal egg counts were first recorded on day 21 
for MSRB treated and day 28 for infected calves continuing at a low 
level and reaching’mean maxima of 70 and 230 epg respectively. A small 
but significant increase in plasma pepsinogen relative to the clean 
controls was noted for both infected and bolused groups from day 21. 
MSRB treated calves reached a mean maximum value of 1.483 I.U. on day 
42 while values for the infected calves ranged from 0.472 to 1.863 I.U.
Apparent digestibility coefficients
Examination of apparent digestibility data for each of the four 
separate recording periods revealed significant treatment related 
differences for most of the standard proximate feed fractions during 
days 56-63 immediately following a feed increase. In general, apparent 
digestibilities were highest for the MSRB treated calves and lowest for 
the control group with the infected group being intermediate. Similar 
trends were apparent during days 14-21 and 35-42 but statistical 
significance was not attained. Mean values for each recording period, 
together with the overall mean for all four recording periods are 
presented in Table 14. (Values for individual calves are given in 
Appendix 4).
Nitrogen balance
Mean results for the daily nitrogen (N) input, output in urine and 
faeces and the calculated retentions for the three treatment groups in 
each of the four recording periods together with that for the overall 
experiment are presented in Table 15. Individual values and the data 
expressed in terms of a percentage of nitrogen input are given in 
Appendix 4. No significant differences in nitrogen balance occurred 
except in period III when the MSRB group of calves showed a
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Table 14. Mean apparent digestibility coefficients for calves 
infected with cold-conditioned 0. ostertagi larvae, 
infected after prior administration of a MSRB or
maintained as clean controls (sseJ
Days 14-21 Clean MSRB Infected
DM 0.566 ±0.006 0.588 ±0.004 0.580 ±0.019
CP 0.597 ±0.005 0.598 ±0.017 0.605 ±0.019
CF 0.180 ±0.015 0.239 ±0.016 0.215 ±0.033
EE 0.916 ±0.004 0.921 ±0.003 0.916 ±0.007
ASH 0.416 ±0.009 0.465 ±0.016 0.434 ±0.020
NFE 0.663 ±0.006 0.676 ±0.004 0.674 ±0.018
OM 0.581 ±0.005 0.600 ±0.004 0.595 ±0.019
Energy 0.573 ±0.007 0.601 ±0.004 0.599 ±0.017
Days 35-42 
DM 0.572 ±0.006 0.612 ±0.011 0.581 ±0.016
CP 0.609 ±0.010 0.630 ±0.019 0.614 ±0.005
CF 0.219 ±0.018b 0.321 ±0.019A 0.266 ±0.027Ab
EE 0.907 ±0.001 0.914 ±0.003 0.901 ±0.005
ASH 0.399 ±0.018 0.423 ±0.018 0.387 ±0.025
NFE 0.672 ±0.001 0.703 ±0.008 0.675 ±0.015
CM 0.590 ±0.005 0.632 ±0.011 0.601 ±0.015
Energy 0.583 ±0.004 0.620 ±0.013 0.585 ±0.016
Days 56-63
DM 0.564 ±0.007Bb 0.613 ±0.007A 0.582 +0.004b
CP 0.610 ±0.012 0.638 ±0.007 0.621 ±0.009
CF 0.162 +0.022B 0.261 +0.024Ab 0.224 +0.007b
EE 0.930 ±0.004A 0.911 +0.001b 0.902 +0.003Bb
ASH 0.398 ±0.008a 0.435 ±0.011b 0.383 ±0.014Aa
NFE 0.667 ±0.007Bb 0.710 +0.007A 0.679 ±0.004b
CM 0.582 ±D.009Aa 0.630 ±0.009b 0.601 +0.004a
Energy 0.574 ±0.011Aa 0.623 ±0.009b 0.593 ±0.006a
Days 77-84
DM 0.603 ±0.024 0.587 ±0.008 0.588 ±0.003
CP 0.649 ±0.023 0.628 ±0.014 0.634 ±0.008
CF 0.223 ±0.057 0.195 ±0.012 0.210 ±0.010
EE 0.923 ±0.007 0.910 ±0.003 0.917 ±0.002
ASH 0.424 ±0.037 0.413 ±0.019 0.390 +0.011
NFE 0.701 ±0.015 0.681 ±0.006 0.686 ±0.006
OM 0.621 ±0.023 0.599 +0.008 0.607 ±0.003
Energy 0.617 ±0.021 0.595 ±0.006 0.595 ±0.006
Overall
DM 0.577 ±0.007b 0.599 ±0.005a 0.583 +0.006ab
CP 0.616 ±0.008 0.623 ±0.008 0.619 +0.006
CF 0.196 ±0.016b 0.254 ±0.014a 0.229 ±0.011ab
EE 0.919 ±0.003A 0.914 ±0.002Ab 0.909 ±0.003b
ASH 0.409 ±0.010ab 0.434 ±0.009a 0.399 +0.010b
NFE 0.676 +0.006 0.693 ±0.005 0.678 ±0.006
OM 0.594 ±D.007b 0.615 ±0.006a 0.601 +0.006ab
GE 0.587 ±0.007b 0.609 ±0.005A 0.593 ±0.006Ab
Significance ab PC0.05, Ab P<0.01,AB P<0.001
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Table 15. Mean nitrogen balance (g/day ±SE) for calves infected 
with cold-conditioned 0.ostertagi larvae, infected 
after prior administration of a MSRB or maintained
Days 14-21 
Intake 
Faeces 
Urine 
Rstention
Days 35-42 
Intake 
Faeces 
Urine 
Retention
Days 56-63 
Intake 
Faeces 
Urine 
Retention
Days 77-84 
Intake 
Faeces 
Urine 
Retention
Overall
Intake
Faeces
Urine
Retention
clean controls
Clean 
64.59 ±0.61
26.02 ±0.32
23.34 ±2.09
15.23 ±2.19
62.63 ±0.00
24.48 ±0.61 
26.43 ±0.41 
11.72 ±0.98
83.98 ±0.51
32.74 ±0.90
32.15 ±1.41
19.10 ±0.98b
84.75 ±0.00
29.77 ±1.91
34.95 ±0.69 
20.04 ±2.36
73.99 ±2.69 
28.25 ±0.97 
29.22 ±1.32 
16.52 ±1.16
MSRB
64.88 ±0.41 
26.10 ±1.06 
25.66 ±1.69
13.12 ±2.61
62.63 ±0.00
23.16 ±1.18
25.61 ±1.55
13.86 ±2.68
84.86 ±0.00
30.74 ±0.62
30.24 ±1.05
23.88 ±0.74a
80.87 ±3.38
29.96 ±0.65 
32.70 ±1.81 
18.21 ±3.70
73.35 ±2.63
27.49 ±0.89 
28.55 ±1.05
17.27 ±1.62
Infected
65.26 ±0.04
25.76 ±1.24 
24.41 ±0.80
15.09 ±1.64
62.63 ±0.00
24.17 ±0.31 
25.40 ±2.57 
13.06 ±2.84
84.86 ±0.00 
32.15 ±0.73 
31.54 ±0.78
21.17 ±1.45ab
84.75 ±0.00
31.03 ±0.71
31.61 ±0.70
22.12 ±0.77
74.37 ±2.70
28.28 ±0.95
28.24 ±1.08
17.86 ±1.29
Significance ab P<0.05
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significantly improved nitrogen retention compared to the clean, but 
not the infected group of calves. This was apparently the result of 
reductions in both urinary and faecal nitrogen output.
Radioisotopic measurements
Faecal clearances of both -^I-albumin and ^crC^ were 
elevated for infected and to a lesser extent MSRB treated calves 
relative to clean controls during the first recording period indicating 
an increased loss of plasma into the gastrointestinal tract. This 
persisted into the second recording period for one infected and one 
MSRB treated calf. Values calculated using -^I-albumin were lower 
than those using ^CrC^ because of enzyme action and reabsorption 
of a considerable portion of the iodine label which was later excreted 
in the urine. Increased plasma faecal clearances were partially 
reflected by a reduced -^I-albumin half-life in one MSRB treated and 
one infected calf but the catabolic rate of albumin did not differ 
between treatment groups to any marked extent.
Plasma volumes expressed as ml/kg were increased for infected 
calves in both recording periods. Relatively lower values were 
recorded in the second period for all calves, this possibly being an 
effect of increased body weight. Body water turnover rates were also 
marginally increased for infected calves during days 35-47.
Pathology and parasitology
Occasional nodules due to 0. ostertagi infection were apparent 
in the fundic region of abomasa from the infected and MSRB treated 
calves slaughtered 21 days after the initial larval inoculation.
The gross appearance of the abomasa from both the infected and 
MSRB calves necropsied at 42 and 84 days was similar, few nodulel^u^ 
to 0. ostertagi again being confined to the fundic region. There was 
no evidence of widespread abomasal damage and lymph nodes were only 
slightly enlarged.
Worm burdens at necropsy for infected and MSRB treated calves are 
given in Table 16. No 0. ostertagi were recovered from clean control 
calves. Larval establishment in the infected calves necropsied at 21 
and 42 days was 32 and 45% of the L3 given respectively whereas in 
the MSRB treated calves it was 20 and 22%. By day 84 post infection 
means of 14343 and 11657 0. ostertagi were recorded for the infected 
and MSRB treated calves (17 and 14% of the L3 given respectively).
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Table 16. Pathophysological changes in calves infected with cold-conditioned 0.ostertagi 
larvae, infected after prior administration of a MSRB or maintained as a 
clean control
Clean MSRB Infected
Days 35-47 B31 B32 W35 W36 037 040
Plasma Vp (mlAg) 43.1 44.3 42.8 41.3 48.4 46.9
Volume
Faecal I-albumin 54.0 44.2 69.3 79.0 80.7 75.4
Clearance (ml/day)
Faecal Cr 216.9 175.5 268.7 295.7 336.7 317.4
Clearance (ml/day)
Catabolic rate % • 5.2 4.3 5.2 5.0 5.3 5.3
of albumin
Albumin I-albumin 20.2 26.0 22.0 14.5 23.0 17.5
Disappearance Tl/2 (days)
Total body % bodyweight 73.7 70.4 72.0 68.4 70.1 68.6
water
Body water (1/day) 6.4 7.5 6.6 9.3 8.2 8.0
turnover
TOH Tl/2 11.7 8.4 11.0 7.0 8.9 7.4
Disappearance (days)
Days70-82 B31 B32 W35 W36 037 040
Plasma Vp (mlAg) 37.1 39.9 38.5 37.6 41.9 40.9
Volume
Faecal I-albumin 40.8 42.9 41.8 67.8 98.3 53.2
Clearance (ml/day)
Faecal Cr 308.7 258.1 438.4 248.1 651.3 301.1
Clearance (ml/day)
Catabolic rate % 6.8 5.3 5.3 6.4 5.9 6.0
of albumin
Albumin I-albumin 15.4 24.9 18.4 11.9 18.2 18.4
Disappearance Tl/2 (days)
Total body % bodyweight 65.7 65.4 68.5 71.0 70.0 68.3
water
Body water (1/day) 10.9 12.5 12.3 14.4 12.1 14.1
turnover
TOH Tl/2 4.2 4.7 5.5 4.7 6.4 3.9
Disappearance (days)
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Table 18. Abomasal pH at necropsy of calves infected
cold-conditioned 0. ostertagi larvae, infected after 
prior administration of a MSRB or maintained as 
a clean control
Treatment
Clean
MSRB
Infected
Calf Abo.pH Mean ±SE
B13 3.48 4.23
B14 4.32 +0.20
B15 -
B16 4.19
B17 -
B31 4.66
B32 4.50
W1 4.70 4.31
W2 3.84 +0.23
W3 3.99
W4 -
W5 -
W35 4.01 (no bolus)
W36 5.00
06 3.95 4.15
07 4.35 +0.17
08 4.21
09 3.47
010 -
037 4.13
040 4.76
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Of these 79% in the infected calves and 87% in the bolused calves were 
in the form of arrested fourth stage larvae.
Larval infections occurred without significant alterations in the 
pH of the abomasal fluid (Table 18).
Discussion
The results reported here endorse those of Experiment lib in that 
relatively short term exposure to low temperatures (4oq was 
sufficient to induce arrested development in O. ostertagi third stage 
larvae. This is at variance however with the findings of Kloosterman 
et al (1984) who observed only a sporadic occurrence of arrested 
development following storage of 0. ostertagi third stage larvae at 
4oc for up to•twelve weeks prior to oral inoculation of calves.
Worm burden data again provides evidence that the MSRB is 
primarily active in promoting the expulsion of adult worms, numbers of 
inhibited and developing stages of O. ostertagi being similar in both 
infected and MSRB treated calves particularly at the 84 day necropsy. 
Removal of adult worms by the action of morantel did not promote the 
continued development of early fourth larval stages (Michel, 1971) and 
thus the arrested development induced by limited chilling was truly 
akin to the hypobiotic state of Pre-Type II ostertagiasis.
The established infections resulted in some abomasal mucosal 
damage as is evidenced by elevated plasma pepsinogen values for both 
infected and MSRB treated calves. These occurred from day 21 following 
the initial larval inoculation and may be attributed to the emergence 
of adult worms from the gastic mucosa and associated stretching and 
breakdown of cell junctions resulting in pepsinogen leakage from the 
abomasum (Armour, 1970). It is possible that higher values were 
observed in infected compared to MSRB treated calves because the 
presence of the bolus limited larval infection (Jones and Bliss, 1983). 
However in view of the similar numbers of developing stages in both 
groups of calves, a more likely explanation is that the enhanced 
removal of adult worms in MSRB treated calves promoted repair of 
abomasal damage. McKellar (1984) has demonstrated that the 
establishment of an adult population of O. ostertagi by 
transplantation can result in dramatic increases in plasma pepsinogen 
in the absence of any developmental damage to the abomasal mucosa. The 
presence and limited development of the nematodes stimulated the immune 
systems of both infected and MSRB treated calves as is evidenced by the
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slight enlargment of the lymph nodes.
Radioisotopic measurements indicated that the physiological 
effects of a predominantly arrested 0. ostertagi population were 
small. Increased plasma faecal clearances for infected and MSRB 
treated calves may be attributed to abomasal damage resulting from the 
development to and emergence of adult worms. However leakage of plasma 
into the gastrointestinal tract did not occur to a sufficient extent to 
affect the catabolic rate of albumin. The absence of body water 
effects possibly reflects the normal feed intake maintained by all 
calves.
Significant treatment effects on the apparent digestibilities of 
the various proximate feed fractions and on nitrogen retention occurred 
only during days 56-63 immediately following a feed increase. 
Interestingly it was the clean control calves rather than the infected 
calves which were poorest for both of these parameters, with the MSRB 
treated calves being superior in each case. Similar, but non 
significant trends were noted for days 14-21 and 35-42. An explanation 
for this may lie in the regular treatment of clean control calves with 
fenbendazole. Various authors (Entrocasso et al, 1986b; Fellenius
. c Qi
et al, 1981) have suggested that benzimidoles such as fenbendazole 
( I—*
may inhibit acid secretion by the abomasum and thus impair protein
digestion. There was no significant difference in abomasal pH at
necropsy between the three treatment groups but, while slightly
elevated values for infected and MSRB treated calves may have been due
to 0. ostertagi, those for the clean calves may indeed have been
attributable to the continued use of fenbendazole. However effects on
apparent digestibility are more than effects on acid production alone
as the significantly depressed digestibility values for clean control
calves occurred at a time when 0. ostertagi was likely to be exerting
its maximum on the abomasa of calves in the other treatment groups.
Jara et al (1984) have demonstrated that benzimidazoles depress the
rumen fermentation ability of sheep and that fenbendazole has the
greatest effect on rumen volatile fatty acid production. Increased
frequency of dosing results in a sustained depression and molar
concentrations of volatile fatty acids may also be altered (Hodgson and
Jessop, 1987). Ihus the use of fenbendazole may have reduced the
productive efficiency of the clean control calves by interfering
primarily with rumen fermentation, this being particularly apparent at
a time when the digestive system was adapting to a feed increase. In
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contrast, the continuous administration of morantel from the MSRB was 
without digestibility effects.
It may be concluded that Pre-Type II ostertagiasis does not 
produce marked pathophysiological changes in infected calves, that the 
MSRB is primarily active against adult 0. ostertagi and that 
fenbendazole may interfere with ruminant digestion.
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EXPERIMENT lid
EMHOmgSKHCGICM, AND PARASITQCflGICAL STUDIES CN A CPNCQRRENT 
INFECTION OF OSTERiaGIA OSTER33V5I AND OOOPERIA ONOOPBORA IN CALVES
Introduction
In North Western European countries the most abundant species of 
gastrointestinal nematodes of cattle are Ostertagia ostertagi and 
Cooperia oncophora (Kloosterman et al, 1984). Most published work 
indicates that the establishment of significant populations of C. 
oncophora in first season grazing calves is confined to the spring and 
summer months, the rapid acquisition of immunity resulting in 
expulsion of most of the worms by the autumn. In contrast, 0. 
ostertagi has greater persistency in the host and it is the 
accumulation of this nematode which is generally credited as the cause 
of late season clinical parasitic gastroenteritis (PGE). However 
significant numbers of C. oncophora were reported in clinically 
affected calves which had been grazing infective pastures for four 
ironths (Entrocasso et al, 1986b) and it is clearly possible that 
absolute immunity to this nematode may not develop in all cases. Even 
where infection is expelled the possible role of early season C. 
oncophora in precipitating late season disease has not been discounted 
(Baker 1988). The following study investigates the effects of a 
concurrent experimental infection of 0. ostertagi and C. oncophora 
on the digestive efficiency, nitrogen economy and pathophysiology of 
parasite naive calves.
Materials and methods
Animals and experimental design
Twenty-five castrated male Friesian calves aged four months, 
weighing approximately 120 kg, and which had been reared under 
helminth-free conditions were allocated to three treatment groups.
Group A calves (clean) were maintained free of parasites. Five 
were used as control animals for digestion arri nitrogen economy studies 
and a further two for pathophysiological investigations using 
radioisotopes.
Group B calves (MSRB) were each given a morantel sustained release 
bolus (MSRB, Paratect; Pfizer). The calves were subsequently dosed 
per os with 2,000 0. ostertagi and 10,000 C. oncophora infective
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larvae daily for six weeks. Five calves were allocated to the 
digestion studies, two to the radioisotopic investigation and two 
necropsied 21 and 42 days after initial infection.
Group C calves (infected) were treated similarly, but without 
prior MSRB administration, with five calves allocated for digestion 
studies, two for radioisotopic work and two for necropsy during the 
course of the trial (days 21 and 42).
Clean control calves were housed separately from those in infected 
groups to prevent possible autoinfection from bedding material. All 
calves were clinically examined and weighed every three weeks and blood 
and faecal samples were collected weekly for biochemical, 
heamatological and parasitological analyses.
The remaining calves in the metabolism and radioisotope studies 
were slaughtered on day 84 of the experiment.
Feed allowance
The calves were individually given a complete ration twice a day 
(Superstar cubes; Hamlyn Milling). Mean analyses were 0.88 dry matter 
(DM), with 170 g crude protein (CP), 130 g crude fibre (CF), 56 g ether 
extract (EE), 105 g ash and 18 MJ gross energy (GE) kg DM- -^. This 
was supplemented with barley husks (siftings) to produce a uniform 
mixture during periods when calves were accommodated in metabolism 
stalls. The daily feed allowance of 3.0 kg starcubes and 300 g 
siftings was calculated to give a mean average daily gain of 
approximately 0.4 kg/day. Where calves became inappetent as a result 
of the experimental infection feed was initially offered four times per 
day and subsequently continuously in an attempt to stimulate intake.
Larval infections
Infective larvae were harvested from faecal cultures less than 21 
days prior to oral inoculation of the calves and were maintained at 
room temperature (17°C) until required.
Parasitology and Pathology
Faecal egg counts, pathological techniques and the post-mortem 
recovery of trichostrongylate parasites was as described in General 
Materials and Methods.
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Blood analyses
Blood total protein and albumin concentrations for calves used in 
the pathophysiological study were determined using continuous flow 
analysis (Standard Technicon Auto-Analyser II). Plasma pepsinogen 
activity was assayed by the method of Edwards et al (1960) where one 
international unit is equivalent to the release of one m mol 
tyrosine/litre plasma/minute.
Digestibility and nitrogen balance
The fifteen calves involved in the metabolism study were allocated 
to three equal sized treatment groups such that the mean weight and 
weight range of each group was similar. Four calves from each group 
were used for- digestibility and nitrogen balance studies during days 
14-21, 35-42, 56-63 and 77-84 post infection as described in Experiment 
Ila, the fifth animal being maintained as a potential replacement.
Radioisotopic measurements
Radioisotopic studies using 51crCl3f 125i-albumin and 
tritiated water (TOH) were conducted with two calves from each of the 
treatment groups clean, MSRB and infected on days 35-47 and 70-82 
following the first infection. Each calf received 74 MBq of 
S1CrCl3 and 15 MBq of 125i-albumin by intrajugular catheter at 
the beginning of each study period. This followed an injection of 110 
MBq of TOH four days earlier. Calves were dosed daily per os with 10 
ml 0.75% KI solution for three days prior to and ten days after the 
^-^I-albumin injection to ensure rapid excretion of 125j from 
catabolised 125j-aibumin. Collection of plasma, faecal and urine 
samples, and a calculation of pathophysiological parameters was as 
described in Experiment Ila.
Statistical Analyses
Statistical analyses were performed using 'Minitab' (Ryan, Penn 
State University) on a microcomputer. Metabolism study and blood 
biochemical data were analysed using a standard analysis of variance. 
Where treatment effects were shown to be significant a multiple 
comparisons procedure was performed. Two sample t-tests were performed 
on log transformed parasitological data for infected control and MSRB 
treated calves.
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Results
Clinical observations
Clean control calves remained clinically normal throughout the 
trial. All infected control calves displayed symptoms typical of Type 
I ostertagiasis, these first becoming noticeable at around day 21 and 
varying in severity from a reduced rate of eating and intermittent 
diarrhoea in some individuals to almost complete inappetence, lethargy, 
profuse watery diarrhoea and a dramatic liveweight loss in others.
These symptoms necessitated the premature necropsy of two infected 
calves on days 58 and 66. One clean control calf also died from bloat 
on day 74. Symptoms subsided towards the end of the trial but the 
appearance of the infected control calves was greatly inferior to that 
of clean control and MSRB treated calves at necropsy on day 84. Prior 
administration of an MSRB prevented adverse clinical changes other than 
a slightly reduced rate of eating compared to the clean controls and an 
occasional softening of the faeces.
The mean liveweights of the 15 calves used in the metabolism study 
are shown in Figure 17. A statistically significant difference 
(P<0.01) in liveweight between the infected calves and those in the 
other treatment groups first became apparent on day 42, this being 
highly significant (P<0.001) on day 63. After 84 days when the 
experiment ended total mean liveweight gains were 39, 41 and 5 kg for 
the clean, MSRB and infected groups respectively.
Biochemistry
Mean plasma pepsinogen values for infected and MSRB treated 
metabolism study calves were significantly elevated above clean control 
levels from day 7. Values for infected calves reached a mean maximum 
of 5.41 I.U. on day 42 and remained elevated at just below this level. 
MSRB treated calves similarly displayed peak plasma pepsinogen values 
on day 42 (3.78 I.U.) but these subsequently returned to clean control 
levels by day 84. Mean plasma pepsingoen values are presented in Table 
19 and complete individual calf data is contained within Appendix 5.
Blood total protein and albumin concentrations were determined for. 
calves involved in the radioisotopic studies using each of the two 
recording periods (Table 20). There was no evidence of 
hypoalbuminaemia and associated hypoproteinaemia for either of the MSRB 
treated calves compared to the clean controls. During days 35-42 
infected calves were hypoalbuminaemic and hypoproteinaemic compared to
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Figure 17. Mean liveweights of metabolism study calves
concurrently infected with Qstertagia ostertagi 
and Cooperia oncophora, infected after administration 
of a MSEB or maintained as clean controls.
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Table 20. Serum constituents (g/litre) of radioisotope calves 
infected with Ostertagia ostertagi and Cooperia 
oncophorar infected after administration of a MSRB 
or maintained as clean controls
35-47 Clean MSRB Infected
Total protein
Day B17 B18 Y79 Y80 020 023
36 72 71 67 63 66 59
39 72 72 73 67 64 60
43 71 72 72 67 67 58
46 70 69 69 66 63 55
Day Serum albumin
36 34 35 32 32 29 26
39 35 37 34 33 29 25
43 33 36 32 31 27 22
46- 32 34 31 31 25 20
77-84 Clean MSRB Inf
Total protein
Day B17 B18 Y79 Y80 024
71 69 67 67 67 60
74 68 68 69 66 59
78 72 . - 69 67 62
81 70 — 68 67 63
Day Serum albumin
71 32 34 32 30 22
74 31 33 33 30 21
78 34 - 33 30 21
81 32 - 33 32 20
Severity of clinical symptoms necessitated the premature 
necropsy of calves 020 and 023 on days 58 and 66 respectively 
Calf B18 died from bloat on day 74
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both clean and MSRB treated calves. Similar reductions in the 
respective blood constituents were also apparent for the replacement 
infected calf used during days 70-84.
Apparent digestibility coefficients
Examination of the apparent digestibility of each of the standard 
proximate feed fractions for each of the four separate recording 
periods revealed a consistent depression in the digestive efficency of 
the crude protein, ether extract and gross energy fractions for 
infected calves compared to calves in the other treatment groups once a 
patent infection was established. These effects were most marked 
during days 35-42 and at this time the apparent digestibility of the 
ash proximate• fraction was also reduced. Over the entire experiment 
the apparent digestibility of the dry matter was significantly reduced 
for infected compared to MSRB treated but not clean control calves.
Mean data for each recording period is presented in Table 21 and 
individual calf values are contained within Appendix 5. _
Nitrogen balance
Nitrogen retention was significantly reduced for infected compared 
to clean control and MSRB treated calves during days 35-42 and 56-63 
(Table 22) as a result of increases in both faecal and urinary nitrogen 
output. The increase in faecal nitrogen loss was highly significant 
during days 35-42. During days 77-84 nitrogen retention was improved 
for calves in all treatment groups mainly as a result of reduced 
urinary nitrogen loss compared with preceeding periods. At this time 
significant differences between treatments did not occur but mean 
faecal nitrogen loss was increased with a consequent decrease in 
nitrogen retention for infected compared to MSRB treated and clean 
control calves. Over the entire experiment nitrogen retention of 
infected calves was significantly reduced, this principally arising 
from both a significant reduction in intake and a significantly 
increased faecal nitrogen loss compared to other treatment groups. 
Nitrogen balance data for individual calves, and also that expressed as 
a percentage of nitrogen intake is given in Appendix 5.
Radioisotopic measurements
Pathophysiological changes in the calves, as measured using 
radioisotopic techniques are summarised in Table 23. During days 35 to
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Table 21. Mean digestibility coefficients (+SE) for calves 
concurrently infected with Ostertagia ostertagi 
and Cooperia oncophorar infected after prior 
administration of a MSFB or maintained as clean 
controls
Clean MSRB Infected
14-21 n=4 n=4 n=4
DM 0.6403 ±0.0115 0.6600 +0.0094 0.6568 ±0.0153
CP 0.6051 ±0.0112 0.6343 ±0.0077 0.6080 ±0.0122
CF 0.3882 ±0.0247 0.4109 ±0.0215 0.4232 ±0.0321
EE 0.9345 +0.0027 0.9346 £0.0017 0.9307 ±0.0028
ASH 0.4784 +0.0196 0.4630 ±0.0331 0.4576 ±0.0203
NFE 0.7163 ±0.0091 0.7410 ±0.0051 0.7353 ±0.0160
CM 0.6600 +0.0105 0.6810 +0.0078 0.6780 ±0.0167
Energy 0.6119 ±0.0156 0.6308 ±0.0104 0.6301 ±0.0173
; 35-42. n=4 n=4 n=3
DM 0.6294 ±0.0180 0.6352 +0.0082 0.5958 ±0.0095
CP 0.6258 ±0.0125a 0.6346 ±0.0103A 0.4972 +0.0319B
CF 0.3327 ±0.0366 0.3571 ±0.0236 0.3580 +0.0237
EE 0.9026 +0.0066A 0.9023 ±0.0043A 0.8146 ±0.023IB
ASH 0.4816 +0.0188A 0.4690 +0.0269a 0.3260 +0.0469b
NFE 0.7117 ±0.0175 0.7183 ±0.0038 0.7190 ±0.0054
OM 0.6472 +0.0182 0.6552 +0.0069 0.6283 ±0.0074
Energy 0.6630 +0.0190a 0.6379 ±0.0063a 0.5773 ±0.0076b
3 56-63 n=4 n=4 n=3
DM 0.6366 ±0.0172 0.6401 +0.0089 0.6003 ±0.0111
CP 0.6242 ±0.0147A 0.6154 +0.0170A 0.5280 ±0.0181b
CF 0.3492 +0.0299 0.3532 +0.0168 0.3750 ±0.0163
EE 0.9206 ±0.0050a 0.9224 +0.0013A 0.8898 ±0.0124b
ASH 0.4647 ±0.0268 0.4804 ±0.0186 0.4106 ±0.0780
NFE 0.7207 ±0.0202 0.7256 +0.0070 0.6872 ±0.0182
CM 0.6561 ±0.0174 0.6654 +0.0112 0.6214 +0.0128
Energy 0.6395 ±0.0216 0.6478 ±0.0096 0.5789 +0.0167
Days 77-84 n=4 n=4 n=4
DM 0.6475 ±0.0168 0.6508 ±0.0098 0.6180 +0.0126
CP 0.6175 ±0.0169 0.6085 ±0.0075 0.5788 ±0.0119
CF 0.3585 +0.0302 0.3611 ±0.0237 0.3405 ±0.0239
EE 0.9265 ±0.0025a 0.9285 ±0.0093a 0.8944 ±0.0104B
ASH 0.4604 ±0.0366 0.4879 +0.0206 0.3962 ±0.0643
NFE 0.7582 +0.0128 0.7606 ±0.0088 0.7367 ±0.0089
OM 0.6694 +0.0150 0.6700 ±0.0103 0.6440 ±0.0104
Energy 0.6659 ±0.0165a 0.6592 +0.0090a 0.6066 ±0.0138B
Overall
DM
CP
CF
EE
ASH
NFE
CM
Energy
0.6384
0.6181
0.3571
0.9211
0.4713
0.7267
0.6582
0.6375
+0.0074ab
±0.0066A
+0.0147
+0.0036A
+0.0121A
±0.0084
+0.0073
±0.0096A
0.6465
0.6232
0.3706
0.9219
0.4851
0.7363
0.6679
0.6439
±0.0048a
+0.0051A
±0.0114
±0.0033A
+0.0117A
±0.0051
±0.0048
±0.0049A
0.6205
0.5588
0.3753
0.8867
0.4018
0.7238
0.6455
0.6011
+0.0089b 
±0.0143B 
+0.0146 
±0.0126b 
±0.0272b 
+0.0078 
+0.0084 
±0.0089B
Significance ab P<0.5, Ab aB P<0.01, AB P<0.001
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Table 22. Mean nitrogen balance (g/day) for calves concurrently 
infected with Ostertagia ostertagi and Cooperia 
oncophora. infected after prior administration of a 
MSRB or maintained as a clean control (tst)
Days 14-21 
Intake 
Faeces 
Urine 
Retention
Clean 
n=4
72.35 ±0.28
28.74 +0.85 
22.98 ±0.57 
20.63 ±1.10
MSRB 
n=4
72.29 +0.34
26.42 ±0.56 
21.69 ±1.38
24.18 ±1.88
Infected 
n=4
72.22 ±0.25
28.29 ±0.85
22.19 ±0.91
21.74 ±0.55
Days 35-42 
Intake 
Faeces 
Urine 
Retention.
Days 56-63 
Intake 
Faeces 
Urine 
Retention
Days 77-84 
Intake 
Faeces 
Urine 
Retention
n=4
72.78 ±0.00 
27.23 ±0.91b 
29.67 ±0.91 
15.88 +0.93A
n=4
75.04 ±0.00
28.22 ±1.10
29.50 ±1.53 
17.32 ±0.78A
n=4
72.13 ±1.70
27.56 ±1.06
17.56 ±0.79 
27.01 ±1.82
n=4
72.57 +0.21 
26.52 +0.76b
27.92 +1.82
18.13 ±2.31A
n=4
75.04 ±0.00
28.79 +0.85 
26.25 ±1.15 
20.00 ±0.84A
n=4 
73.83 +0.00 
28.91 ±0.56
21.50 ±1.34 
23.43 +0.85
n=3
65.22 +4.63
32.49 ±0.72A
30.57 ±1.06 
2.15 ±5.00b
n=3 
70.90 ±3.14
33.50 +2.23 
30.48 ±2.55
6.92 ±3.59b
n=4
72.35 ±1.48
30.42 ±0.32 
19.60 ±2.97 
22.34 ±4.02
Overall n=16 n=16 n=14
Intake 73.08 ±0.49a 73.43 ±0.30a 70.47 +1.33b
Faeces 27.94 ±0.47A 27.66 +0.44A 30.91 ±0.69B
Urine 24.93 ±1.38 24.34 ±0.97 25.02 ±1.65
Retention 20.21 ±1.24a 21.43 +0.96A 14.54 +2.88b
Significance ab P<0.05r Ab aB P<0.01, AB P<0.001
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Table 23. Pathophysiological changes in calves concurrently infected with Ostertagia 
ostertagi and Cooperia oncoohora, infected after prior administration of a 
MSRB or maintained as clean controls
Clean MSRB Infected
Days 35-47 B17 B18 Y79 Y80 020 023
Plasma Vp (ml/kg) 56.8 52.6 54.7 52.3 55.7 47.0
Volume
Faecal I-albumin 58.8 32.9 87.2 104.2 142.0 208.5
Clearance (ml/day)
Faecal Cr 320.6 378.6 417.0 599.0 714.8 782.0
Clearance (ml/day)
Catabolic rate % 5.1 4.8 4.9 5.7 6.2 9.7
of albumin
Albumin I-albumin 19.3 21.6 19.1 17.8 13.0 10.0
Disappearance Tl/2 (days)
Total body % bodyweight 69.5 66.1 73.0 74.5 77.6 69.0
water
Body water (1/day) 9.3 12.7 8.1 8.4 9.5 10.1
turnover
T0H Tl/2 6.7 4.3 7.9 9.5 7.1 5.9
Disappearance (days)
Days 70-82 B17 B18 Y79 Y80 024
Plasma Vp (ml/kg) 52.6 55.7 56.6 55.7 53.8
Volume
Faecal I-albumin 66.5 21.0 60.7 100.7 94.8
Clearance (ml/day)
Faecal Cr 384.7 248.4 371.4 519.5 903.7
Clearance (ml/day)
Catabolic rate % 4.8 3.2 4.4 4.5 7.8
of albumin
Albumin I-albumin 20.3 - 20.0 17.3 10.4
Disappearance Tl/2 (days)
Total body % bodyweight 60.0 59.8 62.0 69.4 71.1
water
Body water (1/day) 8.5 9.0 8.5 9.6 10.1
turnover
TOH Tl/2 6.5 6.0 7.0 6.5 5.7
Disappearance (days)
Acute clinical ostertagiasis necessitated the premature necropsy of calves 020 and 023 
on days 58 and 66 respectively 
Calf B18 died of bloat on day 74
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47 both infected and to a lesser extent MSRB treated calves showed 
increased faecal clearances of 125I-albumin and 51cr compared to 
clean controls with consequent increases in the catabolic rate of 
albumin and decreases in the l25i-albumin half-life. In infected 
calves these changes were associated with hypoalbuminaemia and 
hypoproteinaemia and were particularly marked in one calf (023) in 
which plasma volume was also reduced.
Measurements using TQH provided evidence of increased water 
retention in both MSRB treated and one infected control calf but values 
for infected calves must be regarded with some caution as inappetence 
and diarrhoea prevented steady state conditions from operating.
During days 70-84 one clean control calf (B18) died as a result of 
non-treatment.related causes and the physiological values obtained may 
be atypical as they are based on incomplete data. A direct comparison 
between values obtained for infected calves during days 35-47 and 70-84 
cannot be made because of the premature necropsy of both calves used 
during the first part of the study. However values obtained for the 
similarly infected replacement calf indicate a continued increase in 
the faecal clearance of both 125i-albumin and 51cr accompanied by 
an increase and decrease of approximately 100% in the catabolic rate of 
albumin and the l25i-albumin half-life respectively compared to clean 
controls.
Responses of the two MSRB treated calves during days 70-84 
differed in that one calf (Y80) displayed evidence of continued 
physiological disturbances (increased faecal clearances of 
^■^I-albumin and 51cr and reduced half-life of 125i-albumin) 
compared to clean controls, while physiological values for the other 
calf (Y79) had returned to control levels. Examination of worm burdens 
at the 84 day necropsy reveals that this may have been attributable to 
the greater residual infection in Y80 rather than any differential 
effects on repair of the gastric mucosa.
Plasma volume for the infected calf was again slightly reduced 
compared to clean and MSRB treated calves and there was evidence of 
hypoalbuminaemia resulting in slight hypoproteineamia. There were no 
major differences in body water measurements between treatment groups.
Pathology
Oedema was apparent in the abomasum of the infected calf 
necropsied 21 days after initial infection. Microscopic examination of
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abomasa from both the infected and MSRB treated calves revealed small 
areas of necrosis, cellular infiltration of the lamina propria and 
replacement of zymogen and parietal cells with hyperplastic 
undifferentiated cells, particularly in the pylorus. Developing 0. 
ostertagi were present in the dilated gastric glands and on the 
mucosal surface.
The entire small intestines from both infected and MSRB treated 
calves displayed evidence of mucosal damage attributable to the 
development of C. oncophora, this being particularly marked in the 
jejunum. Here, in addition to stunting and thickening, some areas of 
villi were completely flattened and villous adhesion was apparent. In 
the MSRB treated calf sloughed epithelial cells formed a sheet around 
lumen dwelling worms. No worms were detected in the ileum of either 
calf.
At the 42 day necropsy the gross appearance of the abomasa from 
the infected and MSRB treated calf was similar to that at day 21 but 
microscopic examination revealed a strong cellular reaction, 
particularly in the pyloric region. In the infected calf there was 
destruction of the surface epithelium, congestion of mucosal blood 
vessels and developing 0. ostertagi in dilated gastric glands.
Dilated gastric glands for both calves contained macrophages but for 
the MSRB treated calf worms were only present on the mucosal surface.
For the infected calf necropsied at this time there was extensive 
damage to the entire small intestinal mucosa with severe destruction 
and removal of epithelial cells, especially the tips of the villi, 
mucosal oedema and congestion of mucosal and submucosal blood vessels. 
Mucosal damage in the MSRB treated calf was limited to some stunting 
and thickening of the villi in the duodenum and jejunum. A strong 
cellular reaction was apparent in both calves, there being an 
infiltration of the lamina propria by eosinophils and lynphocytes.
Worm penetration of the lamina propria was also apparent.
There was no obvious mucosal damage to the abomasum of the MSRB 
treated calf examined on day 84 but a cellular reaction was still 
apparent. In contrast, the mucosa from the infected calf showed 
extensive ulceration, oedema and necrosis particularly in the fundic 
region where there was replacement of most of the zymogen and parietal 
cells by non-functional, undifferentiated hyperplastic cells. 
Hyperplasia of the mucus cells was apparent in the pyloric region.
Persistent damage to the mucosa of the small intestine was
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apparent in both calves, this being more severe and extensive in the 
infected calf. Large numbers of sloughed epithelial cells were present 
in the proximal lumen and there was cellular infiltration of the lamina 
propria.
Parasitology
The weekly trichostrongyle faecal egg counts (Table 24, Appendix 
6) showed that the faeces of clean control calves were negative 
throughout the trial. A positive faecal egg count was recorded on day 
14 for both MSRB treated and infected calves, with positive counts for 
all calves in each of these treatment groups being first recorded on 
days 35 and 21 respectively. Values for MSRB treated calves reached a 
mean maximum of 150 epg on day 35 while a mean maximum of 4980 epg was 
recorded for infected calves on day 49 followed by a subsequent decline 
to 430 epg on day 84 when the experiment was terminated.
Similar total burdens of 0. ostertagi were recorded for MSRB 
treated and infected calves at the 21 day necropsy but the 
establishment of C. oncophora in the MSRB treated calf was only 19% 
of that in the infected calf. At the 42 day necropsy this percentage 
was reduced to 5%, prior administration of the MSRB also promoting a 
25% reduction in 0. ostertagi burdens. The infectivity of the 0. 
ostertagi L3 in the mixed infection was particularly high, there 
being a greater than 100% establishment (possibly attributable to 
natural variation during preparation of infective larval doses) in both 
MSRB and infected calves necropsied on day 21, and establishments of 65 
and 85% respectively of the larval dose administered at day 42.
By day 84 a marked loss of worms had occurred mean burdens of 0. 
ostertagi and C. oncophora being reduced from 71800 and 128200 on 
day 42 to 19983 and 16017 respectively on day 84 for infected calves. 
For MSRB treated calves reductions from 54200 and 6800 to 1457 and 386 
0. ostertagi and C. oncophora respectively were recorded.
C. oncophora was mainly located in the duodenum of calves 
necropsied on day 21, but by day 42 appreciable numbers of worms were 
additionally recovered from the jejunum and ileum, particularly in the 
infected calf where the total population was considerably greater. By 
day 84 the low numbers of C. oncophora recovered from MSRB treated 
calves were principally located in the duodenum, while the larger 
numbers recovered from infected calves were more evenly distributed 
along the entire small intestine. Mean total worm burdens are
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Table 24. Mean faecal egg counts (epg +SE) for 
calves concurrently infected with 
O.ostertagi and C.oncophora or infected 
after prior administration of a MSRB
Day MSRB Infected
0
o-Ho 0 ± 0
7 0 ± 0 0 ± 0
14 10 ± 0 10 ± 10
21 0 + 0 1030 ± 108
28 50 ± 22b 1270 ± 270a
35 150 ± 42B 2220 ± 626A
42 50 ± 39b 3290 ± 868A
49 50 ± 7b 4980 ±3458a
56 90 ± 40b 3270 +2012a
63 90 ± 46 980 ± 523
70 30 ± 20b 860 ± 566a
77 50 ±101b 1770 ±1258a
84 50 ± 16 430 ± 162
Significance ab P<0.05, Ab P<0.01r AB P<0.001 
No positive counts were recorded for clean controls
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presented in Table 25 while individual calf values are detailed in 
Appendix 5.
Discussion
The results of this study demonstrated that a combined infection 
of 0. ostertagi and C. oncophora produced sustained severe 
metabolic and pathophysiological changes in young growing calves which 
were far in excess of those produced by either monospecific infection 
given in an entirely comparable manner (Armour et al, 1987a? Taylor 
et al, 1988). Experimental infections were given at levels which may 
be encountered under natural grazing conditions in the west of Scotland 
(Entrocasso 1984) but it is debatable how closely oral dosing can mimic 
the intake of.infective larvae from pasture. Epidemiological studies 
(Rose, 1962 and 1963) have demonstrated that moisture availability has 
an effect upon the migration of infective larvae from the faecal pat to 
the pasture and that during conditions of low moisture availability 
highly contaminated pastures are not necessarily highly infective.
Thus the true pattern of natural calf infection may well not be a 
continuous low level intake but rather a saw-tooth pattern where each 
peak of infection represents the liberation of from the faecal 
reservoir following rainfall. The relative availability and 
infectivity of 0. ostertagi and C. oncophora L3 must also be 
considered in that, while pasture levels of both species are maximal 
during the latter part of the grazing season (Ibarra-Silva, 1988; Rose, 
1963), early season exposure of susceptible calves to low levels of C. 
oncophora infective larvae may have stimulated the immune response so 
that animals are refractory to maximal levels of challenge. However 
Entrocasso et al (1986b) reported considerable numbers of C. 
oncophora in calves clinically affected with parasitic gastroenteritis 
which had been grazing for four months and it is possible that absolute 
immunity to . this nematode may not develop in situations where the 
increase in pasture infectivity is delayed, as was the case in this 
study. Thus where climatic conditions are such, simultaneous intake of 
infective 0. ostertagi and C. oncophora larvae by completely 
susceptible animals may predispose to severe clinical disease as 
reported in the current work.
Several interesting findings emerge from the parasitological data 
obtained during this study, both from the infected control and MSRB 
treated groups of calves. Firstly establishment of 0. ostertagi was
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extremely high with over one hundred percent of administered infective 
larvae establishing in both infected and MSRB treated calves at three 
weeks. This compares with 77 and 33% respectively in calves similarly 
infected with 0. ostertagi alone (Experiment Ila) and an expected 20% 
where larvae are given as a single inoculum (Ibarra-Silva, 1988). In 
contrast the establishment of C. oncophora at three weeks in the 
infected calf was only 58% of that recorded for a comparable 
monospecific infection (Armour et al 1987a) but necropsy at 
subsequent dates revealed that the establishment of this nematode was 
also relatively increased. Previous experimental studies have reported 
increased establishment rates for infections of mixed species or genera 
compared to pure infections (Al-Saqur, 1982; Ross et al, 1968) and it 
has been postulated that this may be due to an immunosuppressive 
effect. However, Kloosterman et al, (1984) failed to demonstrate any 
interactions between C. oncophora and 0. ostertagi when given as a 
concurrent infection and the identification of cross reacting 
antibodies (Keus et al, 1981) suggests that the presence of one 
species may actually be detrimental to the other. Prior administration 
of a MSRB was apparently less effective in controlling C. oncophora 
when given concurrently with 0. ostertagi than when given alone, but 
worm burdens were maintained at low levels with a mean of only 386 
worms being recorded on day 84.
The failure of the MSRB to bring about notable reductions in 0. 
ostertagi burdens at 21 days again suggests that morantel is primarily 
active against adult worms of this species. This suggestion is further 
supported by examination of the 42 and 84 day worm burdens, the 
observed reduction in O. ostertagi in the MSRB treated calves being 
principally due to a reduction in adults, numbers of developing stages 
being similar for both treatment groups. Conversely prior MSRB 
treatment brought about apparent reductions in both developing and 
adult C. oncophora. This species has been previously regarded to be 
lumen dwelling but both Armour et al (1987a) and the current study 
have demonstrated some larval penetration of the small intestinal 
mucosa. The length of time which larvae spend within the mucosa is not 
known, nor indeed is it known whether mucosal penetration is a 
prerequisite for parasitic development. It is likely however that 
developing larval stages of C. oncophora are more greatly exposed to 
morantel than those of 0. ostertagi which develop deep within the 
gastric glands. Morantel acts by the induction of a neuromuscular
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block and paralysis (Harrow and Gration, 1985) and this mode of action 
can only be effective if paralysed worms are subsequently removed with 
digesta. Any developing C. oncophora larvae lying deep between the 
villi in close association with the intestinal mucosa may evade 
anthelmintic action and complete their parasitic development.
Armour et al (1987a) reported the migration of C. oncophora 
populations through the small intestine. In contrast evidence from the 
current study suggests that the duodenum is the predilection site. 
However this may be attributable to the induction of a more favourable 
duodenal microclimate by the presence of 0. ostertagi in the 
abomasum. Duodenal overpopulation apparently resulted in colonisation 
of the more distal jejunum and ileum. Data pertaining to the 84 day 
necropsy suggested that adult worms remained in that region of the 
small intestine where their parasitic development took place and that 
no anterior migration occurred to more preferred sites following loss 
of worms from these regions.
Despite burdens of 54200 0. ostertagi and 6800 C. oncophora 
recorded for the MSRB treated calf at the 42 day necropsy, a peak mean 
faecal egg count of only 150 epg was recorded for remaining MSRB 
treated calves at approximately this time. This compares with 4980 epg 
recorded for infected calves and may be indicative of greatly reduced 
populations of the more prolific C. oncophora. Additionally 
anthelmintic action may have resulted in suppression of egg laying or 
an almost absolute effect against emerging prepatent adult females. It 
was noted that adult C. oncophora from MSRB treated calves appeared 
stunted and that gravid females contained fewer eggs compared to those 
from infected calves. Hie reduction in faecal egg output is extremely 
pertinent in that the main application of controlled release technology 
has been considered to be a reduction in pasture contamination 
(Anderson, 1985).
There was a considerable variation in the severity of clinical 
symptoms among infected calves and necropsy data suggests that this was 
attributable to variations in the ability to resist parasite 
establishment rather than variations in the ability to withstand the 
effects of an established infection. Hie combined stresses of larval 
challenge, confinement in metabolism stalls and injection of 
radioisotopes may have predisposed to the large infections and acute 
clinical symptoms which necessitated the premature necropsy of two 
calves.
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Examination of plasma pepsinogen data reveals increased values for 
both infected and MSRB treated calves compared to clean controls from 
as early as seven days post initial infection. Such increases are 
usually attributed to the emergence of young adult 0. ostertagi from 
the gastric glands and associated epithelial stretching and breakdown 
of cell junctional complexes resulting in increased mucosal 
permeability. In view of the high numbers of establishing larvae in 
this study, a possible explanation for the observed pre-emergence 
increases in plasma pepsinogen concentrations may be the causation of a 
hypersensitivity type reaction at the gastric mucosa. Such a reaction 
has been reported in older immune animals (Armour et al, 1979) and in 
rats infected with Nippostronglyus brasiliensis worm expulsion is 
inititated by .an increase in mucosal permeability to facilitate 
antibody passage (Barth et al, 1966; Jones and Ogilvie, 1971).
However calves in this study were parasite-naive and it is unlikely 
that an effective antibody response would develop in such a short time. 
An alternative explanation is that the presence of C. oncophora in 
the duodenum may have damaged G-cells resulting in an indirect 
suppression of abomasal acid secretion. It may be speculated that this 
reduced the conversion of pepsinogen to pepsin, increasing the 
concentration gradient for pepsinogen between the abomasum and plasma, 
and resulting in elevated plasma levels. Elevated plasma pepsinogen 
levels have been observed in monospecific infections of C. oncophora 
(J. Armour, personal communication). Fox et al (1987) have reported 
increased plasma pepsinogen values by day seven in calves orally 
inoculated with 100,000 0. ostertagi larvae. Given an expected 20% 
establishment (Ibarra-Silva, 1988), numbers of larvae invading the 
gastric mucosa would actually be less than the current study and 
increased plasma pepsinogen levels may thus be a consequence of the 
purely physical effects of mucosal invasion on a massive scale.
For MSRB treated calves the duration of elevated plasma pepsinogen 
levels approximated to the time required for larvae within the mucosa 
to complete their development and thereafter levels returned to those 
of control calves indicating repair of mucosal damage. In contrast 
levels for infected calves remained elevated until the trial was 
terminated demonstrating the severe and sustained mucosal damage in 
these calves. Both the magnitude and duration of the increase was 
greater than that recorded for a monospecific infection (Experiment 
Ila) and reflects the greater establishment achieved.
153
In the interests of animal welfare, only the least clinically 
affected animals were used for metabolism studies and consequently the 
data obtained cannot indicate the full detrimental effects of 
infection. In comparison to clean and MSRB treated calves, apparent 
digestive efficiencies for gross energy and the crude protein and ether 
extract proximate feed fractions were consistently and significantly 
reduced for infected calves once a patent infection had established.
This contrasts with data obtained for either monospecific infection in 
which no treatment related differences in apparent digestive efficiency 
were reported. Protein digestion is initiated in the abomasum and 
conpleted in the proximal small intestine, liberated amino acids being 
principally absorbed from the mid third of the small intestine (Steel 
and Symons, 1982). Abomasal 0. ostertagi infection is thought to 
produce a pH mediated limitation on abomasal protein digestion but in a 
monospecific infection this is nullified by a compensatory increase in 
protein digestion in the small intestine. In the present concurrent 
infection, colonisation of the entire small intestine by C. 
oncophora, and associated mucosal damage, evidently prevented any 
compensatory response resulting in a reduction in the apparent 
digestibility of crude protein in infected calves. No such reduction 
was apparent in MSRB treated calves as the bolus restricted nematode 
populations minimising abomasal pH changes and confining the damage due 
to C. oncophora infection to the anterior small intestine allowing a 
possible compensatory response in the posterior portion.
Ihe reduced apparent digestibility of dietary protein was 
undoubtedly one source of the significantly increased faecal nitrogen 
losses recorded for infected calves. Perhaps the major contributor to 
this additional faecal nitrogen however was the greatly increased 
losses of plasma into the gastrointestinal tract. Studies using
1 OC
I-albumin and 51crCl3 revealed that plasma losses in infected 
calves were double those in clean controls with losses for MSRB treated 
calves being increased by 50%. Sloughed epithelial cells arising as a 
result of mucosal damage represent a third, and possibly very 
significant source of increased faecal nitrogen but methods for 
quantification of these losses are as yet unavailable. Bacterial 
degradation of some of this additional nitrogen entering the caecum to 
ammonia may have been responsible for increased urinary nitrogen losses 
in infected calves. It is probable that increased turnover of 
epithelial cells and plasma albumin were primarily responsible for the
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observed reduction in the apparent digestibility of gross energy.
Radioisotopic measurements revealed marked deviations from control 
values in the physiological parameters measured for infected calves. 
Although direct comparison between the two recording periods could not 
be made due to the premature necropsy of the calves used during days 
35-47, disturbances in albumin metabolism apparently persisted until 
the end of the trial despite the expulsion of a large proportion of the 
worm burden. Studies using 51crCl3 an£ 125i-albumin revealed a 
substantial loss of plasma into the digestive tract, presumably through 
a severely disrupted mucosa while blood analysis revealed that the 
reverse loss of pepsinogen was also occurring. This leakage of albumin 
was the cause of the observed reduction in the half-life of 
•^I-albumin, the increase in catabolic rate of albumin and the 
resultant hypoalbuminaemia. Previous studies (Mahrt et al, 1964) 
have reported a concommitant increase in serum globulin to maintain a 
constant level of serum proteins but in this study the extent of 
albumin leakage was such that hypoproteinaemia also occurred. During 
both recording periods there was evidence of declining serum albumin 
concentrations but serum proteins were maintained at a slightly 
subnormal level giving indication of some degree of globulin 
compensation.
Comparison of radioisotopic data for the present concurrent 
infection with similar data for a monospecific O. ostertagi infection 
(Experiment Ila) demonstrates the greatly increased pathogenicity of 
the two nematodes in combination compared to 0. ostertagi alone. C. 
oncophora infection was associated with considerable damage to the 
mucosa of the small intestine which would significantly contribute to 
increased gastrointestinal plasma loss. Moreover, the apparent 
increase in establishment of 0. ostertagi in the presence of C. 
oncophora would increase abomasal damage over that for a monospecific 
infection and also contribute to the relative increase in plasma loss 
and detrimental changes in albumin metabolism.
Clinical symptoms and adverse changes in digestive efficiency and 
nitrogen economy were prevented by prior administration of a MSRB but 
radioisotopic studies revealed slightly increased gastrointestinal 
plasma loss, and small deviations from normal albumin metabolism, 
particularly during the first recording period. Together with 
increased plasma pepsinogen levels these provide evidence of limited 
mucosal damage attributable to developing nematode larvae. However
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there was no apparent insult to the animals metabolism and liveweight 
gains for MSRB treated animals were actually superior to those for 
clean controls. By the second recording period plasma pepsinogen 
values had returned to control levels as had physiological values for 
one MSRB treated calf. Hie sustained elevated gastrointestinal plasma 
loss of the other MSRB calf was not associated with alterations in 
albumin metabolism.
Studies using TOH provided slight evidence for water retention by 
both infected and MSRB treated calves during the first recording 
period. While accurate values for MSRB treated calves were obtained, 
those recorded for infected calves must be regarded with some caution. 
Body water determination by either extrapolation or equilibration 
methods assumes that water intake and output by an animal are 
approximately equal so that steady state conditions apply. In animals 
clinically affected by ostertagiasis, diarrhoea and inappetence dictate 
that water output exceeds input and under these conditions extrapolated 
plasma values based on the dilution principle may give an 
overestimation of body water. During body water measurements all 
calves showed some liveweight loss associated with the stress of 
confinemsnt in metabolism stalls and changes in gut fill. Liveweight 
changes for infected calves were greater than for the other treatment 
groups as they were additionally attributable to metabolic effects of 
nematode activity and this would again lead to an overestimation of 
total body water on a ml/kg basis. Examination of total body water 
volumes does however still indicate some degree of water retention by 
infected calves during the first recording period.
The results of this study demonstrated that in combination O. 
ostertagi and C. oncophora produce severe adverse alterations in 
calf metabolism which far exceed those produced by either species 
alone. A synergistic effect apparently operates in that the reciprocal 
establishment of either species is increased in the presence of the 
other, thereby increasing the relative pathogenicity. Additionally the 
presence of C. oncophora in the small intestine limits the extent of 
compensatory digestive responses to 0. ostertagi infection of the 
abomasum and thus limits the ability of the metabolic response to 
replace plasma constituents lost to the gastrointestinal tract through 
a damaged mucosa. Prior administration of a MSRB limited metabolic and 
physiological changes by limiting nematode populations, although it was 
apparently ineffective against developing stages of 0. ostertagi.
15 6
The limited larval development which did occur resulted in non- 
consequential alterations in plasma pepsinogen concentrations and sane 
physiological parameters measured while permitting stimulation of the 
immune response as was evidenced by enlarged abomasal lymph nodes at 
necropsy.
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UnSRfflUKE REVIEW
Introduction
Epidemiology may be defined as a study of the factors affecting 
the occurrence of disease in a population (Armour and Ogbourne, 1982). 
The main features governing the epidemiology of parasitic 
gastroenteritis of cattle and sheep in Britain are now well recognised 
(Michel 1969a; Pott et alf 1978; Armour 1980; Hiomas et alf 1986). 
Regular seasonal patterns of pasture contamination and host animal 
infection are known to occur, these being modified to some extent by 
weather conditions and grazing control. Clinical disease is generally 
only manifest towards the end of the grazing season and may be 
controlled by-the use of modern anthelmintic drugs. However, it is 
known that subclinical disease, and even the continual intake of 
infective larvae from pasture are associated with production losses 
(Jacobs et al, 1981; Sykes and Coop, 1977) and, from an understanding 
of the population dynamics of the free-living nematode larvae, 
prophylactic control programmes have been devised which limit the 
exposure of susceptible stock.
Epidemiology of Ostertagia ostertagi and Cooperia oncophora
Observations on the ecology of the free-living stages of O. 
ostertagi and C. oncophora revealed that their development 
requirements were similar (Rase, 1961 and 1963). Infective larvae of 
both species can survive on herbage over winter until the spring of the 
following year when the rate of mortality increases sharply and pasture 
larval numbers fall to a low level. Ingestion of residual larvae by 
susceptible stock facilitates the completion of development and adult 
worms produce eggs which are passed with the faeces to recontaminate 
the pasture. C. oncophora is more fecund than 0. ostertagi and is 
primarily responsible for early season increases in pasture 
contamination. Infective larvae ingested by grazing cattle stimulate 
immunity within approximately two months of exposure and consequently 
the cycling of C. oncophora infection through the host animal falls 
to a low level in the latter part of the grazing season. However, 
residual pasture infectivity from early season contamination may be 
maintained at high levels and experimental studies have demonstrated 
the accumulation of considerable worm burdens in parasite-naive tracer 
calves (Ibarra-Silva, 1988). Large numbers of C. oncophora have also
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been reported in calves clinically affected by ostertagiasis and which 
had been grazing infective pastures for four months (Entrocasso et 
al, 1986b). However in this study pasture numbers of C. oncophora 
infective larvae did not increase significantly until the end of July, 
and this atypically late increase may have been responsible for the 
apparent lack of immunity (K. Bairden, personal communication).
Field experiments concerned with the epidemiology of 0. 
ostertagi (Michel, 1966 and 1969b) demonstrated that calves turned out 
in late April became infected and were excreting eggs in their faeces 
by the third week of May. However infective larvae resulting from this 
infection were not recovered from the herbage until July when the 
pasture larval population rapidly increased to a high level which was 
maintained until the following spring. Larvae ingested after July 
either caused clinical disease in the autumn or were accumulated as 
inhibited fourth stages in the host. Diseased calves excreted large 
numbers of eggs during September and October but these did not 
appreciably increase pasture larval contamination.
0. ostertagi usually only completes one generation a year and 
the cycling between pasture and the host animal comprises of two 
phases. The 'contamination phase' occurs during the early part of the 
grazing season during which infection of susceptible stock acts to 
multiply herbage infection. Ihis results in a massive increase in 
pasture contamination during the latter part of the grazing season, the 
'autoinfection phase', where eggs excreted during the contamination 
phase have developed into infective larvae reinfecting stock and 
precipitating clinical disease.
The exact timing of the two phases is primarily dependent on 
weather conditions. Environmental tenperature controls the rate of 
development of eggs to infective larvae and moisture influences 
survival of the preinfective stages and migration of onto herbage. 
Provided that environmental temperature is sufficiently high and faeces 
remain in a compact pat, eggs will complete their development during 
both rainy and dry periods. The rate of development increases with 
increasing temperature and a minimum of 2-3 weeks is required for 
completion during July. Differential rates of development of eggs 
excreted before July predisposes to the synchronous appearance of large 
numbers of infective larvae on the pasture during July when rates of 
development are maximal. Eggs passed in faeces during September and
160
October m y  fail to develop to the resiliant infective stage before the 
faeces disintegrates. Mortality of the preinfective stages is greatest 
when faecal pats are subject to rapid drying. Dry weather m y  also 
restrict the movement of onto herbage if the disintegration rate 
of faecal pats is reduced by surface crusting. Under these conditions 
the faecal pat acts as a reservoir of infective larvae giving rise to 
widespread herbage infestation when wetting facilitates disintegration 
(Rose, 1962 and 1970). As a consequence of the effects of moisture a 
highly contaminated pasture m y  not be highly infective to stock until 
rain and/or heavy dews permit the free movement of infective larvae.
At such time a mssive intake of these larvae by host animls m y  
precipitate clinical disease and herein lies an explanation for 
clinical symptoms occurring typically during the autumn months when 
misture is more freely available.
Epidemiology of Ostertagia circumcincta
Closely allied to 0. ostertagi, O. circumcincta has been 
considered to be the predominant sheep abomasa! nemtode in Northern 
Britain (Boag and Thoms, 1971 and 1977). Serial slaughter trials 
(Armour et al, 1966) have demonstrated that the parasitic stages of 
0. circumcincta in sheep produce similar pathophysiological and 
biochemical changes to 0. ostertagi in cattle but that the rate of 
development to the young adult stage is more rapid, requiring 
approximately eight days. Patent infections are established within 21 
days of larval ingestion by which time a loss of some adult worms has 
occurred. Like 0. ostertagi infective larvae of 0. circumcincta 
can successfully overwinter on pasture persisting until May and 
providing an immediate source of infection for susceptible grazing 
animls. However the epidemiological picture is complicated as post­
parturient ewes m y  provide an additional source of infection due to 
the temporary breakdown of immunity during lactation. The increased 
faecal egg output ('spring-rise*) of ewes observed at this time has 
been attributed to the redevelopmnt of inhibited early fourth larval 
stages within the ewes (Thoms and Boag, 1973) but in the same 
publication these authors also suggest that where inhibited larvae are 
effectively controlled a characteristic post-parturient rise in ewe 
faecal egg output can arise solely as a result of their ingestion of 
overwintering infective larvae while in an immunosuppressed state. The 
relative importance of the two sources of infection m y  vary with
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climatic conditions. Boag and Thomas (1971) could detect no residual 
overwintered infection on pastures contaminated in the previous autumn 
by grazing ewes and suggested that this was attributable to low ewe 
faecal egg output and a newly established sward which afforded little 
protection. Gibson and Everett (1967) recognised the existence of 
overwintered infection but considered it to be small and unimportant 
compared with the egg output of the ewes. However they later concluded 
that both were significant factors in lamb infection (Gibson and 
Everett, 1971). The population dynamics of infective larvae on 
initially clean pastures and those harbouring overwintering larvae form 
two distinct patterns. On initially contaminated pasture, availability 
of infective larvae increases to a peak during April/May this being 
attributable to overwintering infection. Following a decline, pasture 
larval numbers reach a second and more substantial peak in 
August/September, the original generation of larvae being replaced by 
one derived from ewe egg excretion in the springtime. On initially 
clean pasture only the second peak of infection is apparent. The 
magnitude of the increases is dependent on the initial contamination 
and the patterns indicate the probable occurrence of one major 
generation of parasites in the clean pasture lambs and two generations 
in those on contaminated pasture (Boag and Thomas, 1977). On clean 
pasture lambs do not appear to be appreciably involved in the cycling 
of pasture infection until the larval population explosion attributable 
to ewe contamination and thus may safely graze with the ewes until such 
time as this occurs (Boag and Thomas, 1971).
Control
Measures aimed at preventing clinical parasitic gastroenteritis 
generally attempt to avoid exposure of susceptible stock to heavily 
contaminated pasture during the latter part of the grazing season.
This may be achieved by the strategic use of anthelmintics and/or 
grazing control. Mixed or alternate grazing by cattle and sheep where 
pasture nematodes are mutually exclusive promotes the removal of L3 
by the non-receptive host without harmful effect, thus reducing 
contamination for the receptive host. Mixed or alternate grazing by 
animals of the same species but different ages may be used to similar 
effect, the older immune animals reducing the contamination to which 
the younger susceptible animals are exposed. Theoretically rotational 
grazing systems should promote the control of parasitic gastroenteritis
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by breaking the cycle of infectivity between the herbage and the host 
during periods when pastures are rested. However, Morley and Donald 
(1980), stated that practicable rotational grazing systems do not 
control trichostrongyles as resting periods are relatively short 
compared to the longevity of the infective larvae. Michel (1969c) has 
shown that a straightforward rotational system involving only cattle is 
less effective than set-stocking, possibly because the latter denudes 
free-living larvae of grass cover so that they succumb more readily to 
adverse environmental conditions.
Perhaps the most successful grazing control measure was that 
advocated by Michel (1966, 1968) in which susceptible stock are treated 
with anthelmintic and moved to safe pasture, usually a hay or silage 
aftermath, just prior to the infective larval population explosion on 
the original pasture. However, due to vagaries in weather conditions, 
the exact timing of the dramatic increase in pasture larvae is 
difficult to predict and may not always coincide with the availability 
of alternative clean grazing.
Where clean grazing is available at turnout the safest control 
strategy for both cattle and sheep enterprises is to limit pasture 
contamination by grazing stock in early season thus preventing a 
massive build up by late season. For sheep enterprises, removal of the 
existing ewe worm burden prior to turnout onto clean pastures 
effectively controls lamb infection, but no such control is achieved 
for ewes and lambs grazing contaminated pastures in the spring due to 
autoinfection from overwintering larvae (Boag and Thomas 1973, Thomas 
and Boag 1973). Alternative anthelmintic treatment of lambs at weaning 
may be equally effective where this is accompanied by a move to clean 
pasture, but treated lambs remaining on contaminated pasture may 
actually harbour greater worm burdens than untreated animals due to 
interference with the development of immunity. The size of the 
post-parturient rise in ewes, and the extent of the contamination phase 
in cattle determine the magnitude, but not the timing of late season 
increases in pasture infectivity and hence indirectly influence the 
occurrence of clinical disease.
A variety of modern anthelmintic drugs are available with both 
broad and narrow spectrums of activity and these have been subject to 
recent reviews (Marriner 1986; Arundel 1985; Behm and Bryant 1985). 
Control strategies may be prophylactic employing regular use of 
anthelmintics throughout the grazing season to remove existing worm
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burdens and prevent pasture contamination (Taylor et al, 1985) or may 
be instigated once clinical symptoms become apparent. However severe 
production losses may result from both clinical and subclinical 
ostertagiasis and experimental studies suggest that in the latter case 
these may arise primarily from a reduction in voluntary food intake 
attributable to the continual presence of developing larvae in the 
abomasal mucosa (Sykes and Coop, 1977).
Anthelmintic efficacy and persistency are governed by the dose 
rate administered and the pharmacokinetic behaviour of the drug within 
the host animal. Conventional anthelmintic formulations are 
administered by oral, dermal or parenteral routes and, with the 
exception of ivermectin, peak blood concentrations are maintained for 
only relatively short periods facilitating the removal of an existing 
infection and concurrently ingested larvae but failing to prevent the 
establishment of infective larvae subsequently ingested. As a 
consequence, treatment is required at intervals of two to three weeks 
to prevent patent infections. More recently systems for the continuous 
administration of anthelmintics have been developed and have the 
advantages of a reduced need to handle stock and possibly more complete 
control of incoming infection achieved at a daily dose rate which is a 
fraction of the therapeutic dose.
Systems include medication of feed or drinking water (Jones et 
al 1978; Downey et al 1974; Downey and O'Shea 1977; Downey 1987) and 
intraruminal devices providing either pulsed or continuous medication 
e.g. the oxfenbendazole pulse release bolus designed to provide five 
therapeutic doses of oxfenbendazole at approximately three weekly 
intervals, the first of which is released three weeks after 
administration (Morgan and Rowlands 1986; Jacobs et al 1987a;
Mitchell 1987), the morantel sustained release bolus designed to 
release morantel tartrate continuously for 90 days (Jones 1981; 
Borgsteede et al 1985; Armour et al 1981) and the prototype 
ivermectin sustained release bolus (Pope et al, 1985, Egerton et al 
1986, Soil et al, 1987). Anderson (1985) considered that the main 
application of controlled release technology was for the prolonged 
reduction in the levels of pasture contamination prior to and during a 
period when development and survival of free-living nematode larvae was 
especially favourable. Delaying administration until after turnout has 
produced reduced benefits with respect to acquired worm burdens and 
daily liveweight gains (Jacobs et al 1987b; Armour et al 1981).
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A sudden increase in numbers of larvae on pasture late in the 
grazing season has been noted in several experiments in which 
contamination rates early in the season have been reduced by either 
conventional treatments or the use of a morantel bolus. Thus early 
season anthelmintic treatment may delay rather than prevent the rise in 
herbage contamination and thus predispose cattle to Type II rather than 
Type I ostertagiasis.
There is some evidence to suggest that the use of controlled 
release devices interferes with the development of immunity to 
gastrointestinal nematodes (Jacobs et al, 1987c; Borgsteede et al 
1985) but not to such an extent as to influence clinical disease.
Concern has been expressed that controlled release devices may 
increase the selection pressure on nematodes for anthelmintic 
resistance. This is especially pertinent for diffusion devices such as 
the morantel sustained release bolus where the release rate is 
considerably below the effective level during the terminal stages. 
However Tornguist and Tolling (1987) presented no evidence for reduced 
efficacy when the MSRB was used in six successive years. Such devices, 
applied only once in the early grazing season for a relatively short 
time are in fact likely to produce a lower selection pressure than 
frequent anthelmintic dosing throughout the grazing season as the 
period of drug release will be small in comparison to the total 
survival time of the infective stages.
A wide choice of control strategies for gastrointestinal nematodes 
exists and the choice of system is dependent on cost effectiveness and 
integration with other farm enterprises. Management decisions aimed at 
helminth control cannot be considered in isolation from other parts of 
the farm enterprise as they compete for labour, finance, land, skills 
and perhaps other resources.
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EXPERIMEOT III
EARASITODDGICAL AND ME33VBCHJSM STUDIES CONDOCTED WTTO GROWING 
IAMBS EXPERIMENTALLY INFECTED WITH OBTEKEftGIA CIRCCMCINCm AND 
GIVEN GRADED DOSES OF I£VAMISQLE
Introduction
Parasite control programmes which employ regular use of 
anthelmintics to maintain a low infection status in stock provide the 
greatest independence from other farm enterprises. However they are 
costly with respect to both time and labour and prolonged use of 
anthelminitics in this manner may increase selection pressure for 
nematode resistance. Administration of an intraruminal device to 
cattle at turnout prevents early season pasture contamination and 
consequently late season disease (Jones, 1981). Similar administration 
to lambs at weaning may control both lamb and pasture infection where 
animals are moved to 'safe' pastures and weaning occurs within 12 weeks 
of birth. For lambs maintained with their dams throught the grazing 
season, administration of a controlled release device at approximately 
10 weeks of age may control lamb infection in the face of increasing 
pasture contamination although constant exposure to infective larvae 
may give reduced benefits compared with weaning to safe pasture.
At time of writing the anthelmintic levamisole hydrochloride is 
available for use in sheep as an oral drench, in-feed granules, an 
injectable solution or a topical application and all of these routes 
require regular administration to achieve effective parasite control. 
The present work assesses the effectiveness of continuous delivery into 
the rumen of graded doses of levamisole hydrochloride in controlling a 
lew level infection of Ostertagia circumcincta in growing lambs and 
thus gives an indication of the payload which would be required should 
this anthelmintic be incorporated into a sustained release device.
Materials and Methods
Animals and experimental design
Thirty six parasite naive cross-bred lambs, of average liveweight 
35 kg were allocated to six treatment groups. Lambs in groups 1-5 were 
dosed daily per os with 4,000 infective O. circumcincta larvae for 
21 days, while those in group 6 were maintained as a parasite-free 
control. In addition, lambs in groups 2-5 received continuous
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infusions, directly into the rumen, of levamisole hydrochloride in 
solution in 0.9% w/v saline at rates of 1.0, 1.5, 2.0 and 3.0 wg/kg/ 
liveweight/day for 24 days commencing on the first day of experimental 
infection. The animals were restrained in standard metabolism stalls 
and the levamisole solutions were administered via surgically fitted 
indwelling ruminal catheters. The infusion rates were controlled by 
constant running peristaltic pumps (Watson-Marlow Ltd.). A full 
description of the infusion system is given in General Materials and 
Methods. Group 1 lambs remained untreated and acted as an infected 
control.
Allocation to treatment was on the basis of sex and liveweight, 
there being three female and three castrated male lambs in each of 
treatment groups 1-4 and in group 6. Effects of 3.0 wg/kg/day 
levamisole (group 5) were examined after preliminary analysis of data 
from the other treatments and consequently all lambs in treatment group 
5 were female.
Three female lambs from each treatment group were necropsied on 
day 24 post initial infection; necropsy of the remaining lambs being 
undertaken on day 28.
Feed allowance
Lambs were individually given a daily allowance of 1 kg grassnuts 
in two approximately equal feeds at 07.30 and 16.30h. Mean analysis 
was 0.92 dry matter (DM) with 123 g crude protein (CP), 286 g crude 
fibre (CF), 30 g ether extract (EE) and 56 g ash per kg EM.
Larval infections
The 0. circumcincta larvae were harvested from faecal cultures 
no more than four days prior to oral inoculation of the lambs and were 
maintained at room temperature (17QC) until required.
Parasitological techniques
Faecal samples were obtained from all lambs per rectum on day 0,
7, 14, 21 and for remaining lambs on day 28 and were examined for the 
presence of strongylate eggs by the modified McMaster technique of 
Gordon and Whitlock (1939). At necropsy examination of the abomasa and 
recovery of adult and developing Ostertagia cirumcincta was as 
previously described.
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Digestibility and nitrogen balance studies
Digestive efficiency studies were carried out separately during 
days 0-7, 7-14, 14-21 and 21-28, Concurrent nitrogen balance studies 
were conducted for male lambs in each treatment group except the 
parasite-free control during days 0-7, 7-14 and 14-21, and for all male 
lambs during days 21-28. Collection and analyses of urine and faeces 
was as described in General Materials and Methods.
Statistical analysis
A analysis of variance was carried out for each data set. For 
parasitological parameters this was performed using 'Minitab1 (Ryan, 
Penn State University) on a microcomputer. Analysis of digestibility 
and nitrogen balance data was performed using the programme 'Rummage' 
(PLU Edinburgh) on an ICL 2988 computer. Ihe model incorporated 
treatment, time and sex (in the case of digestibility coefficents) as 
main effects and allowed for first and second order interactions.
Results
General observations
During the trial none of the lambs became inappetent or showed 
overt signs of clinical ostertagiasis. Hiis contrasts with Sykes and 
Coop (1977)' where a similar rate of infection in similar animals 
resulted in a 20% reduction in voluntary food intake within two to 
three weeks. The catheter insertion procedure was highly successful in 
all cases and there was no evidence of infection or inflammation. Hie 
extent to which the skin contracted around the inserted catheter varied 
between individual sheep but generally leakage of rumen fluid at the 
insertion site was small, and was minimized by the presence of the 
rubber disc.
Apparent digestibility coefficients
The apparent digestibilities of several proximate feed fractions 
were significantly affected by treatment over the whole 28 day period. 
Dry matter, crude protein, crude fibre and ash digestibilities were 
reduced with a consequent increase in nitrogen-free-extract 
digestibility for lambs receiving 3.0 wg/kg/day levamisole (Table 26). 
Treatment did not affect the digestibility of the gross energy. Sex 
influenced the apparent digestibility of the crude protein and ash 
proximate fractions during the whole 28 day period, these being
168
r—I OS in rH
O H O r-1 r—1
(U 0  W O o O
r—I cu • • ' •
o o o o
in•H
O  (0 a) > i—l 0 0
iw 0 C O  ^ J1 rH CO
C iH to U CN OS rr
•H 0 4J in
HH i—1 c  • • •
w  o u o  o o o
(3 0
rH w
o
u
X X X
>h TD o 00 VO
O rH co 00
iw fO ro in CO
(1) • • •
r-irj o o o
in to
>1 »-t 
t0 CP 
TJ
C
00 0 o CN
o
0
CN > CN r- CO
1 »H CN in
o  rj\ • • •
o o o
w  *8
4-1 (0 
C 
<1) (0 
•H 4-> in CO
o
0
CN
O  O in CN r-~ CN
•H c • in
M-! -H rH • • •
m-i y o o O
0 g
o 3 
o  u
IH 
>l*H 
44 U
(000 CN
u
0
CN
•H 00
rH (0 rH in
•H -H • • •
x> o o o o
•H to 
44 4-> 
(0 U 
0  0 
CP 4-1
•H in 
H3 O
XI
CN VO
o
rH
O r- O
o in rt<
c  x • • •
(0 4-> o o O
0  -H
S  5 
• 0 > i S a* HVO r—1 0 3 V O
CN
0
rH
X
8
O  HD 
W  \  
•H CP|<
in CP00 o C 4HrH o rH •H Oo o o W• • • 3 rHo o O 0t! > C 0 0 rH lH 0 0CN OS 00 MH or- 00 o UH CCO in in •H 0• • • T3 Uo o o •iH >ilM rH -rH
x cC CPX 0 0 -HOS CO- 00 u inCN rH OS •HCO VO UH r-i• • • •H rHo
0
o o C 0 CP Jh•H 0in >
<D °00 OS lH SZ00 00 o 0 44CO in in •H• • • in £o
0
o o 4->a 0•H l-lV4 3 U »n V) 0VO in o >H uOS os rH 0 oCO in in a u• • • 3 ao
0
o o in
. w cc o
0  WM *H
00 00 CO 0  uo OS rH UH 0in in U-J Qj• • • •H go o
X
o TJ O O
5 0 
S ao CO VO
00 00 W 4-1CO in 0  rH• • • 3 3 mo o o rH E  O
,0 • 
>  0  O
AS
H
NF
E GE
Ta
bl
e 
27
. 
Me
an
 
ni
tr
og
en
 
ba
la
nc
e 
(g
/d
ay
 
+S
E)
 
fo
r 
la
mb
s 
in
fe
ct
ed
 
wi
th
 
Os
te
rt
ag
ia
 
ci
rc
um
ci
nc
ta
 
an
d 
gi
ve
n 
gr
ad
ed
 
do
se
s 
of 
le
va
mi
so
le
169
<D -U 
CU
O  H  t"» CN o n h  rf 
• • • .0 0 0  o. -H+l+l+l
o  co in  
on 00 m  
• • • •
r -  00 rH
>1<u (0•H 33
0 ^  w u>
•H J *
> a
So
*04
O  CO CN O  
O  CN (N CN 
• • • •
0 , 0 0 0  
+1 -H +1 -H
CD CO rH in 
O  CD CO CO 
- • • • •
00 CO O' iH
O  H  ON CN O  VO (N Is
O  CN H 1 VO O  CN CN ^
a a a a a a a a
0  0 , 0 0  
-H +1 -H +1
0 , 0 . 0  0  
+ ! +1 + l -H
rH O  CO 00 O  O  O  CD
VO rH r r  O on co r *  00
a a a a a a a a
00 CD I"- CN r^ - <d 0
rH rH
O CD 00 
O i—t rH CN
o  tj* ro co 
cd 0- co in 
• • • •
r *  00 r-* h
>1 <1) CO 
rH fQ O <  tO tD 
•H AC
o  00 vo o  
o  co co r" ....
o, o, o. o, +! +1 +i -M
CD CN O  VO 
O  CD CD CN
• . a •
00 00 r"  ih
O  rH in VO 
O  Is  ^  CD 
• • • •
0 0 0,0 +1 +\ +1 +1
H  CN CN f' 
VO CN CN H  ....
00 CD 00 iH
O VO VO r r 0 CO 00 coO CO H 1 rH 0 CO CN CO• a a a • a a a
O O O O O O O O+1 +1 H-l +1 +1 +1 +1 + !
ON r r rH in 0 CO in rH
a rH VO 00 ON 00 t"- CO
a a • • a a •
rH O
rH
00 0
l rH
00 r - rH
>1 CD (0 •H 33 O \  
tO CD
I?
So
O  ON CN CO O n H N 1
•  a •  •
0 0 0,0 -H -H +1 -H
CD in O  N* 
O  00 VO VO
a a a a
00 00 n- rH
O H C O N 1 
O  CO N1 Is
a a a a
0 , 0 0 , 0+1 -H +1 +1
rH CN CO VO VO O  1—I H1 
a a a a
00 CD n* CN
o vo rr vo Ohrlh
a a a a
0 0 0,0 
+1 "H +1 Hn
o o in voON N1 00 VO 
a a a a
r->- 00 h
o cn vo in o r'~ o r-~
a a a a
0 0 0.0 +1 +1 +1 +1
O CO CD CD 
CD 00 Ln
a a a a
cd r-- o
T3
CD rH 
4J O O U 
d) 4J 
U4 C
c oH U
O CN CD in 
O N* CN in
a a a a
O O O O  
+1 *n *H *H
1— 1 cd r^ - in
VO H  VO C*
a a a a
CO ON C* H
o  in co
O  rH H 1 CO 
a a a a
0,0 0,0 
-H +1 +1 4H
O  Is  CN rl 
ON CN O  VO
a a a a
r -  CD ["■ H
o vo rH
O  CN O  CO
a a a a
0,0.0 0 
+1 +1 -H +1
o  m d  co 
ON ON in  CO
a a a a
00 r -  rH
co cd w cd c
1 JC G) c O
O CO U -H -H
4J CD U  4J
tO C CO D C
>t H  Cl,
2
CD
4J
CD&
^ Q) tO QJ 
H  JC (U 
I CO o  
r- 4J <U U  4J
C CO D  c11) H  fa 
2
c o
H
0)
4J
§>
H  fl) ID (D C
CN AC CD C O| (0 CD -H -H'f 4J (D U JJ
r-t C  CO D  CH [fat d) 
4J&s
00 a; 01 CD 
CN AC d) c 
I CO O 
H 4J dJ 
CN C CO D H  Du
S.
2
c o
H *H 
H 4J
C d) 4->a
Ta
bl
e 
28
. 
Me
an
 
fa
ec
al
 
eg
g 
ou
tp
ut
 
(e
pg
) 
at 
da
ys
 
21 
an
d 
28 
an
d 
me
an
170
U <13
CO CO
o w o wCM
m
CN
in
<13 >1
rHO fp 
CO \  
•h  cn
o
CN
X !inr-
incn
cn
cn
cn
i5
inoo
o
in
CN
in
cncn
cn
CN
cn
oo 
inco cn
2iH oo CN CN
0  >1  > 1  s a
00 cn 00 ino vo cn ocn CN CN o *rH cn o
V
Or
X
o X O GQ)C" O in CN HrH in f" H1 QJr - 00 in rH XrH X•H
'U
>1rH
cn X X X XCN 00 cn c00 in 00 CO<n cn o cn ucn cn cn
rH ■HX•H
c
cn
cn XI co X
•H
wcn in CN00 00 CN cn 0)o cn urH CNrH 00iH CO
(0X
a•H<0 CO CO 14r - o CN 00 uvo in cn O 03CTv rH cn in V4CN 00 cn
rH ocn 10)
X10 CO co co CN 00 <13vo o cn in V4n* o CN CDrH r- CN
CN rHcn XX•H
CO in X rH X4J
E t-3 rH CO •HU
i
3a Xe 03
<13
DrHs
171
(000 , , )  ue p jn q  ui j o m
•rJ
>* 
(0 
"a\ 
O) 
JC N 
O)
« S
Fi
gu
re
 
18
. 
Me
an
 
wo
rm
 
bu
rd
en
s 
at 
ne
cr
op
sy
 
of 
la
mb
s 
in
fe
ct
ed
 
wi
th
 
Qs
te
rt
ag
ia
 
ci
rc
um
ci
nc
ta
 
gi
ve
n 
gr
ad
ed
 
do
se
s 
of 
le
va
mi
so
le
 
by 
co
nt
in
uo
us
 
in
tr
ar
um
in
al
 
in
fu
si
on
.
172
>i
5 u.
CO
( 0 0 0 ‘) u e p j n q  u i j o m
CO
T3
\
O)
X.
s
O)
E
O
0
<0
1 
(0 
> 
o
3
’Ss
fd0)
•Po0)
•H
03
0)
r-J
<D«H
'd
©i—I
O
CQ
P<
O
u
0Q) 
Pi
-P
d
ra
Pi
<i>
1
£
ON
•Hft
P 
0) i—I
<H
O
CQ
©
CQ
0 nd
a)fd
£
pi
(D
1
fd
§
d
-P
o
Pi
•H
O
OPi
•H
O
d
d-p
Pi
©
-p
CQ
O
173
significantly (PC0.05) reduced for female compared to male lambs.
Recording period had a significant (PC0.05) effect on the apparent 
digestibility of each proximate feed fraction and a significant 
interaction also occurred between recording period and treatment. Mean 
digestibility data for the various proximate feed fractions in each 
recording period and values for individual animals are contained within 
Appendix 6.
Nitrogen balance
Mean results for the daily nitrogen input, output in urine and 
faeces together with the calculated retentions for each of the four 
recording periods are given in Table 27. Individual values and the 
data expressed in terms of percentage of nitrogen input are given in 
Appendix 6. There were no significant differences in nitrogen economy 
between treatments. Urinary nitrogen loss did differ significantly 
between recording periods and was generally greatest during 14-21 days 
post initial infection.
Parasitology
Infusions of 1.5 and 3.0 mgAg/day levamisole resulted in a 
significant reduction in faecal egg output on day 21 compared to 
infected controls (Table 28).
Increasing daily doses of levamisole resulted in increasing 
reductions in 0. circumcincta worm burdens at necropsy compared to 
the infected control. These reductions were significant for the 1.5, 
2.0 and 3.0 mgAg/<3ay treatments (Figure 18, Table 28, Appendix 6). 
Comparison of data for male lambs necropsied on day 24 and female lambs 
necropsied on day 28 reveals deviations from the general overall 
pattern (Figure 19) which may be attributable to differences in 
slaughter date and/or sex.
The pH of the abomasal contents at necropsy (Appendix 6) was not 
significantly affected by treatment but for lambs on all treatments 
values were greater than the accepted norm (<pH 2.5).
Discussion
The system of intraruminal infusion used in this study provided an 
extremely accurate means of administering titrated doses of 
anthelmintic to individual animals. It did not completely mimic a 
sustained release device in that effects of rumen environment on
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diffusion or dissolution rates of such a device were not taken into 
account, but it did provide a precise method of assessing the effect of 
different drug levels on the parasite population.
Sykes1 and Coop (1977) reported a 20% reduction in voluntary food 
intake for lambs infected with 4000 O. cjrcumcincta but no
such effect was apparent in this study possibly because lambs were 
offered a standard amount of food per day which was below appetite and 
so consequently differences in voluntary food intake were not 
expressed. The same authors also reported reductions in the apparent 
digestibility of nitrogen and energy for infected lambs compared to 
controls fed ad libitum and in contrast apparent digestibility data 
here reveals only a significant reduction in crude fibre digestibility 
for infected compared to clean control lambs.
O. circumcincta completes its parasitic development in the 
gastric glands of the abomasum and the emergence of young adult 
parasites ©-12. days after ingestion is associated with mucosal damage. 
It may be expected therefore that lambs harbouring the highest numbers 
of 0. circumcincta, i.e. those on the lower levamisole treatments, 
would have the poorest apparent digestive efficiencies. However 
examination of the digestibility data for the whole 28 day period 
reveals the reverse to be true and suggests that levamisole, like the 
substituted benzimidazoles, may adversely affect rumen fermentation. 
Reduced apparent digestibility of crude fibre may be attributable to 
reduced volatile fatty acid production as a result of suppression of 
both cellulolytic and carbohydrate dependent microorganisms (Jara et 
al, 1984; Hodgeson and Jessop, 1987). Concommitant inhibition of acid 
secretion in the abomasum (Felenius et al, 1981) may have been 
responsible for the significant reduction in crude protein 
digestibility. At necropsy abomasal pH of all lambs was elevated above 
normal values and this may be evidence of inhibition of acid secretion 
in lambs receiving the highest levels of levamisole, while reflecting 
mucosal damage in lambs on the low/zero levamisole treatments. Despite 
alterations in crude protein digestibility and abomasal pH, nitrogen 
economy did not differ between treatment groups.
Hie significant treatment-time interaction for digestive 
efficiencies possibly occurred because the suppressant effect of 
levamisole operated throughout the trial while that due to parasitic 
mucosal damage only became apparent following maturation and emergence 
of the adult worms.
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Increasing daily doses of levamisole hydrochloride resulted in 
increased reductions in total worm burden at necropsy, this response 
being curvilinear in nature. The data predicts that a daily dose rate 
of 4.7 mg/kg is required for complete control. Hiis compares with 3.5 
mgAg/<3ay required for the control of 0. ostertagi in grazing calves 
when administered via the drinking water (Downey and O'Shea, 1977) and 
may not be an economic proposition as a single oral dose of only 7.5 
mgAg administered at 21 day intervals provides effective control at 
present. Continual administration at a dose rate which provides only 
partial parasite control may accelerate selection for resistance to 
this anthelmintic. Resistance of Os ter tag ia to levamisole has 
already been reported in sheep, goats and cattle (Le Jambre 1979; 
Gillham and Obendorf, 1985; Geerts et al, 1987).
Separate examination of the worm burden data for male and female 
lambs reveals deviations from the overall pattern. Uiese may be 
attributable to differences in sex and/or slaughter date. For rat and 
mice host-parasite systems infections are relatively more persistent in 
male hosts and this has been attributed to differences in steroid 
hormones (Waddell et al, 1971; Dobson 1961a and 1961b). A similar 
effect has been reported in sheep for parasites with extensive somatic 
migrations (Dobson, 1965). The intimate contact between developing 
0. circumcincta and the abomasal mucosa would ensure exposure to sex 
hormones but effects are likely to be minimal in this study as male 
sheep were castrated and female sheep were physiologically immature.
Hie results of this study demonstrate that continuous 
administration of levamisole hydrochloride directly into the rumen can 
limit the establishment of the abomasal parasite 0. circumcincta but 
a daily dose in excess of 3.0 mgAg/<3ay is required which must be 
conpared with the recommended therapeutic treatment dose of 7.5 
mgAg • Continuous administration at a dose effective for parasite 
control may interfere with ruminant digestion.
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GENERAL GCNCE05ICN5 AND DISCUSSION
The experimental work described in this thesis used similar 
techniques to explore two separate aspects of nitrogen metabolism in 
the ruminant. One study investigated the effect of exogenous 
beta-adrenergic agonists on the digestive efficiency and nitrogen 
econony of young growing cattle. Similar nitrogen balance and 
digestive efficiency techniques were used to investigate the 
detrimental effects of gastrointestinal parasitism in both cattle and 
sheep. Additional studies utilising radioisotopes provided more 
detailed information on the metabolism of nitrogen in infected cattle. 
In persuit of each of the study objectives a continuous infusion system 
was developed for the accurate long-term administration of exogenous 
substances by either intravenous or intraruminal routes.
Beta-agonists, also termed repartitioning agents, have been shown 
to increase lean tissue accretion in farm livestock at the expense of 
fat but the precise mode of action has yet to be elucidated. Increased 
lean tissue deposition may result from reduced protein degradation or 
increased accretion, while converse changes in lipid metabolism may 
result in decreased fatness. Initial experimental work investigated 
the effects of clenbuterol or graded doses of bitolterol 
(beta-agonists) on the digestive efficiency and nitrogen economy of 
growing Friesian calves. The experimental design was that of two 
identical 5 X 5  Latin squares using ten calves and five treatments 
which were changed after each three week period. Administration of 1 
mg/day clenbuterol or 25 mg/day bitolterol resulted in a significant 
increase (P<0.01) in nitrogen retention as a result of a significant 
(P<0.001) reduction in urinary nitrogen excretion. Apparent digestive 
efficiency and faecal nitrogen excretion were unaffected by treatment 
indicating that nutrients were being repartitioned within the animal.
Improvements in nitrogen retention accruing from the use of 
beta-agonists were enhanced during the latter part of the experiment 
following an increase in daily feed allowance to allow for the 
sustained growth of the calves. It is possible that relative increases 
in nitrogen and energy availability from the ration at this time 
permitted a greater beta-agonist mediated stimulation of nitrogen 
accretion. However, it is equally possible that use of these agents 
resulted in a reduction in protein degradation which was magnified by
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increased protein turnover attributable to increased nutrient intake. 
Effective dose rates (on the basis of wsight of agent per kg 
liveweight) of the beta-agonists were reduced throughout the trial as a 
result of increased calf liveweight and the enhanced responses, 
coincident with increased nutrient intake at lower effective dose rates 
emphasises the importance of nutrient supply when administering these 
substances.
Further studies, possibly involving radioisotopes, are required to 
fully elucidate the mechanism by which beta-agonists exert their 
repartitioning effect. Studies are also necessary to investigate the 
effect of these agents in animals of different age, sex and 
physiological condition. Finally, investigations into possible residue 
accumulation are required. The leaner more muscular animals resulting 
from use of beta-agonists produce carcasses which are in line with 
current consumer requirements but exogenous manipulation to achieve 
this end is perhaps unlikely to find widespread consumer acceptance at 
the present time.
In the second and third sections of this thesis the detrimental 
effects of gastrointestinal parasitism in both cattle and sheep were 
investigated. In all studies animals were orally inoculated with 
infective larvae over an extended period of time in order to simulate 
intakes in a field situation. However in the field, larval 
availability and animal grazing behaviour are very much influenced by 
climatic vagaries and thus exact simulation is not really possible. 
Declining pasture quality towards the end of the grazing season, as 
opposed to a consistent experimental diet, may also influence animal 
response to infection. Howsver importantly, experimental infection 
does permit a comparison of the pathogenicity of nematode species under 
standardised conditions.
In section II the detrimsntal effect of a monospecific infection 
of Ostertagia ostertagi in cattle and that of a similar concurrent 
infection with Cooperia oncophora were examined. Previous work 
(Armour et al, 1987a) permitted further conparison with a monospecfic 
C. oncophora infection given in an indentical manner to the C. 
oncophora in the combined infection. Results of these studies 
demonstrated that the pathogenicity of concurrently administered 0. 
ostertagi and C. oncophora was far greater than that of either 
species alone. Enhanced establishment of both species in a combined
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infection was partially responsible for this effect but the cause of 
this enhancement is unclear and contradicts Kloosterman et al (1984) 
who failed to demonstrate any interactions in a concurrent infection of 
these two nematodes. Increased establishment of 0. ostertagi gave 
rise to more severe abomasal damage as was evidenced by greater and 
more persistent increases in plasma pepsinogen levels, this persistency 
being attributable to the increased time required for repair of the 
abomasal mucosa. Severe damage to the intestinal mucosa resulting from 
C. oncophora infection was apparent even after expulsion of the 
majority of the worms and in some animals extended for the entire 
length of the small intestine. This contrasts with most published work 
which suggests that C. oncophora is a relatively non-pathogenic lumen 
dwelling species, and confirms the results of Armour et al (1987a).
Mucosal damage resulting from both monospecfic and the combined
infections permitted the leakage of pepsinogen from the abomasum and
the reverse leakage of small plasma constituents (albumin) into the
gastrointestinal tract. In concurrently infected calves the
considerable loss of plasma by this route greatly increased the
catabolic rate of albumin such that increased rates of synthesis
couldnot compensate and hypoalbuminaemia associated with
hypoproteinaemia occurred. Together with inappetence, reduced apparent
digestibilities of both dietary crude protein and energy, and an
additional energy requirenent for repair of a damaged mucosa, this
placed severe limitations on nutrients available for growth and
represented a severe insult to the animals metabolism. In addition
increased bacterial degradation of undegraded protein reaching the
«
caecum, its absorption as amnonia, and its subsequent conversion to 
urea prior to excretion in the urine also represented an extra drain on 
available energy.
Prior administration of a morantel sustained release bolus limited 
larval infection and prevented clinical symptoms. The anthelmintic 
morantel tartrate was apparently primarily active against adult 
parasites, development of immature stages resulting in minor 
alterations in pathophysiological values and the stimulation of 
immunity in the absence of disease. The study on Pre-Type II 
ostertagiasis demonstrated that morantel is inactive against inhibited 
fourth stage larvae of 0. ostertagi.
Both the combined infection described in this thesis and the study 
of Armour et al (1987a) have demonstrated the potential pathogenicity
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of C. oncophora infection in parasite naive calves. Further studies 
are required to more clearly define the parasitic development of this 
.nematode and in particular to identify the predeliction site and the 
proportion of time spent by developing stages within, or in close 
association with, the intestinal mucosa. Thus underlying metabolic 
causes of the disease processes attributable to this nematode could be 
more clearly identified. Further studies are also required into 
possible interactions between 0. ostertagi and C. oncophora and the 
pathogenic consequences of infections established using different 
proportions of these two species. Finally, detailed studies on the 
morphological and reproductive characteristics of nematodes from 
morantel treated cattle may help to elucidate the precise mode of 
action of this anthelmintic.
In section III nitrogen balance and digestive efficiency studies 
were used to investigate the adverse effects of Ostertagia 
circumcincta infection in growing lambs. The effectiveness of 
continuously administered levamisole in controlling the infection was 
also investigated using intraruminal infusion to mimic a controlled 
release device. Daily infections of 4000 0. circumcincta to sheep 
for 21 days did not cause any clinical signs. There wsre no 
significant differences in nitrogen economy between treatments but the 
apparent digestibilities of the dry matter and crude fibre fractions of 
the diet were significantly (P<0.05) reduced for infected compared to 
clean control lambs. An infusion of 3.0 mg/kg/day levamisole resulted 
in a 77% reduction in worm burden at necropsy compared to the infected 
control but, compared to the clean control, it also resulted in 
significant (PC0.05) reductions in the apparent digestibilities of all 
of the major feed fractions. Abomasal pH at necropsy was similar for 
infected lambs and those receiving 3.0 mg/kg/day levamisole indicating 
that the inhibitory effect of levamisole on acid secretion was similar 
to that accruing to parietal cell destruction by developing parasites. 
It is interesting that the detrimental effect of low level anthelmintic 
administration on the digestive efficiency of the lambs used in this 
study was apparently more severe than that of parasitic infection and 
this could act as a constraint on production where parasite challenge 
is at a low level. However this effect is likely to be small in 
comparison to that of parasite infection on a massive scale.
The study predicted that a daily dosage in excess of 3.0 mg/kg/day 
levamisole would be required should this anthelmintic be incorporated
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into an intraruminal device and possible future work could include the 
construction of, and experimentation with such a device for control of 
gastrointestinal nematodes in both cattle and sheep. However the 
therapeutic dose of levamisole is 7.5 mg/kg and such a device may not 
be economic.
In conclusion studies for this thesis have demonstrated that the 
use of exogenous pharmacological agents in healthy livestock can alter 
the normal partitioning of nutrients to effect greater retention of 
nitrogen and thus possibly increase the efficiency of lean meat 
production. Subsequent studies very clearly demonstrated the 
detrimental effect of gastrointestinal parasitism on nitrogen 
metabolism in cattle. Mucosal damage resulting from parasite activity 
resulted in a reduced apparent digestibility of dietary crude protein 
and increased losses of plasma proteins to the gastrointestinal tract. 
Together with increased turnover of mucosal cells this caused a 
diversion of nitrogen from productive to less productive sites in order 
to maintain homeostasis. Studies with sheep demonstrated that the use 
of modern anthelmintic drugs at concentrations and dosing frequencies 
required for complete parasite control may adversely affect ruminant 
digestion.
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APPENDIX 1 
INFUSION STUDIES PROCEDURES
Catheter Insertion Procedures
The insertion of an indwelling jugular vein catheter 
The insertion of a ruminal catheter
Procedure for changing Pumphead Tubing
Procedure for Preparing Infusion Packs
Procedure for Exchange of Infusion Packs
Problems Encountered during Infusion Studies 
Immediate action 
Problems with infusion tubing 
Problems with catheters
Catheter insertion procedures
The insertion of an indwelling jugular vein catheter
The calf was anaesthetized by giving 0.5 to 1.0 ml of Rompun 
(xylazine, Bayer UK Ltd, Suffolk) as an intramuscular injection in the 
runp region. An area of the calf's neck immediately over the jugular 
vein midway between the jaw and shoulder was shaved and cleaned with 
sterilising solution (1:500 Marinol blue : 70% alcohol with a few 
crystals of sodium nitrate). Approximately 2 ml of Locaine 2% local 
anaesthetic (lignocaine hydrochloride BP 2% with adrenaline acid 
tartrate BP, Veterinary Drug Co. PLC, York, UK) was injected under the 
skin in front of and above the proposed insertion site, and a cut 
approximately 1 cm long was made through the skin above the raised 
jugular vein.
The teflon catheter together with its internal trochar were 
inserted into the jugular vein through the dermal cut, the trochar 
being removed when the catheter was in position. For PVC and Tygon 
catheters a 14 G x 2 inch hypodermic needle was inserted into the 
jugular vein through the dermal cut and a metal stylet was fed down 
through the needle until it was approximately 20 cm inside the vein.
The needle was then removed and the catheter was fed into the jugular 
vein over the stylet, the stylet being removed when the catheter was 
correctly positioned.
Once in position, all catheter types were flushed with heparinized 
saline solution (2 ml 5000 IU heparin in 1000 ml 0.9% saline), drawing 
back also to obtain blood and thus verify the correct position of the 
catheter in the vein. Flushed catheters were filled with 0.75 ml of 
5000 IU heparin and stoppered before being stitched to the skin and 
finally connected to an air free infusion line.
The insertion of a ruminal catheter
The insertion of an indwelling catheter into the dorsal ruminal 
pouch of a sheep involved a two stage surgical procedure. Each sheep 
was sedated using 0.25 ml Rompun and prepared by shaving an area 
approximately 15 cm x 15 cm in the region betwen the last rib and the 
tuber coxae directly below the transverse processes. This area was 
cleaned using sterilising solution (Hibitane) and a vertical incision, 
approximately 4 cm long, was made through the skin, muscle and 
peritoneum to expose the surface of the rumen. The skin was stitched 
to the surface of the rumen using eight sutures of fine nylon, one at
either end of the incision and three along either side. The suturing 
needle did not penetrate the rumen itself.
For the following 10 days sheep were maintained in individual peat 
bedded pens. The area of surgery on each sheep was thoroughly cleaned 
twice daily with sterilising soltution (Hibitane) and sprayed with 
antibiotic (Polybactrin). If infection was detected by the presence of 
pus an intramuscular injection of long acting antibiotic (Terramycin 
L.A., Pfizer) was given. By day 10, sheep were beginning to shed 
stitches and any remaining stitches were removed allowing relaxation of 
the skin around the incision and exposure of any pockets of infection. 
In all cases the skin had completely knitted on to the surface of the 
rumen. During the subsequent four days any slight infections were 
rigorously treated with antibiotic (Polybactrin). On day 14 a scalpel 
and artery forceps were used to puncture the surface of the rumen 
through the original incision and a Foley catheter (size 22 Fr, Warne 
surgical products) was inserted. The 30 ml balloon was inflated using 
20 ml of warm water, thus anchoring the catheter in the rumen. Prior 
to insertion, a tightly fitting rubber washer, approximately 5 cm in 
diameter, was mounted onto each catheter. This was maintained against 
the animals skin preventing the catheter from falling into the rumen 
and also minimising leakage of ruminal fluid from around the insertion 
site.
Once inserted, catheters were immediately connected to the 
infusion system and approximately 30 ml of fluid was rapidly infused to 
ensure that the catheter was free of ruminal contents.
Procedure for changing pumphead tubing
The pumphead tubing associated with each pump was changed 
sequentially. For each infusion line the squeeze valve on the 
administration set was closed, effectively immobilizing the infusion 
fluid. A pair of artery clamps were attached to the marzinal tubing of 
the same line close to the connection at the pumphead. The pumphead 
connectors were lifted out of their supporting slots and a 
disconnection was made between one connector and the marzinal tubing. 
The ground 14 G hypodermic needle of the pumphead tubing unit was then 
unscrewed from the administration set connector permitting removal of 
the complete pumphead tubing unit. A new unit was attached to the 
administration set and the squeeze valve was partially opened to allow 
the unit to fill with fluid and thus prevent an air lock. Finally
reconnection was made to the marzinal tubing and the pumphead 
connectors were placed in their supporting slots, tensioning the new 
pumphead tubing across the rotor. The artery clamps were removed and 
the squeeze valve fully opened.
Procedure for preparing infusion packs
Infusion packs were prepared directly prior to requirement by 
replacing aliquots of 0.9% saline taken from one litre packs (Viaflex) 
with the same quantity of the drug to be infused, taken from a 
concentrated stock solution. Each pack was infused over four days.
The stock solution of levamisole hydrochloride was freshly 
prepared by dissolving 1.40 g levamisole hydrochloride in 100 ml of 
glass distilled water. The required infusion rates were 1.0, 1.5, 2.0 
and 3.0 mgAg/<3ay (35, 52, 70 and 105 mg/day for sheep of mean 
liveweight 35 kg). Thus infusion packs administered over four days 
required 0.14, 0.21, 0.28 and 0.42 g of levamisole and hence 10, 15, 20 
and 30 ml of the stock solution respectively. Packs were prepared 
simply by replacing either 10, 15, 20 or 30 ml of saline with the same 
quantity of stock solution using a sterile 30 ml syringe. The intended 
infusion rate was marked on each pack prior to its preparation and once 
injected levamisole and saline were mixed by inverting the pack several 
times. Any levamisole hydrochloride stock solution remaining after 
preparation of each batch of infusion packs was discarded.
Stock solutions of beta-agonists were supplied in sealed bottles 
with rubber caps. The concentration of the clenbuterol stock solution 
was 5 rag/15 ml and the three stock solutions of bitolterol were at 
concentrations of 4, 20 and 100 mg/15 ml. Three ml of the clenbuterol 
stock solution was required for a four day infusion at a rate of 1 
ml/day, and 15 ml of each bitolterol solution was required for infusion 
rates of 1, 5 and 25 mg/day respectively. There was evidence to 
suggest that the 100 mg/15 ml stock solution of bitolterol was
deteriorating at a rate of 5% per 4 weeks and in an attempt to retard)
this, the solution was stored at 4 ° c .  Prior to injection the 
solution was gently warmed to reverse floculation. The other stock 
solutions were stored at room temperature.
Greater care was required when preparing packs for intravenous 
rather than intraruminal infusion as complete asepsis within the 
infusion system was paramount. Beta-agonist stock solutions were 
injected in a similar way to levamisole stock solution but separate
syringes were maintained for each separate stock solution and also for 
the withdrawal of saline. Both the rubber caps of the stock solution 
bottles and the injection sites on the saline bags were sprayed with 
sterilising solution (1:500 Marinol blue : 70% alcohol with a few 
crystals of sodium nitrate). A bacterial filter (Millex-GSr Millipone) 
was also placed between the injection needle and syringe during the 
injection process. It was important to ensure that this filter was 
full of stock solution and that the syringe contained the required 
amount before injection commenced as some solution was always retained 
by the filter. Injected stock solution was thoroughly mixed by 
inversion of the infusion pack.
Procedure for exchange of infusion packs
Infusion packs were exchanged on every fourth day at the same time 
(11.00 h). Any residual fluid in existing packs was rapidly infused by 
lifting the connectors out of their supporting slots on the infusion 
pack side of the pumphead, effectively removing the influence of the 
pump on each infusion line and allowing gravity assisted flow of 
infusion fluid. As each existing infusion pack emptied, the squeeze 
valve on the associated administration set was closed and the connector 
was replaced in its slot at the pumphead. The empty infusion pack was 
taken down from it supporting nail, disconnected from the 
administration set and discarded. The reservoir and connector for the 
administration set were then inverted and inserted into the replacement 
infusion pack, its connecting tube being uppermost. Once connected, 
the infusion pack and reservoir were turned the right way up and the 
infusion pack was placed on its supporting nail. The inversion of the 
reservoir and replacement pack reduced the occurrence of air locks 
during the exchange procedure. Generally, when the squeeze valve on 
the administration set was opened, a drip formed immediately in the 
reservoir and no air locks were present.
Problems encountered during infusion studies
Immediate action
On discovery of any abnormal occurrence during infusion studies, 
the flow of fluid in the particular infusion line was temporarily 
terminated by closing the squeeze valve on the administration set until 
the problem could be resolved. In most cases it was also necessary to 
flush the catheter and establish its patency. Jugular vein catheters
were flushed with heparinized saline. A pair of artery forceps were 
applied to the catheter prior to and during its disconnection from the 
infusion tubing and reconnection to a sterile syringe of heparinized 
saline. The forceps were then removed to permit flushing. If the 
catheter was patent the forceps were reapplied and the syringe was 
removed and replaced with a stopper. Catheters flushed with 
heparinized saline were thus stored over short periods while any 
problems with the infusion system were resolved. If long term catheter 
storage was required, catheters were filled with 0.75 ml 5000 IU 
heparin. Artery forceps were always applied to a jugular catheter 
before disconnection from the infusion system or from a syringe, or 
before stopper removal as this prevented blood backflow into the 
catheter possibly resulting in occlusion. If, on flushing, a jugular 
vein catheter was found to be non-patent it was removed and surgically 
replaced.
Intraruminal catheters were flushed with warm water using a 60 ml 
syringe and fitted with a luer-lock connector from an administration 
set. The connector permitted a tight junction to be formed at the top 
of the catheter. If a catheter was found to be non-patent, the water 
was withdrawn from the balloon into a syringe, permitting removal from 
the sheep. The catheter was reinserted following thorough washing 
under running water to remove ruminal contents, the usual cause of the 
obstruction.
Problems with infusion tubing
Occasionally animals would chew through the marzinal tubing. The 
section of tubing below the chewed portion would rapidly empty of 
infusion fluid resulting in a back flow of blood or rumen contents into 
the catheter causing an obstruction. If this occurred the patency of 
the catheter was established by flushing, and patent catheters were 
temporarily 'stored' while a repair was effected. Small sections of 
chewed tubing were cut out using a sterile scalpel blade and the two 
cut ends were joined using a double ended connector (Watson-Marlow, 
delta S). If a large section of tubing was damaged, the whole of the 
marzinal tubing was renewed, commencing at the pumphead. Before 
connection to the catheter, it was essential to ensure that the whole 
of the marzinal tubing was filled with fluid and this was most readily 
achieved by temporarily releasing the infusion line from the influence 
of the peristaltic pump allowing gravity assisted fluid flow.
If a significant air-lock was detected in the marzinal tubing 
during intravenous infusion studies it was removed by disconnecting the 
catheter and instigating gravity assisted fluid flow.
During either of these procedures, the amount of fluid, and drug, 
lost from the system was estimated and the drug loss was rectified by 
injection of an additional quantity of stock solution into the infusion 
pack.
Problems with catheters
Very few problems were encountered with the intraruminal catheters 
or the indwelling jugular catheters made from Tygon microbore tubing. 
The major problem with PVC jugular catheters was fissuring during 
periods of cold weather. The fissure was located by flushing with 
heparinized saline. Artery forceps were applied immediately below the 
damaged portion and the top and damaged part of the catheter were 
removed using sterile scissors. The 14 G hypodermic needle was then 
inserted into the remaining part of the catheter and held in place with 
suture material. A second flushing with heparinized saline established 
the patency of the catheter and, if patent, it was reconnected to the 
infusion tubing.
If a PVC jugular catheter began to loop out of a calf's neck it 
was generally rapidly expelled from the jugular vein. Early detection 
permitted slight prolongation of the life of the catheter by 
immobilisation with an additional suture or bandaging and medical 
adhesive. If the outer sleeve of a PVC catheter was becoming detached 
from the main catheter body, it was rejoined using 'super glue' or 
tightly bound in place using suture material.
Teflon jugular catheters had no external portion and so artery 
forceps could not be applied if disconnection was required. If a 
Teflon catheter was observed to be lying subcutaneously it was removed 
immediately.
Each time a jugular catheter was replaced a slight thickening of 
the jugular vein wall was detected and thus there was a finite number 
of times that replacement could occur. For this reason PVC and Teflon 
catheters were superceded by the longer life Tygon catheter.
APPENDIX 2 
ADDITIONAL DATA FOR EXPERIMENT 1
2a. Individual calf apparent digestibility coefficients.
2b. Individual calf nitrogen balance data (g/day).
2c. Individual calf nitrogen balance data (% intake).
2d. Overall mean nitrogen balance data (% intake).
Table 2a. Individual digestibility coefficients for calves receiving 
infusions of physiological saline, 1 mg/d clenbuterol (clen) 
or 1, 5 and 25 mg/d bitolterol (Bi)
CALF 1 2 3 4 5 7 8 9 10 1 1
Period IA Saline Bil Bi5 Bi25 Clen Saline Bil Bi5 Bi25 Clen
DM 0.6310 0.6293 0.6109 0.6002 0.6328 0.5980 0.5912 0.6020 0.5968 0.5765
CP 0.5622 0.5677 0.5293 0.5349 0.5436 0.5297 0.5114 0.5430 0.5307 0.5036
CF 0.4530 0.4572 0.3956 0.3874 0.4365 0.3768 0.3570 0.3856 0.4151 0.3600
EE 0.8356 0.8598 0.8388 0.8193 0.8287 0.8328 0.8318 0.8337 0.8263 0.8306
Ash 0.3731 0.4159 0.3910 0.3441 0.3887 0.3341 0.3248 0.3601 0.3518 0.3105
NFE 0.7324 0.7187 0.7181 0.7104 0.7429 0.7111 0.7110 0.7076 0.6946 0.6882
CM 0.6594 0.6528 0.6351 0.6284 0.6596 0.6271 0.6206 0.6286 0.6238 0.6054
E 0.6406 0.6431 0.6174 0.5998 0.6440 0.6064 0.6659 0.6161 0.5967 0.5841
Period
DM
IB
0.6500 0.6099 0.5999 0.5899 0.5910 0.6498 0.6100 0.5997 0.5899 0.6002
CP 0.6123 0.5586 0.5476 0.5308 0.5239 0.5764 0.5493 0.5184 0.5170 0.5749
CF 0.4380 0.3978 0.3459 0.3046 0.3603 0.4209 0.3779 0.3555 0.3413 0.3299
EE 0.8640 0.8409 0.8491 0.8410 0.8481 0.8534 0.8287 0.8320 0.8507 0.8592
Ash 0.4005 0.3422 0.3840 0.3763 0.3105 0.4630 0.3831 0.4068 0.3148 0.3926
NFE 0.6856 0.7137 0.7051 0.7051 0.7203 0.7512 0.7154 0.7065 0.7085 0.7008
OM 0.6780 0.6399 0.6241 0.6139 0.6324 0.6707 0.6354 0.6214 0.6208 0.6234
E 0.6550 0.6240 0.6042 0.5506 0.6093 0.6575 0.5913 0.5987 0.6019 0.6093
Period IIA Clen Saline Bil Bi5 Bi25 Clen Sal Bil Bi5 Bi25
DM 0.6452 0.6455 0.6202 0.6191 0.6284 0.6160 0.6016 0.6812 0.6148 0.5962
CP 0.6107 0.5944 0.5734 0.5555 0.5739 0.5502 0.5453 0.6013 0.5529 0.5507
CF 0.4563 0.4717 0.4030 0.3930 0.3974 0.3945 0.3761 0.5429 0.3505 0.3025
EE 0.8599 0.8536 0.8807 0.8333 0.8533 0.8195 0.8140 0.7650 0.8296 0.8303
Ash 0.3786 0.3937 0.4333 0.3729 0.3873 0.4282 0.3848 0.4430 0.3943 0.4249
NFE 0.7369 0.7345 0.7056 0.7243 0.7311 0.7109 0.6998 0.7734 0.7283 0.7010
OM 0.6746 0.6732 0.6408 0.6463 0.6550 0.6367 0.6255 0.7074 0.6413 0.6150p 0.6484 Q.6593 0.6306 0.6217 0.6439 0.6214 Q, £0cn 0.6832 C.S246 0.6042
Period
DM
IIB
0.6317 0.6108 0.6416 0.6126 0.6960 0.6323 0.6114 0.6420 0.6440 0.6008
CP 0.6038 0.5942 0.6154 0.6039 0.6777 0.6246 0.6034 0.5914 0.5848 0.5947
CF 0 , 3 9 9 9 0.4131 0.3454 0.3658 0.5411 0.3781 0.3392 0.4387 0.4956 0.2257
EE 0.8953 0.8705 0.8591 0.8631 0.9077 0.8723 0.8712 0.7955 0.8592 0.8620
Ash 0.4119 0.3181 0.4527 0.4315 0.5006 0.4628 0.4756 0.4034 0.3693 0.4510
NFE 0.7166 0.6956 0.7410 0.6918 0.7638 0.7120 0.6894 0.7348 0.7330 0.7078
OM 0.6534 0.6397 0.6602 0.6305 0.7174 0.6490 0.6247 0.6656 0.6739 0.6156
E 0.6337 0.6255 0.6471 0.6020 0.7103 0.6373 0.6124 0.6427 0.6474 0.6027
Perion TTTa 6125 Clen Saline Bil Bi5 Bi25 Clen Saline Bil Bi5
DM 0.6598 0.6496 0.6289 0.6511 0.6116 0.6253 0.6446 0.6387 0.6153 0.6130
CF 0.6314- 0.6445 0.6307 0.6551 0.5260 0.6353 0.6503 0.6089 0.6144 0.6804
CF 0.4149 0.4007 0.3401 0.3806 0.3163 0.2828 0.3606 0.3669 0.2911 0.3521
EE 0.8782 0.8590 0.8452 0.8810 0.8648 0.8783 0.3874 0.8780 0.8922 0.8831
Ash 0.5044 0.5060 0.4968 0.5403 0.5601 0.5037 0.5317 0.4838 0.5315 0.4101
NFE 0.7430 0.7272 0.7135' 0.7260 0.6782 0.7182 0.7199 0.7281 0.6970 0.6981
CM 0.6752 0.6639 0.6420 0.6621 0.6168 0.6373 0.6558 0.6540 0.6237 0.6332
E 0.6576 0.6550 0.6209 0.6442 0.6081 0.6218 0.6401 0.6380 0.6101 0.6166
Table 2a, continued
Period IIIB 
EM 0.6563 0.6845 0.6603 0.6903 0.6352 0.6607 0.6468 0.6576 0.6463 0.6515
CP 0.6522 0.6609 0.6359 0.6935 0.6344 0.6644 0.6416 0.5972 0.6456 0.6233
CF 0.4200 0.4610 0.3828 0.4329 0.3483 0.3666 0.3518 0.4252 0.3515 0.3445
EE 0.8805 0.8762 0.8339 0.8734 0.8396 0.8747 0.8584 0.8446 0.8500 0.8663
Ash 0.5166 0.5605 0.5697 0.6087 0.5312 0.5676 0.5322 0.4749 0.4831 0.5907
NFE 0.7271 0.7561 0.7424 0.7589 0.7142 0.7387 0.7305 0.7491 0.7363 0.7353
CM 0.6698 0..6965 • 0.6690 0.6982 0.6452 0.6697 0.6579 0.6752 0.6622 0.6574
E 0.6550 0.6848 0.6552 0.6897 0.6432 0.6610 0.6508 0.6597 0.6461 0.6532
Period IVA Bi5 Bi25 Clen Saline Bil Bi5 Bi25 Clen Saline Bil
DM 0.6593 0.6234 0.5948 0.6049 0.6238 0.6487 0.6115 0.5963 0.6410 0.6409
CP 0.6575 0.5942 0.5799 0.5660 0.6232 0.6393 0.6039 0.6171 0.6295 0.6478
CF 0.4165 0.3364 0.2459 0.3060 0.2690 0.3497 0.2804 0.2284 0.3430 0.3341
EE 0.8658 0.8562 0.8465 0.8317 0.8612 0.8678 0.8554 0.8607 0.8552 0.8370
Ash 0.5130 0.4380 0.4887 0.4635 0.5446 0.5496 0.5226 0.5180 0.5171 0.5169
NFE 0.7317 0.9058 0.6894 0.6987 0.7136 0.7300 0.6976 0.6782 0.7252 0.7257
CM 0.6731 0.6410 0.6048 0.6182 0.6313 0.6581 0.6199 0.6035 0.6527 0.6526
E 0.6597 0.6281 0.6035 0.6031 0.6285 0.6531 0.6126 0.5960 0.6409 0.6434
Period
DM
IVB
0.6317 0.6055 0.5794 0.6105 0.6004 0.6123 0.6138 0.5823 0.6290 0.5507
CP 0.6329 0.5817 0.5762 0.5715 0.6098 0.5805 0.5953 0.5602 0.6275 0.5633
CF 0.3152 0.2779 0.2380 0.3372 0.2710 0.3742 0.2785 0.2306 0.2967 0.1344
EE 0.8965 0.8847 0.8310 0.8414 0.8674 0.8311 0.8524 0.8546 0.8654 0.8490
Ash 0.4607 0.4197 0.4143 0.4557 0.4682 0.4497 0.4771 0.4667 0.5275 0.4127
NFE 0.7185 0.7020 0.6736 0.6955 0.6829 0.7008 0.7066 0.6781 0.7119 0.6531
CM 0.6475 0.6228 0.5947 0.6248 0.6127 0.6318 0.6264 0.5936 0.6384 0.5635
E 0.6356 0.6118 0.5815 0.6032 0.6033 0.6077 0.6144 0.5863 0.6294 0.5466
Period VA Bil Bi5 Bi25 Clen Saline Bil Bi5 Bi25 Clen Saline
DM • 0.6578 0.6579 0.5974 0.6395 0.6229 0.6607 0.6022 0.6148 0.6164 0.6066
CP 0.6282 0.6066 0.5796 0.6195 0.6107 0.6485 0.5538 0.5555 0.6007 0.5818
CF 0.4218 0.4017 0.2900 0.3798 0.3027 0.3741 0.2842 0.3645 0.3119 0.2935
EE 0.8811 0.8671 0.8616 0.8465 0.8742 0.8875 0.8535 0.8276 0.8828 0.8769
Ash 0.5144 0.5749 0.5211 0.5206 0.5469 0.5600 0.4834 0.4379 0.5251 0.5561
NFE 0.7403 0.7415 0.6825 0.7232 0.7111 0.7430 0.7057 0.7144 0.7010 0.6900
CM 0.6736 0.6670 0.6058 0.6526 0.6313 0.6719 0.6153 0.6361 0.6266 0.6121
E 0.6563 0.6527 0.5949 0.6284 0.6178 0.6580 0.6002 0.6072 0.6125 0.6055
Period V B  
O M 0 . 6 3 2 9 0 . 6 4 2 6 Q . 5 9 3 7 0 . 6 1 0 3 0 . 5 9 8 5 q ^c k 2 c n  c o i  c n  cf\c\c\J • u o u u n c\
CP 0 . 5 7 9 7 0 . 5 3 4 2 0 . 5 4 0 0 0 . 5 3 6 7 0 . 5 3 8 1 0 . 4 9 9 3 0 . 5 8 2 7 0 . 6 5 5 2 0 . 5 3 7 1 0 . 5 5 9 4
C F 0 . 3 9 6 9 0 . 4 1 8 < t 0 . 3 3 7 2 U.37G5 0.3567 0.2857 0.4397 0.3549 0.3179 0.37RQ
E E 0 . 8 6 6 1 0 . 8 6 9 0 0 . 8 2 8 8 0 . 8 5 2 1 0 . 8 3 7 7 0 . 7 8 6 3 0 . 8 5 0 0 0 . 8 7 7 4 0 . 8 1 4 9 0 . 8 4 1 9
Ash 0 . 4 3 7 7 0 . 4 6 5 7 0 . 4 7 3 1 0 . 4 3 9 2 0 . 4 5 1 8 0 . 3 9 9 4 0 . 4 9 3 2 0 . 4 5 3 6 0 . 4 3 9 1 0 . 4 9 3 4 -
N F E 0 . 7 2 9 5 0 . 7 4 5 4 0 . 6 8 2 5 0 . 7 0 7 7 0 . 6 8 9 0 0 . 6 6 9 6 0 . 7 4 2 4 0 . 7 0 1 5 0 . 7 0 5 6 0 . 7 0 7 2
OM 0 . 6 5 5 3 0 . 6 6 2 9 0 . 6 0 7 6 0 . 6 3 0 0 0 . 6 1 5 4 0 . 5 8 2 8 0 . 6 7 0 9 0 . 6 3 9 8 0 . 6 1 9 3 0 . 6 3 4 1
E 0 . 6 3 8 4 0 . 6 4 6 0 0 . 5 9 7 2 0 . 6 1 0 5 0 . 6 0 0 5 0 . 5 6 4 1 0 . 6 5 6 9 0 . 6 2 8 2 0 . 6 0 5 4 0 . 6 2 4 7
Table 2b. Individual nitrogen balance data (g/day) for calves 
receiving infusions of physiological saline, 1 mg/d
clenbuterol (clen) or 1,
CALF No. 
N (g/d)
1 2 3 4
PERIOD 1A Saline Bil Bi5 B125
Food 68.24 68.24 68.24 68.24
Faeces 29.87 29.87 32.11 31.92
Urine 18.52 14.99 16.53 11.64
Balance 19.85 23.38 19.60 24.68
PERIOD IB
Food 68.24 68.24 68.34 68.24
Faeces 26.83 30.55 31.30 32.46
Urine 20.58 19.67 14.69 11.34
Balance 20.83 18.02 22.25 24.44
PERIOD IIA Clen Saline Bil Bi5
Food 66.49 66.49 66.49 66.49
Faeces 23.71 26.97 28.36 29.55
Urine 22.62 26.07 17.66 14.93
Balance 20.16 13.45 20.47 22.01
PERIOD I IB
Food 66.15 66.15 66.15 66.15
Faeces 26.21 26.85 25.44 26.21
Urine 17.90 18.09 19.15 19.19
Balance 22.04 2 1 . 2 1 21.56 20.75
PERIOD IIIA Bi25 Clen Saline Bil
Food 89.15 89.15 89.15 89.15
Faeces 32.86 31.69 31.39 30.75
Urine 29.12 29.92 23.10 23.81
Balance 27.17 27.54 34.66 34.59
PERIOD IIIB
Food 89.39 89.39 89.39 89.39
Faeces 31.09 30.31 32.55 27.39
Urine 32.83 30.28 21.40 23.07
Balance 25.47 28.80 35.44 38.93
PERIOD IVA Bi5 Bi25 Clen Saline
Food 98.48 98.48 98.48 98.48
Faeces 33.73 39.96 41.36 42.72
Urine 34.77 24.48 17.92 29.02
Balance 29.98 34.04 39.19 26.74
PERIOD IVB
Food 100.13 95.85 1 0 0 . 0 2 100.13
Faeces 36.75 40.10 42.39 42.91
Urine 27.54 22.16 19.59 33.80
Balance 35.84 33.60 38.04 23.42
PERIOD VA Bil Bi5 Bi25 Clen
Food 95.84 95.84 95.84 95.84
Faeces 35.63 37.70 40.29 36.46
Urine 29.84 23.71 25.04 22.52
Balance 30.37 34.43 30.51 36.86
PERIOD VB
Food 94.28 94.28 94.28 94.28
Faeces 39.62 43.91 43.37 43.68
Urine 23.66 20.67 19.23 18.85
Balance 31.00 29.70 31.68 31.75
and 25 mg/d bitolterol (Bi)
5 7 8 9 10 11
Clen Saline Bil Bi5 Bi25 Clen
68.24 68.24 68.24 68.24 68.24 68.24
31.14 32.08 33.34 31.19 32.03 33.87
15.58 18.71 14.71 18.45 16.46 12.48
21.52 17.45 20.19 18.60 19.75 21.89
68.24 68.24 68.24 68.24 68.24 68.24
32.94 29.31 31.19 33.33 33.43 29.41
14.75 21.67 15.62 16.77 17.68 16.81
20.55 17.26 21.43 18.14 17.13 2 2 . 0 2
B125 Clen Saline Bil Bi5 Bi25
66.49 66.49 66.49 66.49 61.75 66.49
28.33 29.90 20.23 26.51 27.61 29.87
14.53 17.53 19.81 18.95 22.62 19.97
23.63 19.06 16.45 21.03 11.53 16.65
56.33 66.15 66.15 66.15 62.44 66.15
18.16 24.83 26.23 27.03 25.93 26.81
19.18 18.99 17.95 16.87 20.65 18.96
18.99 22.33 21.97 22.25 15.86 20.38
Bi5 Bi25 Clen Saline Bil Bi5
80.71 89.15 89.15 89.15 86.96 89.15
30.19 32.42 30.29 34.87 33.53 32.95
15.90 23.92 17.68 24.93 23.63 26.30
34.62 32.81 41.18 29.35 29.80 29.90
87.82 89.39 89.39 89.39 88.84 89.39
32.10 30.00 32.04 36.01 31.48 33.68
22.76 21.43 15.94 19.45 23.78 21.70
32.96 37.96 41.41 33.93 33.58 34.01
Bil Bi5 Bi25 Clen Saline Bil
98.48 98.48 98.48 98.48 97.57 98.48
37.10 35.52 39.01 38.34 36.15 34.69
26.89 18.88 18.66 15.55 26.75 28.96
34.49 44.08 40.81 44.59 34.67 34.83
100.13 92.63 100.13 100.13 96.40 100.04
39.07 38.86 40.52 42.27 36.97 43.69
26.04 24.54 22.04 20.46 29.62 23.18
35.02 29.23 37.57 37.40 29.81 33.17
Saline Bil Bi5 Bi25 Clen Saline
95.84 80.31 95.84 81.25 83.45 95.84
37.31 28.10 42.76 36.11 33.32 40.03
29.76 27.38 24.46 17.20 17.52 37.92
28.77 24.83 28.62 27.94 32.61 23.84
91.50 93.99 94.28 87.18 89.31 90.36
42.26 47.06 39.34 30.06 41.34 39.81
29.66 29.03 22.90 22.34 17.89 26.89
19.58 17.90 32.04 34.78 30.08 23.66
Table 2c. Individual nitrogen balance data ( % intake) for calves 
receiving infusions of physiological saline, 1 mg/d 
clenbuterol (clen) or 1, 5 and. 25 mg/d bitolterol (Bi)
Calf No. 1 . 2 3 4 5 7 8 9 1 0 1 1
PERIOD 1A Saline Bil Bi5 B125 Clen Saline Bil B15 B125 Clen
Feed N g/d 68.24 68.24 68.24 68.24 68.24 68.24 68.24 68.24 68.24 68.24
N% Faeces 43.77 43.77 47.05 46.78 45.63 47.01 48.86 45.71 46.94 49.63
N% Urine 27.14 29.97 24.22 17.06 22.70 27.42 21.56 27.04 24.12 18.29
in Retained 29.09 34.26 28.72 36.17 31.54 25.57 29.59 27.26 28.94 32.08
PERIOD IB
Feed N g/d 68.24 68.24 68.24 68.24 68.24 68.24 68.24 68.24 68.24 68.24
Nt Feed 39.32 44.77 45.87 47.57 48.27 42.95 45.71 48.84 48.99 43.10
Nt Urine 30.16 28.82 21.52 16.62 21.61 31.76 22.89 24.57 25.91 24.63
Nt Retained 30.52 26.41 32.60 35.81 30.11 25.29 31.40 26.58 25.10 32.27
PERIOD IIA Clen Saline Bil B15 B125 Clen Saline Bil B15 Bi25
Feed N g/d 66.49 66.49 66.49 66.49 66.49 66.49 66.49 66.49 61.57 66.49
Nt Feed 35.66 40.56 42.65 44.44 42.61 44.97 45.46 39.87 44.71 44.92
N% Urine 34.02 39.21 26.56 22.45 21.85 26.36 29.79 28.50 36.63 30.03
N% Retained 30.32 20.23 30.97 33.10 35.54 28.67 24.74 31.63 18.67 25.04
PERIOD I IB
Feed N g/d 66.15 66.15 66.15 66.15 56.33 66.15 66.15 66.15 62.44 66.15
Nt Feed 39.62 40.59 38.46 39.62 32.24 37.54 39.65 40.86 41.53 40.53
Nt Urine 27.06 27.35 28.95 29.01 34.05 28.71 27.13 25.50 33.07 28.66
Nt Retained 33.32 32.06 32.59 31.37 33.71 33.76 33.21 33.64 25.40 30.81
PERIOD IIIA B125 Clen Saline Bil Bi5 Bi25 Clen Saline Bil Bi5
Feed N g/d 89.15 89.15 89.15 89.15 80.71 89.15 89.15 89.15 86.96 89.15
Nt Feed 36.86 35.55 35.21 34.49 37.41 36.37 33.98 39.11 38.56 36.96
Nt Urine 32.66 33.56 25.91 26.71 19.70 26.83 19.83 27.96 27.17 29.50
Nt Retained 30.48 30.89 38.89 38.80 42.89 36.80 46.19 32.92 34.27 33.54
PERIOD IIIB
Feed N g/d 89.39 89.39 89.39 89.39 87.82 89.39 89.39 89.39 88.84 89.39
Nt Feed 34.78 33.91 36.41 30.64 36.55 33.56 35.84 40.28 35.43 37.68
Nt Urine 36.73 33.87 23.94 25.81 25.92 23.97 17.83 21.76 26.77 24.28
Nt Retained 28.49 32.22 39.65 43.55 37.53 42.47 46.32 37.96 37.80 38.05
PERIOD IVA Bi5 B125 Clen Saline Bil Bi5 Bi25 Clen Saline Bil
Feed N g/d 98.48 98.48 98.48 98.48 98.48 98.49 98.48 98.48 97.57 98.48
Nt Feed 34.25 40.58 42.00 43.38 37.67 36.07 39.61 38.93 37.05 35.22
Nt Urine 35.31 24.86 18.20 29.47 27.30 19.17 18.95 15.79 27.42 29.41
Nt Retained 30.44 34.56 39.79 27.15 35.02 44.76 41.44 45.28 35.53 35.37
PERIOD IVB
Peed N g/d 100.13 95.85 1 0 0 . 0 2 100.13 .100.13 92.63 100.13 100.13 96.40 100.04
Nt Feed 36.70 41.84 42.39 42.88 39.02 41.95 40.47 42.21 38.35 43.67
Nt Urine 27.50 23.11 19.57 33.76 26.01 26.49 2 2 . 0 1 20.43 30.73 23.17
Nt Retained 35.80 35.05 38.04 23.39 34.97 31.56 37.52 37.36 30.92 33.16
PERIOD VA Bil Bi5 Bi25 Clen Saline Bil Bi5 Bi25 Clen Saline
Feed N g/d 95.84 95.84 95.84 95.84 95.84 80.31 95.84 81.25 83.45 95.84
Nt Feed 37.18 39.34 42.04 38.04 38.93 34.99 44.62 44.44 39.93 41.82
Nt Urine 31.13 24.74 26.13 23.50 31.05 34.09 25.52 21.17 20.99 33.31
Nt Retained 31.69 35.92 31.83 38.46 30.02 30.92 29.86 34.39 39.08 24.87
PERIOD VB
Peed N g/d 94.28 94.28 94.28 94.28 91.50 93.99 94.28 87.18 89.31 90.36
Nt Feed 42.03 46.57 46.00 46.33 46.19 50.07 41.73 34.48 46.29 44.06
Nt Urine 25.09 21.93 20.40 19.99 32.41 30.89 24.29 25.63 20.03 29.76
Nt Retained 32.88 31.50 33.60 33.68 21.40 19.04 33.98 39.89 33.68 26.18
Table 2d. Mean nitrogen balance data (% intake) for 
days 7-21 inclusive for calves receiving 
infusions of physiological saline, 1 mg/d 
clenbuterol or 1, 5 and 25 mg/d bitolterol
Period I and II Faeces Urine Retention
Saline (A) 42.42 29.08 27.58
Bitolterol 1 (B) 43.12 27.34 31.28
Bitolterol 5 (C) 44.03 25.86 27.62
Bitolterol 25 (D) 43.93 25.61 31.41
Clenbuterol 1 (E) 43.05 25.24 31.50
SE Mean 0.68 2.25 1.00
Significance NS NS NS
between treatments
Period III to V
Saline (A) 40.28 28.96 30.75
Bitolterol 1 (B) 38.34 27.77 33.88
Bitolterol 5 (C) 39.24 25.42 35.55
Bitolterol 25 (D) 39.22 25.22 35.56
Clenbuterol 1 (E) 39.63 21.97 38.39
SE Mean 0.88 1.39 1.69
Significance NS BE* NS
between treatments AE**
All periods
Saline (A) 41.13 29.38 29.49
Bitolterol 1 (B) 40.26 26.90 32.84
Bitolterol 5 (C) 41.37 26.14 32.49
Bitolterol 25 (D) 41.10 25.05 33.90
Clenbuterol 1 (E) 41.00 23.36 35.64
SE Mean 0.56 1.01 1.21
Significance NS AC,BE* AD*
between treatments AD** AE***
AE***
Significance * P<0.05, ** P<0.01, *** P<0.001
APPENDIX 3 
ADDITIONAL DATA FOR EXPERIMENT H a
3a. Individual calf apparent digestibility coefficients.
3b. Individual calf nitrogen balance data (g/day).
3c. Individual calf nitrogen balance data (% intake).
3d. Mean nitrogen balance data (% intake).
3e. Mean faecal egg counts (epg).
3f. Individual calf worm burdens at necropsy.
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Table 3d. Mean nitrogen balance (% intake +SE) for calves
infected with Ostertagia ostertagi, infected after 
prior administration of a MSRB or maintained as 
clean controls
Days 14-21 
Faeces 
Urine 
Retention
Clean 
n=4 
38.33 ±1.38
39.91 ±2.26 
21.76 ±2.82
MSRB 
n=4
39.85 ±1.16 
37.78 ±2.06 
22.37 ±1.31
Infected 
n=4 
39.71 +1.93 
35.30 ±1.67 
24.99 ±2.41
Days 35-42 
Faeces 
Urine 
Retention
n=4 
40.65 ±1.51
34.49 ±3.62 
24.86 ±3.24
n=4 
41.45 ±1.06
38.49 ±1.55 
20.07 ±1.82
n=4 
40.59 ±1.66
40.85 ±2.80 
18.56 ±4.05
Days 56-63 
Faeces 
Urine 
Retention
n=4 
37.75 ±1.28 
40.22 ±1.99 
22.04 ±2.09
n=4 
38.53 ±1.14 
37.16 ±1.11 
24.31 ±1.96
n=4
35.91 ±0.93 
38.68 ±2.08 
25.41 ±1.93
Days 77-84 n=3 n=4 n=4
Faeces 41.25 ±2.91 36.19 ±1.21 37.45 ±0.23
Urine 36.36 ±1.39 35.68 ±2.20 38.99 ±1.81
Retention 22.39 ±2.95 28.13 ±2.32 23.57 ±1.79
Missing data during days 77-84 is due to one 
calf suffering from bloat.
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APPENDIX 4 
ADDITIONAL DATA FOR EXPERIMENT lie
4a. Individual calf apparent digestibility coefficients.
4b. Individual calf nitrogen balance data (g/day).
4c. Individual calf nitrogen balance data (% intake).
4d. Mean nitrogen balance data (% intake).
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Table 4d. Mean nitrogen balance (% intake +SE) for calves
infected with cold-conditioned Ostertagia ostertagi 
larvae, infected after prior administration of a 
MSRB or maintained as a clean control
Days 14-21 
Faeces 
Urine 
Retention
Clean
40.29 +0.49
36.19 +3.37
23.53 +3.25
MSRB
40.24 +1.74
39.58 +2.68
20.18 +3.95
Infected
39.47 +1.89 
37.40 +1.21
23.13 +2.51
Days 35-42 
Faeces 
Urine 
Retention
39.09 +0.97
42.20 +0.65
18.71 +1.56
36.99 +1.89
40.89 +2.47
22.13 +4.28
38.59 +0.49 
40.56 +4.11 
20.86 +4.20
Days 56-63 
Faeces 
Urine 
Retention
39.00 +1.25
38.27 +1.57 
22.74 +1.14
36.23 +0.73
35.64 +1.23
28.13 +0.87
37.89 +0.86
37.16 +0.92 
24.95 +1.71
Days 77-84 
Faeces 
Urine 
Retention
35.12 +2.26
41.24 +0.19
23.64 +2.78
37.20 +1.44
40.65 +2.77
22.15 +4.00
36.61 +0.84
37.29 +0.82
26.10 +0.91
Overall
Faeces
Urine
Retention
38.38 +0.80
39.47 +1.06
22.15 +1.17
37.66 +0.79
39.19 +1.19
23.15 +1.77
38.14 +0.58
38.10 +1.06
23.76 +1.34
Significance ab PC0.05
APPENDIX 5 
ADDITIONAL DMA FOR EXPERIMENT I M
5a. Individual calf plasma pepsinogen values (I.U.).
5b. Individual calf apparent digestibility coefficients. 
5c. Individual calf nitrogen balance data (g/day).
5d. Individual calf nitrogen balance data (% intake).
5e. Mean nitrogen balance data (% intake).
5f. Individual calf faecal egg output (epg).
5g. Individual calf worm burdens at necropsy.
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Table 5e. Mean nitrogen balance (% intake +SE) for calves
concurrently infected with Ostertagia ostertaai and 
Cooperia oncophora, infected after administration of 
a MSRB or maintained as clean controls
Days 14-21 
Faeces 
Urine 
Retention
Clean 
n=4
39.72 +1.11
31.76 ±0.68
28.53 ±1.59
MSRB 
n=4 
36.55 ±0.77 
30.02 ±1.95 
33.44 ±2.53
Infected 
n=4
39.18 ±1.22
30.73 ±1.21
30.10 ±0.77
Days 35-42 
Faeces 
Urine 
Retention
n=4 
37.42 ±1.25b
40.77 ±1.25 
21.82 ±1.28a
n=4
36.54 ±1.03B 
38.46 ±2.44
25.00 ±3.21A
n=3
50.25 ±3.19A 
47.52 ±4.78
2.23 ±7.97b
Days 56-63 n=4 n=4 n=3
Faeces 37.60 ±1.47b 38.37 ±1.13b 47.20 ±1.81A
Urine 39.32 ±2.04 34.98 ±1.53 43.47 ±5.65
Retention 23.08 ±1.05A 26.65 +1.13A 9.33 ±4.83b
Days 77-84 
Faeces 
Urine 
Retention
n=4
38.26 ±1.69
24.39 ±1.24 
37.34 £L.79
n=4
39.16 ±0.76
29.11 ±1.81
31.73 ±1.56
n=4
42.11 ±1.19
27.28 ±4.50
30.59 ±5.16
Overall n=16 n=16 n=14
Faeces 38.25 ±0.67A 37.65 ±0.51A 44.11 ±1.43B
Urine 34.06 ±1.80 33.14 ±1.32 36.07 ±2.94
Retention 27.69 ±1.71a 29.20 ±1.33a 19.82 ±4.05b
Significance ab P<0.05, Ab aB P<0.01f AB PC0.001
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APPHTOIX 6 
ADDITIONAL DATA FOR EXPERIMENT III
6a. Individual sheep digestibility data, days 0-7.
6b. Individual sheep digestibility data, days 7-14.
6c. Individual sheep digestibility data, days 14-21.
6d. Individual sheep digestibility data, days 21-28.
6e. Mean digestibility data for each collection period. 
6f. Individual sheep nitrogen balance data (g/day).
6g. Individual sheep nitrogen balance data (% intake). 
6h. Mean nitrogen balance data (% intake).
6i. Individual sheep worm burdens at necropsy.
6j. Individual sheep abomasa 1 pH at necropsy.
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Table 6j. The pH of the abomasal contents of lambs at 
necropsy following infection with Ostertagia 
circumcincta and treatment with graded doses
of levamisole
Treatment Sheep Abomasal Lesion
pH Score
Infected B13 5.90 +
Control B5 4.40 0
B4 4.80 +
205 4.59 +
198 5.73 +
285 4.65 +
MEAN 5.01
±SE t0.26
Levamisole B3 3.80 0
1.0 mgAg/day B16 6.47 +
266 4.30 +
204 4.28 +
202 4.09 +
291 4.51 1
MEAN 4.58
±SE ±0.39
Levamisole B6 3.50 0
1.5 mgAg/day B14 4.60 0
257 5.20 0
276 4.24 1
243 3.35 +
269 6.58 +
MEAN 4.58
±SE ±0.49
Levamisole B7 5.10 0
2.0 mgAg/day B10 4.80 0
Bll 3.90 +
295 5.30 +
219 5.98 +
212 4.26 +
MEAN 4.89
±SE ±0.30
Levamisole 185 5.30 +
3.0 mgAg/<3ay 244 5.53 0
251 5.09 +
270 6.09 0
271 5.94 0
317 5.27 1
MEAN 5.54
±SE ±0.16
Lesion Score: 0,+,l, indicates no, occasional, or few lesions 
Treatment means are not significantly different.
Table 6i. Worn burdens at necropsy for lambs infected with 
Ostertagia circumcincta and given graded doses of 
levamisole
Treatment Sheep Sex L4 L5 Adult Total
Infected 205 F 650 6100 27600 34350
control 198 F 3400 5600 24000 33000
285 F 150 7150 19900 27200
B13 M 1600 6000 19600 27200
B5 M 4550 3800 14950 23300
B4 M 250 13350 28900 42500
MEAN 1767 7000 22492 31258
SE ±744 ±1346 ±2171 ±2800
Levamisole 204 F 4600 3500 14000 22100
1.0 mgAg/<3ay 202 F 4400 800 11250 16450
291 F 8350 8950 10050 27350
B3 M 50 11800 36000 47850
B16 M 250 12500 16950 29700
266 M 150 11350 28100 39600
MEAN 2967 8150 19392 30508
SE ±1385 ±1990 ±4244 ±4699
Levamisole 276 F 550 4550 9800 14900
1.5 mgAg/day 243 F 500 4900 4350 9750
269 F 4700 3300 26300 34300
B6 M 400 2700 5100 8200
B14 M 150 5100 15350 20600
257 M 200 6350 16650 23200
MEAN 1083 4483 12925 18492
SE ±726 ±536 ±3382 ±3965
Levamisole 295 F 850 1850 1500 4200
2.0 mgAg/day 219 F 50 550 2900 3500
212 F 0 1000 2450 3450
B7 M 1000 9500 22800 33300
B10 M 4000 3300 16100 23400
Bll M 0 3850 8600 12450
MEAN 983 3342 9058 13383
SE ±630 ±1338 ±3547 ±5094
Levamisole 185 F 600 100 300 1000
3.0 mgAg/day 244 F 5900 1750 16350 24000
251 F 1350 1000 750 3100
270 F 300 0 2800 3100
271 F 1150 2050 5150 8350
317 F 1000 200 2100 3300
MEAN 1717 850 4575 7142
SE ±851 ±364 ±2457 +3516
Female lambs were slaughtered on day 24, and male 
lambs were slaughtered on day 28 after the initial 
infection.
